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Summary
Background:
Osteoarthritis (OA) is a chronic, degenerative disease that mainly affects weight bearing 
joints and is the most common disease of the musculoskeletal system (Naredo et al,
2005). It is estimated to affect It is thought that as many as 10% of people over the age of 
65 in the US suffer with the disease (Felson, 1982) leading to an economical cost of 
around $86 billion (Abell 2005). Therefore the best ways to manage the condition are 
important to keep the physical functioning of the individual sufferer high and the cost to 
the economy low.
Aims:
The aim o f this MPhil thesis is to explore and present the current research surrounding 
the use o f exercise therapy and Interferential Therapy (IFT) in the use of Osteo-arthritis 
(OA) o f the knee. The thesis also aims to test whether the combination of the two 
treatment methods is more effective than either treatment used in isolation.
Methods:
The current research on the use of IFT and exercise therapy will be presented as a review 
o f the defined area. The clinical assessment of the treatment modalities will be tested in a 
pilot study that is presented as a single-blind randomised controlled trial.
Results:
The review chapter of the study reports that there is a perceived benefit o f exercise 
therapy and IFT in the treatment of OA knee. However, the types of exercise and 
frequency needed have yet to be clarified. The use of IFT in the treatment of OA knee has 
yet to be researched in any great depth, although previous studies do suggest that it may 
have a beneficial effect even though the optimum settings have yet to be clarified.
In the study presented it was found that exercise therapy produced the best results when 
compared with IFT in isolation. However, the combination of IFT and exercise therapy 
did also produce significant improvements.
Conclusion:
The thesis highlights the need for further research into the areas of IFT and exercise 
therapy as treatments for knee OA. The lack of uniformity in both areas of research 
makes comparison of treatment methods difficult, and as a result it is difficult to draw 
any definite conclusions, although exercise therapy does appear to be successful in the 
treatment of knee OA. The pilot study as part of the thesis demonstrates that the 
methodology used is a robust and innovative way o f assessing the effect o f IFT and 
exercise therapy in the clinical environment, and could be used as part o f a larger scale 
multi-centre trial. The results o f the study chapter appeared to demonstrate that the 
combination o f treatments outlined above was the most effective in the treatment of knee 
OA. Further studies are needed to assess whether any further improvements of the 
combination treatments are cost-effective.
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1.0 Thesis Introduction
1.1 Introduction
Osteoarthritis (OA) is a chronic, degenerative disease that mainly affects weight bearing 
joints and is the most common disease of the musculoskeletal system (Naredo et al, 2005). 
It has been defined by the American College of Rheumatology (ACR) to be “a 
heterogeneous group of conditions that lead to joint signs and symptoms, which are 
associated with defective integrity of articular cartilage.”(Sarzi-Puttini 2005). Several 
authors have previously highlighted the common view that OA most commonly affects the 
joints of the lower limb, in particular the hip and the knee, with the knee being the most 
commonly affected (Felson 1987; Mcalindon 1992; Sisto 2006). Furthermore, Peat et al. 
(2001) stated that OA affecting the knee is the most common form of arthritis and a major 
contributor to functional impairment and reduced independence in older adults.
1.2 Rationale
An estimated 7-11% of the populations of developed countries have symptomatic OA, and 
around 27-44% of that figure, have been diagnosed with radiographic disease (Naredo 
2005). In particular, Rat et al.(2004) reported that the annual incidence of radiographically 
diagnosed OA in the UK is expected to be around 3.1%, compared to the annual European 
incidence of knee replacement surgery being 0.5-0.7 per 1000 (Dieppe 1999). In the US in 
2001, an estimated 70 million Americans reported having arthritis or chronic joint 
symptoms, with an expected 59.4 million expected to suffer from OA alone by 2020, and in 
1997 arthritis cost the US an estimated $86 billion (Abell et al, 2005). Globally, the disease 
is expected to become the fourth most important cause of disability amongst women, and 
the eighth most important among men (Murray 1997).
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Due to the nature of the disease, the prevalence increases with age, and with the average 
age of the population also set to rise (by 2040, the number of people over 65 in the US will 
account for almost 25% of the population (Hamerman 1995)), the incidence of OA is likely 
to increase. With the number o f people living with OA of the knee increasing, combined 
with increasing health costs, it is important to find the most appropriate and cost effective 
way to manage the condition if society is to maintain a healthy population.
1.3 Aims and Objectives
The aim of the presented thesis is to describe the evaluation of currently used treatment 
techniques in OA of the knee. The current chapter aims to describe pathological changes 
that occur in a joint affected by OA with a further description of the pain mechanisms 
related to the stage of the disease. The thesis then aims to present possible methods of 
treatment of OA of the knee with review of the current literature on the described treatment 
techniques. The evaluation of the chosen treatment will then be presented with a 
randomised single blind controlled pilot study with conclusion of the overall process.
1.4 Pathogenesis of OA of the Knee
1.4.1 Causal Factors
Traditionally, OA has been thought to be due to natural ‘wear and tear’ of the joints. 
However, recent research suggests that this view may be too limited (Andriacchi 2004). 
More current thoughts suggest that the disease is a result of multiple causes including local 
and systemic mechanisms, with various mechanical, biochemical and genetic factors 
contributing to pathologic changes around the joint (Sarzi-Puttini 2005; Goldring 2007; 
Rubin 2008; Underwood 2009).
The following theories are postulated to be possible contributing factors towards 
osteoarthritis:
1. Increased load through the joint: Abnormal load through the joint has been 
attributed as the main cause of joint incongruity. When the load is excessive, 
chondrocyte death is thought to lead to articular cartilage damage (Rubin 2008).
2. Stiffness of subchondral bone: If subchondral bone has an increased stiffness, 
the articular cartilage of a joint is forced to cope with an increased load due to the 
subchondral bones inability to dissipate force (Rubin 2008).
3. Biochemical abnormalities: Reduced proteoglycan content leads to water 
binding increasingly to collagen in the joint. This increases swelling of fibrillated 
cartilage. More enzymes have been found in osteoarthritic cartilage than in normal 
cartilage. Collagenase is found in increased quantity along with Acid cathepsin, 
which attacks the essential constituent collagen and the protein cores of the matrix 
macromolecules (Rubin 2008).
4. Genetics: Studies of identical twins have shown an increased genetic disposition 
towards osteoarthritis. It is thought to be due to a mutation in the gene for type II 
collagen (Rubin 2008).
1.4.2 Structural Consequences
As outlined previously, the disease processes cause structural changes that specifically 
affect the articular cartilage, subchondral bone and synovial membranes, whereby the 
cartilage can become degraded, the bone hypertrophied and thickened whilst the synovial 
membranes become inflamed (Pelletier et al., 1998 in Groer, 2001).
This process can be broken into three stages:
• Stage I details the breakdown of the cartilage matrix.
Initially, loss of proteoglycans in the surface articular cartilage and death of chondrocytes 
(chondrocytes are the only cells found in cartilage) can be detected. As a result, any viable 
chondrocytes enlarge and aggregate into groups. The disease process can remain at this
stage for many years before further progression leads to breakdown (fibrillation) of the 
normally smooth surface cartilage (Rubin 2008; Underwood 2009).
• Stage II involves the erosion of the cartilage surface with breakdown products being 
released into the synovial fluid of the joint.
The fibrillation continues, leading to synovial fluid penetrating the cracks in the cartilage, 
almost like a weathering process. This process leads to the cracking of the cartilage which 
leads to pieces of articular cartilage in the synovium of the joint. Further cracking of the 
cartilage can lead to the subchondral bone extending into the cracks inducing subchondral 
osteoclastic bone resorption. It is possible that symptoms are felt at this stage of the disease 
(Martel-Pelletier 2004).
• Stage III results in synovial inflammation and release of various chemicals which 
lead to further collagen degradation (Martel-Pelletier, 2004).
Inflammation in the joint is thought to occur as a result of articular cartilage lodging in the 
synovium. During disease progression, the subchondral bone can extend into the joint 
surface at irregular intervals- this leads to the development of subchondral cysts in the bone 
marrow. Osteophytes (bony spurs) can also develop, usually in the lateral portions of the 
joint causing further irregularity of the joint surface and the characteristic signs on X-ray 
(Rubin 2008).
1.4.3 Clinical Presentation
Signs and symptoms of the above structural changes can vary in timescale and patient, 
although as the disease progresses the involved joint can be expected to exhibit any of the 
following:
1. Joint pain which is present on movement. Pain can be caused by inflammatory 
irritants within the joint, and by the stretching of contractures in the later stages of the 
disease.(Rubin 2008).
2. Stiffness within the joint which is mainly present during inactivity. This is thought 
to be due to the inflammatory process ongoing in the affected joint (Underwood 2009).
3. Audible creaking of the joints (crepitus).
4. Decreased muscle strength in the main muscles surrounding the joint. As a result of
decreased movement, surrounding musculature often atrophies leading to increased 
weakness (Underwood 2009).
5. Reduction in joint range of movement. This can be the result of joint or muscle 
contractures, large osteophytes or joint incongruity. This is often a sign o f disease 
progression (Alkhazim 2004; Rubin 2008).
In various stages of OA the presenting symptoms are often reported as being pain, 
inflammation and swelling (Felson 2006). It is postulated that with the swelling that occurs, 
quadriceps muscle inhibition can follow when as little as 1ml of fluid accumulates in the 
knee (DeAndrade 1965). This is not the only mechanism that can lead to quadriceps 
inhibition, as Hurley and Newham (1993) suggest that abnormal afferent (towards the 
brain) information from the damaged joint can also have a similar affect. The quadriceps 
muscle group is important, as it has been shown that with decreased quadriceps function 
there is a likelihood that there would be decreased postural stability confidence and 
impaired performance on activities of daily living (Hurley 1998). The pain that 
accompanies the quadriceps inhibition can lead to disuse atrophy, which will have a further 
weakening effect on the surrounding musculature (Vad 2002). These effects of OA can, if 
allowed to continue, lead to decreased function and therefore it is essential to try and arrest 
the damaging effects of OA at an early a stage as possible. Exercise therapy can be used as 
it has been shown to increase quadriceps strength (Maurer 1999; Foley 2003; Huang 2005; 
Mikesky 2006; Iwamoto 2007), and has further been shown to decrease pain (Maurer 1999; 
Fransen 2001; Cheing 2002; Evcik 2002; Fitzgerald 2002; Huang 2003; Bennell 2004; 
Eyigor 2004; Ravaud 2004; Huang 2005).
If OA is allowed to progress, a subsequent symptom is reduced range of motion (ROM). 
This occurs due to a number of factors including muscle spasm, muscle contracture, 
capsular contracture, joint surface incongruity and mechanical block due to osteophytes or 
loose bodies (Rubin 2008). The three aforementioned effects often occur earlier in the 
disease process and can possibly be addressed through exercise. Vad et al. (2002) state that
adequate flexibility and elasticity of the periarticular soft tissues and musculature is 
essential in permitting proper ROM as well as protecting the joint from undue stress.
It is usually at this stage of the disease process that the effect on patient function becomes 
apparent. As the disease progresses, patients often complain of increased pain whilst 
weightbearing, and reduced walking distances and stair-climbing ability (Sarzi-Puttini 
2005).
1.5 Pain Mechanisms
Pain is defined as ‘an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage, or described in terms of such damage’ (IASP 1994).
The initial part of the pain nociceptive chain is believed to be the nociceptor (a pain 
receptor that can respond to noxious mechanical and thermal stimuli) which is composed of 
a number of chemical and sensory receptors which leads to the polymodal nature of 
nociceptive neurons (Besson 1987; Millan 1999). Chemical substances which are released 
following actual or potential tissue trauma include Bradykinin, Substance P and 
Prostaglandins. These substances secreted at noxious levels interact with nociceptors 
leading to the generation of a receptor potential, which is the initiation of the action 
potential that will be propagated along the peripheral nerve and then enter the central 
nervous system via the spinothalamic or spinoreticular pathways (Walsh 1997). Activation 
of these pathways leads to the nociceptive nerve impulse arriving at the central nervous 
system, where interpretation of the pain occurs at the brainstem, thalamic and cortical level. 
It is this interpretation process that leads to the psychological and behavioural response to 
the damage that has occurred (Almeida 2004).
The afferent fibres described previously can be split into two main types that transmit 
nociceptive impulses. The two types are A-delta and C-fibres (Snell 2010). The A-delta 
fibres are myelinated and fast conducting, with the C-fibres being the non-myelinated, slow 
conducting fibres (Mountcastle 1980; Kitahata 1993). The fibres terminate in Laminae I 
and V of the dorsal horn o f the spinal cord (Millan 1999). In the presence of more chronic,
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inflammatory noxious stimulus, such as OA, these fibres can become sensitized and start to 
discharge spontaneously which may give rise to the throbbing pain or soreness experienced 
following injury (Bennett 2000; Almeida 2004). When noxious impulses reach the spinal 
cord from the periphery, it reaches the first possible site of modulation, which could be a 
site manipulated by IFT through the pain gate mechanism as described by Melzack and 
Wall (1965) (De Domenico 1982).
1.5.1 Pain Gate Theory
Melzack and Wall (1965) initially conceptualized the idea that pain modulation may be 
achieved via various treatment options, and it has been widely cited as the mechanism of 
action responsible for electrotherapy induced hypoalgesia (Johnson 1999). The postulated 
Gate Control theory outlines the importance of stimulating the small diameter C fibres.
This theory proposes that there is a mechanism by which stimulation of one set of fibres 
will override or close the ‘gate’ to another set of fibres. Evidence suggests this ‘gate’ is 
located in the cells of the substantia gelatinosa, which lie in the dorsal horn of the spinal 
cord (specifically laminae II)(Melzack 1965). It states that the cells in the substantia 
gelatinosa act as a gate control system that modulates the afferent pain stimulus before they 
influence the transmission cell (T-Cell). The T-Cell can then activate neural mechanisms 
which compromise the action system responsible for response and pain perception 
(Melzack 1965). This system can be affected at the dorsal horn level by brain processes 
concerned with previous pain experiences. The theory further suggests that stimulation of 
large diameter fibres following a painful response will dampen down the small diameter 
fibres that will be most active following a painful stimulus. In summary, it is proposed that 
the presence or absence of pain is determined by the balance between the sensory and 
central inputs to the gate control system.
With regards to electrotherapeutic modalities, such as IFT, it is thought that they produce 
their pain relief via the selective activation of the large diameter afferent fibres (De 
Domenico 1982). DeDomenico (1982, 1987) suggested that a treatment frequency of 
approximately lOOFlz may be successful in closing the pain gate, thus producing analgesia.
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In contrast, other authors (Johnson 1999; Palmer 1999) have questioned whether this 
100Hz frequency is effective via this mechanism, whilst it has further been suggested that it 
is difficult to determine whether or not the frequency created deep in the tissues (beat 
frequency) or the carrier frequency is responsible for the selective activation of the large 
diameter nerve fibres. However regardless of mechanism of action, Goats (1990) reports 
that IFT induced analgesia can be created within clinical practice at these frequencies 
(Goats 1990). There remains several unanswered questions as to how this theory, even 
though accepted, can be supported by existing neurophysiological evidence.
1.5.2 Descending Pain Inhibition
In addition to the Gate Control Theory, another postulated mechanism of action for 
effective pain relief is that of the Descending Pain Suppression Pathway. This theory 
documents the important role that ‘biological painkillers’ such as endorphins, dynorphins 
and enkephalins (collectively known as endogenous opioids) have on modulating pain in 
the human body (Basbaum 1978). These opioids have similar pharmacological 
characteristics as morphine and are said to have an important role in the transmission of 
nociceptive impulses from primary afferent nerves (Stamford 1995; Fields 1999).
Recombinant DNA technology has detected that these compounds have specific receptor 
sites and that they are intimately involved in the descending pain suppression system 
(Stamford 1995).
The main areas of this system are:
1. Periaqueductal Grey Matter (PAG), as this area is an area rich in opioid receptors.
2. Rostal Ventral Medulla (RVM), as this comprises the Nucleus Raphe Magnus (NRM) 
and reticular nuclei.
3. The Spinal Dorsal Horn.
The descending pain pathway is based upon the principle that a nociceptive impulse travels 
via the spinoreticular and spinothalamic tracts in the spinal cord to the thalamus in the 
brain, and these pathways have collateral neurological communication with the PAG, NRM 
and RVM. As a consequence, this causes endogenous opioid release at the PAG and NRM,
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which descend via projection neurones to the spinal dorsal horn, resulting in the inhibition 
of pain transmission (Basbaum 1978).
Stamford (1995) documented that stimulation of the PAG has been shown to reduce the 
activity of cells in the Spinothalamic Tract (STT) (which transmits nociceptive impulses) in 
monkeys, thus reducing pain. Furthermore, activation of the PAG has been shown to inhibit 
cells of the nociceptive responses of dorsal horn neurons (Stamford 1995). The PAG has 
connections to the NRM (Hudson 1996). The NRM, which is important in pain modulation, 
is thought to modulate some of the effects o f PAG stimulation (Stamford 1995). The NRM, 
not only modifies the effects of neighbouring groups of cells, but also has its own effects on 
pain, as direct stimulation of this area has been shown to cause analgesia in behavioural 
algeriometric tests (Oliveras 1975) from (Stamford 1995), and has been shown to decrease 
the response of dorsal horn cells to noxious heat (Llewelyn 1986) from (Stamford 1995).
De Domenico (1982) states that stimulation of the smaller diameter fibres is important if 
IFT is to have an effect via this pain mechanism. To achieve this, a pulse frequency of 
approximately 15Hz with a pulse width of approximately 100-200 microseconds is needed 
even though this pulse width is likely to stimulate larger diameter fibres. The method via 
which IFT has an effect on this system remains unclear. Some authors postulate that it may 
be due to the pulse duration which can be altered to between 100-200ps with a low 
frequency, thus stimulating all types of nerve fibre, and favouring the activation of the 
descending pain suppression mechanism (Howson 1978); cited De Domenico (1982).
1.5.3 Physiological Pain Block
This theory states that neurones have a maximum rate at which they can transmit action 
potentials. If the axon of the nerve is stimulated at a rate greater than it is able to transmit, 
the axon will eventually cease conducting (Goats 1990). DeDomenico (1987) proposed that 
A-delta fibres will be unable to transmit nociceptive impulses if a frequency of greater than 
40Hz is applied. Other sources also suggest that 40Hz would lead to the larger neurons 
ceasing transmission (Brown 1985).
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Therefore, a stimulus of 100Hz should cause a ‘physiological block’ leading to an analgesic 
effect. This effect is accepted by other authors (Brown 1985; DeDomenico 1987; Goats 
1990) however, it has yet to be proven by using IFT currents.
1.5.4 Placebo Effect
The Placebo Effect is a less understood mechanism that any therapist has to consider may 
be playing a part during any treatment procedure Richardson (1994) states that a certain 
effect of any treatment procedure could be due, in part, to the placebo phenomenon. In the 
generation and application of IFT, there is a high level of technology involved and the units 
are often visually impressive (Johnson 1999). This is one of various stimuli that could lead 
the patient to believe that they must be receiving an effective treatment. DeDomenico 
(1987) states that an IFT unit is impressive, and in some cases, bewildering for the patient 
and this, combined with the array of flashing lights is likely to induce a certain amount of 
awe in the patient, thus leading to the feeling that the patient must be receiving an effective 
treatment. The therapist-patient relationship can also play a part as (Richardson 1994) 
Richardson (1994) suggests what he calls a ‘Cognitive Dissonance Theory’ where the 
patient holds two beliefs that are psychologically inconsistent- a dissonance. The patient 
tries to resolve this by altering their perception of their symptoms and trying to please the 
treating therapist.
1.6 Current Treatment of Knee OA
Current treatment strategies for the effective management of people with osteoarthritis 
involve pharmacological, non-pharmacological or surgical approaches (Jordan 2003). With 
regards to the pharmacological treatment options, the most common agents currently 
recommended include Paracetamol, Non-steroidal anti-inflammatory drugs (NSAIDS), 
Steroids (Oral or Topical), or opioid analgesics (Jordan 2003). Non-pharmacological 
interventions include different types of exercise (strengthening, aerobic, hydrotherapy), 
patient education, self-management, heat/ice, acupuncture, ultrasound and weight loss.
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Common surgical techniques used include joint lavage, arthroscopic debridement and total 
joint replacement (Jordan 2003).
Due to the large costs involved and the rising average age of the population, surgical 
techniques are often seen as the last resort, therefore other types of treatments are often 
sought to achieve cost effectiveness and maintenance of function (Sevick 1999). Whilst 
pharmacological treatments have been shown to be effective (Zhang et al., 2007), NSAIDS 
have been reported to have possible adverse effects on cartilage metabolism, and can lead 
to bowel irritation and stomach ulcers (Brandt 1987; Bradley 1991).
The most commonly researched area of non-pharmacological treatment is exercise therapy 
(Zhang et al., 2007) and this is the area that will be further explored.
1.6.1 Exercise Therapy
Physiotherapy is one form of non-pharmacological treatment that can be used to treat knee 
OA and one of the forms of physiotherapeutic treatment applied is exercise therapy 
(Jamtvedt 2008). Exercise therapy can be used to address many of the adverse clinical 
effects outlined previously (Maurer 1999; Bennell 2004).
Previous research studies have indicated the therapeutic potential that an exercise based 
intervention could have upon a person’s physical function and mobility (Rejeski 1998; 
Maurer 1999; Deyle 2000; Fransen 2001; Fitzgerald 2002; Foley 2003; Huang 2003; 
Bennell 2004; Eyigor 2004; Deyle 2005; Roos 2005; Karatosun 2006). It is essential that 
OA is controlled as early as possible in its process because if joint surface incongruity and 
mechanical block of the joint has occurred the patient is often unlikely to respond to 
exercise, making surgery the most probable course of action. Therefore, if non-invasive 
techniques (such as exercise therapy) are to be successful in the effective management of 
people with OA of the knee, it is important that these interventions are implemented as 
early as possible in the disease process.
Cheing (2002 and 2004) reports that existing research carried out on the effects of exercise 
therapy has proven to be overall very positive, however the types o f exercises that have 
been researched vary, and often require the use of expensive machinery, such as the Kin-
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Kom machines which measure kinematics around a joint. Due to the level of potential 
financial resources of hospital departments, the clinical implementation of this approach 
would be hindered.
Previously published studies have examined the effects of exercise therapy on knee OA, 
and these will be explored in more depth in the systematic review chapter of this thesis.
Van Baar (1999) carried out a systematic review of the Randomised Clinical Trials (RCT) 
that examined the effects of exercise therapy on pain, self-reported disability, and patients 
assessment of effect in patients with knee and hip OA. Eleven RCTs met the inclusion 
criteria for the systematic review and the author concluded that exercise therapy was 
effective in the treatment of the parameters outlined. However, due to the limited numbers 
of studies that met the criteria it was also recommended that more studies of high 
methodological quality be carried out.
Fransen et al. (2001) carried out a systematic review to determine whether exercise is 
beneficial in terms of joint pain, physical function and patients’ assessment of effectiveness 
for people with OA of the knee. Seventeen studies compared a form of land based exercise 
with a non-exercise group. The results of the review indicate that land based exercise was 
found to be beneficial in terms of self-reported pain and self-reported function. However, 
although it is agreed that quadriceps strengthening needs to be one of the main 
considerations, the types of exercises, frequency of exercises, exercise settings and delivery 
of exercises outlined in the studies varied widely and therefore one of the authors’ 
conclusions was that further investigation needed to be carried out on optimal exercise type 
and dosage.
In 2004 a group of twenty experts in the field of OA were gathered to offer opinions on 
type of exercise to be used in conjunction with knee OA (Roddy 2005). Each expert offered 
ten key points on exercise and each of these key points were scored according to the Delphi 
technique until eventually ten key points were determined. Included in these key points 
were:
1. Exercises needed to be a mix of aerobic and strengthening exercise.
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2. Improvements in muscle strength and proprioception gained from exercise 
programmes may reduce the progression of knee and hip OA.
3. There are few contraindications to the prescription of strengthening or aerobic 
exercise in patients with hip or knee OA.
1.6.2 Interferential Therapy
Although exercise has been shown to be effective in reducing pain (Fransen 2001), many 
patients find that during an acute phase, exercise can increase pain or the thought of 
exercise can be off-putting (Thorstensson 2006), and therefore therapists often look to other 
modalities to have an effect on pain. One other commonly used technique (Lindsay 1990; 
Pope 1995) is Interferential Therapy (IFT).
IFT is a non-invasive electrotherapy technique that can be used for both muscle stimulation 
and pain relief (Noble 2006). In the context of this study it shall be reviewed in terms of its 
pain relieving effect.
1.6.2.1 Generation of interferential therapy currents
IFT is a non-invasive electrotherapeutic modality that uses electrical stimulation through 
adhesive pads, suction pads or sponge pads to stimulate nerves and achieve a variety of 
different effects (Noble 2000). Reported effects include pain relief (Stephenson 1995; 
Werners 1999; Johnson 2003), reduction of swelling (Jarit 2003), healing of wounds and 
fractures (Savage 1992) and restoration of function (Mantle 1991; Savage 1992; Jarit 
2003).
An IFT unit is said to produce a low frequency pulse termed a ‘beat frequency’ which 
generates a nerve impulse (Noble 2000). The beat frequency is usually set by the IFT unit 
but is often able to be modified by the user at between 1 and 250Hz, which enables a strong 
effect at a deeper surface, i.e. within the joint, without irritating the area of skin surface that 
it is applied to (Goats 1990). The same low frequency applied by other modalities, such as
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Transcutaneous Electrical Nerve Stimulation (TENS) would lead to considerable 
discomfort at the skin surface due to the impedance of the skin, which provides high 
electrical resistance. The low frequency treatment of IFT is enabled through the use of 
alternating medium level currents which meet little resistance when penetrating the skin 
surface (Goats 1990). The frequency can be targeted at a certain area which is often within 
a joint, through the use of two medium frequency currents which ‘interfere’ with each other 
at a depth determined by the operator of the IFT (please refer to figure 1) (De Domenico 
1987; Kloth 1987; Noble 2000; Watson 2008).
The interference that is created in the underlying tissue is termed the ‘beat frequency’, and, 
as was explained earlier, imitates a low frequency current. In bipolar machines (a machine 
that employs 2 contact electrodes), the beat frequency is created by the Interferential unit, 
in quadrapolar machines (a machine that employs 4 contact electrodes) the beat frequency 
can be generated within the target tissue, depending on the type of machine. The beat 
frequency is created through the ‘interference’ of one constant ‘carrier’ frequency with 
another frequency generated by a second circuit (Robertson 2006), and is equal to the 
difference in frequency of the two generated currents (i.e. 4000Hz and 4100Hz results in a 
100Hz beat frequency) (Goats 1990).
It is the decision of the operator which frequency to apply as different frequencies will lead 
to differing treatment effects (De Domenico 1981).
Another variable that can be adjusted with IFT units is the mode of the beat frequency. It 
can usually be set at a constant or rhythmical mode. This refers to whether, or not the ‘beat 
frequency’ will change as it is applied to the tissue. In the constant mode, the unit will 
deliver a constant beat frequency, usually set at l-250Hz. In the rhythmical setting, the 
therapist is able to select values that the machine will continuously reflect between. The 
time taken for the unit to ‘sweep’ between the selected frequencies (e.g. 10-lOOHz) can 
often also be selected (e.g. 6/6, meaning that the machine takes 6 seconds to reach the 
highest selected frequency and 6 seconds to reach the lowest selected frequency). A 
possible reason for applying the sweep is that nerves become accustomed to a constant 
frequency (De Domenico 1982), and therefore, by applying the sweep, the frequency can
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change continually reportedly m aking the IFT more effective for a more prolonged period 
(D eD om enico  1987). It has been postulated that use o f  a smaller frequency range will tend 
to be a more efficient use o f  IFT Quirk (1985). There are different types o f  sweep settings 
that can be used according to the desired physiological effect. The different types o f  sweep 
pattern will not be explored in detail in this review. However, the main types o f  sweep 
pattern are the triangular, rectangular and the trapezoidal sweep patterns. A com m on setting 
for IFT might be 80-120Hz, em ploying a 6A6 triangular sweep for 25minutes. This means 
that the ‘beat frequency’ will change from 80-120H z over a period o f  six seconds, and will 
continue to do so for twenty-five minutes (for a list o f  variables that can be adjusted with 
IFT, please see Table 1).
Table 1: Summary table to highlight IFT variables
Treatment Parameter/Method 
of Application
Example of Variable 
Choice
Description
Beat Frequency/Amplitude 
Modulated Frequency
Can usually be 
alternated between 1 - 
250Hz
T his com ponent o f  IFT is traditionally  
considered  to be the m ost important as 
it is thought to be the key factor in 
nerve stim ulation.
Frequency Sweep 6A6, 1A1 T his describes the transition from one  
beat frequency to another.
Electrode Application Placement Four Electrode, Two 
Electrode
Four electrode placem ent is considered  
to produce a ‘c lover lea f pattern' o f  
current, w hereas tw o  electrode  
placem ent m ixes the tw o currents in the  
stim ulator prior to delivery.
Electrode Application Method Suction or Plate 
electrodes
Electrodes can be placed using a suction 
unit which adheres to the skin or using 
carbon rubber electrodes in damp sponges
Current Intensity Weak to strong 
sensation
Setting that is changed according to patient 
description. ‘Strong but comfortable’ is a 
common desirable setting
Treatment Duration Variable Time Settings can apply treatment for as little as 
one minute to 99 minutes in most cases.
1.6.2.2 Pain Relief
As previously discussed in section 1.5, which described the physiology involved in pain 
transmission, this is exploration of how IFT may work to reduce pain via four main 
mechanisms:
1. Gate Control Theory as proposed by Melzack and Wall (1965). This proposes that 
action potentials in the form of impulses, travelling along large diameter fibres, compete for 
access into the central ascending sensory tracts in the dorsal hom of the spinal cord with 
nociceptive impulses travelling along the smaller diameter nociceptive fibres. The larger 
fibres conduct at a faster rate, and therefore their action potentials close the ‘pain gate’ to 
the nociceptive signals travelling along these smaller fibres, thus stopping the pain’ 
reaching a conscious level. Some authors have claimed that IFT can work in this way as it 
can be used to stimulate these large diameter fibres (De Domenico 1982; Goats 1990; 
Adedoyin 2002).
2. Descending Pain Inhibition pathways. This involves the inhibition of pain via 
endogenous opioids such as endorphins, dynorphins and enkephalins. These chemicals 
have similar characteristics to the chemical analgesic Morphine, and are intimately 
involved with the descending pain suppression system. The descending pain suppression 
system relies on the selective stimulation of small diameter nociceptive fibres (Walsh,
1997). Through the use o f IFT it is thought possible to stimulate these fibres through use of 
a low frequency current with a pulse duration of between 100-200ps (DeDomenico, 1987 
(Low 2000).
3. Physiological Block: This is a mechanism proposed to involve the inhibition of 
nociceptive impulses by blocking the A-delta and C fibres with use of frequencies above 
50Hz. DeDomenico (1987) states that C fibres are capable of synchronous firing with an 
electrical stimulus that has a frequency that does not exceed approximately 15Hz. Anything 
greater than this usually results in the cessation of conduction of these nerve fibres. A-delta 
fibres are capable of firing with frequencies up to 40Hz. Therefore a stimulus of 50Hz (as it 
is greater than 40Hz) should cause these fibres to cease firing, as this is at a frequency
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higher than A-delta fibres are capable of firing, thus creating an analgesic effect. This effect 
has been proposed (De Domenico 1982; Low 2000), although never proven.
4. Placebo (Walsh, 1997). The patients undergoing treatment could feel less pain just 
as a result of the level of technology involved (as IFT units are usually quite impressive). 
This may contribute to the ‘cognitive dissonance theory’ that Richardson (1994) proposes, 
whereby the basis of this theory is that the patient holds two beliefs that are 
‘psychologically inconsistent’, thus creating dissonance. The patient will try to resolve this 
by altering their perception of their symptoms as well as attempting to please the therapist.
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1.7 Conclusion
With limited amounts of work done on the effects of IFT on knee OA, it is planned to carry 
out a pilot study comparing the effects of this modality to a clinically relevant and easily 
applicable exercise regime commonly used in clinical practice. The combined effects of 
these two treatments will also be compared against a control group.
It is hoped this study will inform current physiotherapy practice, add weight to the current 
body of evidence currently backing these physiotherapeutic techniques and be one of the 
first studies to compare these two treatment modalities on a UK based clinical population. 
This chapter has presented an overview of the use of IFT and exercise therapy with a 
description of current pain theories. The following chapter plans to review the current 
knowledge base surrounding the use of IFT and exercise therapy in the treatment of OA 
knee. The current knowledge base will guide the planning of a trial which plans to look at 
the effect of both interventions in the clinical setting.
-21  -
M edium  frequency current 1 :4kHz
M edium  frequency current 2 :4.2kHz
Interferential current: 200Hz
Figure 1: An illustration of the generation of interferential currents.
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2.0 Literature Review
2.1 Abstract
Background: The use of exercise therapy is common in the treatment of osteoarthritis of the 
knee (Holden 2008). However, the use of IFT in the treatment of OA knee is less 
researched even though the modality is widely used (Pope 1995). The best types of 
exercise, dosage of exercise and frequency required to achieve pain relief and increased 
function remains unclear, as does a clear rationale for the use of IFT. It is the aim of this 
review to update the existing literature on the effect of IFT and exercise on osteoarthritis of 
the knee, and to try and establish the most effective exercises out of those that are 
commonly used.
Aims and Objectives: The aim of this review chapter is to examine the use of IFT and 
exercise therapy to ascertain the most effective usage in order to plan a future clinical trial. 
Method: A systematic review of English language articles using Medline, Web of 
Knowledge, Pubmed, and CINAHL between the years of 1970 and 2009 was undertaken. 
Eleven search terms were used in all. Search terms included Osteoarthritis, OA, Arthritis, 
Knee OA, Exercise, Exercise Therapy, Rehabilitation, Active Rehabilitation, Physical 
Therapy, Physiotherapy, and Physical Activity.
Study Selection: Only randomised controlled trials comparing the effect of exercise therapy 
with another intervention on knee OA were included. Studies were scored and included 
accordingly using the Pedro scoring system. Studies scoring seven out of ten or above were 
included in the review. Studies on the use of IFT were included following the use of key 
words to identify relevant studies. No scoring system was used in the identification of the 
IFT studies due to the relatively low numbers of studies currently published on the chosen 
area.
Data Extraction: Following identification through searching of key terms, abstracts of 
studies were screened to identify studies meeting the inclusion criteria. After studies had
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met the inclusion criteria, scoring of exercise therapy based studies using the Pedro system 
was carried out to identify those with high methodological quality. Studies on the use of 
IFT were included on the discretion of the author.
Results: Of 124 exercise therapy based papers identified in the initial search using key 
terms, seventeen papers were selected for further critique. Eleven studies assessing the 
effect of IFT were chosen for review.
Limitations: Searches were carried out on the databases outlined above between the years 
of 1970 and 2009. Limits included were English language only. Efforts were made to attain 
all papers highlighted, however if full-text papers were not available, they were not used.
Conclusions: It appears that IFT is beneficial in the treatment of musculoskeletal 
complaints, however there seems to be no optimum settings described for the treatment of 
such conditions. Exercise therapy appears to be effective in reducing pain, improving 
strength and function in patients with knee OA. Furthermore, due to the wide variety of 
exercise protocols used, it is difficult to establish which exercises are most effective. 
However, it does appear that exercises targeting the quadriceps and hamstring muscle 
groups are among the most appropriate in this group of patients.
2.1 Chapter Introduction
This chapter contains a review of the current literature surrounding the use of IFT and 
exercise therapy of the knee. The chapter is split into a narrative review and systematic 
review based on the large amount of literature examining the use of exercise therapy in the 
treatment of OA knee, compared with the relatively scant amount of literature looking at 
the use of IFT in the treatment of OA knee.
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2.2 Interferential Therapy Narrative Review
2.2.1 Introduction
With regards to the effective management of various musculoskeletal conditions, 
physiotherapy as a discipline is commonly employed, as physiotherapists have numerous 
modalities at their disposal to treat such disorders. The objective of this chapter is to 
provide an overview of one of the electrotherapeutic modalities commonly used to treat 
musculoskeletal conditions, namely Interferential Therapy (IFT). The review plans to look 
at the background of this electrotherapeutic modality and examine the evidence base 
(laboratory and clinical) relating to its effectiveness in managing musculoskeletal related 
pain, which is a common clinical feature in people with osteoarthritis. It is important to 
indicate that due to an extensive amount of previous investigations examining the 
effectiveness of electrotherapy focusing upon the effects of TENS, in comparison to the 
limited amount of IFT based research; this review plans to outline the general evidence 
surrounding the use of TENS and IFT in the treatment of musculoskeletal pain with more 
emphasis placed on the research surrounding IFT and musculoskeletal pain. Flowever, it 
has been recognised that there are distinct physiological differences between TENS and 
IFT, and caution needs to be applied in extrapolating the evidence for TENS to IFT 
efficacy.
2.2.2 Popularity of IFT
IFT is a commonly used treatment employed by physiotherapists to treat a variety of 
musculoskeletal pain (Lindsay 1990). It is reported to be widely used (Pope 1995; 
Robertson 1998; Draper 2006) and effective at treating a wide variety of conditions. These 
include acute and chronic pain, stress incontinence and circulatory problems (DeDomenico 
1987), recent injuries, herpes zoster, shoulder pain, incontinence and back lesions (Savage
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1992). Despite the relatively popular use of the modality, the amount of research into its 
use remains relatively scarce and Johnson (1999) suggests that the level of evidence based 
upon the hierarchy of evidence (Hoeken 2009) needs to be considered as various studies are 
reports of anecdotal observations from clinical practice or in the form of descriptive studies 
using personal experience of experts in the field. Whilst Robertson (1998) further reports 
that the relatively common use of electrophysical agents (this includes IFT) is at a rate of 
one for every other treatment, the author concludes by asking why there is little 
documented evidence regarding its clinical effectiveness. Therefore, there is a need for 
more IFT specific research to support its continued clinical application with robust clinical 
research and cost effectiveness analysis.
2.2.3 Interferential Theory
An overview of the theory of the generation of IFT currents has been presented in the 
introductory chapter, section 1.6.2 and therefore a brief outline is now presented.
IFT is a type of electrotherapy that uses two alternating medium frequency currents which 
are applied simultaneously through interrelated electrodes. Medium frequency is applied 
via the electrodes to penetrate the skin surface as it is less painful than low current when 
applied to the skin. After penetrating the surface tissue, these currents are said to interfere 
with each other (essentially cancelling each other out) to produce a therapeutic low 
frequency current within the target tissue (Watson 2008). These individual currents are not 
strong enough to stimulate nerve and muscle directly until the amplitude is modulated by 
interference. This interference augments the currents to create a new frequency deep in the 
targeted tissues which works to try and reduce the pain sensation (Adedoyin 2002; Noble 
2006). The frequency of the remaining current deep within the tissues is equal to the mean 
of the two original currents and will vary in amplitude at a frequency equal to the difference 
between these two currents. This latter frequency is known as the ‘beat frequency’ (Watson 
2008).
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2.2.4 IFT and the Pain theories
The clinical application of IFT is based upon attaining the following four goals:
1. Relieve pain
2. Stimulate Muscles
3. Increase blood flow
4. Reduce oedema
As this study plans to examine the affect of IFT on pain, this will be the main focus of the 
review. There are a number of mechanisms through which IFT is said to affect pain. 
Thesehave previously been outlined in section 1.5 of the study and therefore the reader is 
referred to this section for a description.
Although there are numerous theories as to how IFT may reduce pain, few studies have 
been done that are able to state with any significance that it is understood how IFT has an 
effect on any type of pain or to justify its use (Goats 1990).
2.2.5 Evidence Base
The degree to which electrotherapy and IFT achieves pain relief is widely debated and a 
brief overview on the effect they may have on pain relief within a variety of conditions is 
now presented.
Osiri (2000) presented a Cochrane review on the effect of TENS on pain relief in knee OA. 
In the review seven papers were analysed and the results presented. The review found that 
TENS was found to be effective over placebo for pain control. The review stated that at 
least four weeks of TENS treatment was needed to reduce both knee pain and knee 
stiffness. However, it was recommended that more well-designed studies with a 
standardised treatment protocol were needed before the full effects of TENS on knee OA 
could be concluded.
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2.2.5.1 Laboratory Based Trials
Jorge (2006) examined the effect of IFT influence upon analgesia and inflammation in rats. 
In the study, sixty-nine rats were injected with formulae known to induce pain and 
inflammation separately. The pain response was measured on the basis of certain 
movements that rats display as a result of pain, e.g. flinching or retraction of the injected 
paw, or the ‘freezing reaction’. Objective measures were taken as either counting the 
number of flinching movements the rat made, or the amount of time until either reaction 
was produced. In the study, the formula used to induce the acute pain was Formulin, and 
the formula used to induce inflammation was Carrageenan.
The Formulin was applied to the hind paw of the rat, and the number of nociceptive 
reactions was measured over the period of 1 hour, in 5-minute blocks. Carrageenan was 
used in combination with a syringe piston to induce pain. The piston was used to induce 
pressure onto the hind paw of the rats. The researchers measured a baseline period from the 
application of 20mmHg of pressure on the hind paw, up until the rat produced the ‘freezing 
reaction’. This period of time served as the baseline response period. The researchers then 
injected the Carrageenan, and measured the same response 2, 3 and 4 hours after the 
injection application. The reason the reaction was measured over this time period was that 
Carrageenan is said to have maximum affect 3 hours after being injected. To test the effect 
of IFT application on pain, the rats were divided into seven groups; Group 1 received IFT 
before the Formulin injection, Group 2 received sham IFT before the injection, Group 3 
received IFT immediately after the Formulin injection, Group 4 received sham IFT 
immediately after the Formulin injection, Group 5 received no intervention at all with a 
Formulin injection, Group 6 received IFT 2 hours after Carrageenan injection, and Group 7 
received sham IFT 2 hours after Carrageenan injection. In all cases IFT was applied at a 
beat frequency of 140Hz constant, with a pulse duration of 125 milliseconds, and a carrier 
frequency of 4000Hz for 1 hour.
The results from the study indicated that the IFT applied immediately after the Formulin 
injection, significantly reduced the amount of nociceptive behaviour in the rats when
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compared with the rats receiving sham IFT after the Formulin (p=<0.05). Furthermore, IFT 
applied in Group 6 reduced the nociceptive behaviour immediately after its application, 
however the reduction did not continue for the hour of application. Therefore, the study 
appears to show that application of IFT reduces inflammatory pain for the duration of time 
that it is applied, when compared to no treatment, or to sham IFT treatment. This study 
adds to the body of evidence supporting the use of IFT to reduce pain, and suggests that a 
frequency of 140Hz may be able to be used to achieve analgesia from inflammatory 
pain.However the characteristics of the sample group used reduces the external validity of 
the study as the successful application of IFT on rats may not translate when applied to 
humans. The study showed that IFT reduced pain for the duration of time that it was 
applied, but its lack of effect on swelling (as this was also measured in the study) means 
that the mechanism of pain relief is unlikely to be caused by the movement of inflammatory 
mediators which are known to induce pain. The study suggests that the pain relief as a 
result of IFT application is more likely to be caused by the Pain Gate Theory or 
Physiological Block as described previously. Additionally, the study adds to the research 
suggesting that IFT can have a beneficial effect on pain.
Some authors o f studies involving the use of electrotherapy to produce pain relief argue that 
the mechanisms producing hypoalgesia are the same, regardless of the type of 
electrotherapy (i.e. TENS or IFT) used (Johnson 1999; Johnson 1999; Johnson 2003). This 
could have major financial implications as an IFT unit is significantly more expensive than 
a TENS unit. The following studies examine the use of these two modalities in the 
prevention of different types of pain.
Johnson (2003) compared the effect of two different electrotherapeutic modalities known to 
produce hypoalgesia on pain-free volunteers. In the study, the effects of TENS and IFT 
were compared on ischemic pain in 30 otherwise healthy volunteers. Each participant 
attended the research laboratory twice with a 24-48 hour interval in between. During the 
first visit, each volunteer had baseline data recorded. To achieve this data, subjects 
underwent a submaximal-effort tourniquet test (SETT). This involved attaching a 
sphygmomanometer to the subjects’ forearm which was inflated to a pressure of
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200mmHg. This was kept on for 12 minutes. During the first minute subjects were asked 
to perform 20, 75% hand squeeze contractions on a hand held device (this was determined 
through pre-test grip strength measurement) to induce ischemic pain. Subjects were asked 
to rate their pain every minute using a visual analogue scale (VAS) score. This is 10-point 
line marked on a piece of paper with the words ‘no pain’ at the number 0, leading up to the 
words ‘worst pain imaginable’ at the number 10. A post-test short-form Mcgill pain 
questionnaire was also used to measure pain after the procedure. During the second visit to 
the laboratory, subjects underwent the same procedure, but with 22-minutes of treatment 
which started 10 minutes 40seconds prior to the sphygmomanometer being inflated. The 
treatment was randomly allocated, with 10 subjects receiving IFT at a frequency of 100Hz, 
10 subjects receiving TENS at a frequency of lOOpps and 10 subjects receiving sham 
electrotherapy where electrodes were placed on the skin, with no current being passed. The 
authors found that the IFT produced a significant reduction in pain (p=<0.05) when 
compared to the sham electrotherapy, but not when compared to the TENS. The pain 
reduction induced by the TENS was reported to be insignificant (p=0.06) when compared 
to sham treatment. Even though the authors document this finding, in the discussion the 
authors postulate that ‘IFC (IFT) is at least as effective as TENS when delivered to produce 
a strong but comfortable electrical paraesthesia within the site of pain’, and furthermore 
that it may be more effective to use TENS rather than IFC’. These claims suggest an 
element of bias toward the use of TENS as the study carried out shows that IFT produces a 
significant reduction of pain, and TENS does not when compared to sham electrotherapy. 
This study is another that adds to the body of evidence suggesting that IFT used at a 
frequency of 100Hz could have a significant effect on the reduction of pain. However, it is 
another study that does not fully explain the mechanism through which IFT operates to 
produce hypoalgesia.
Johnson (1999) carried out a double blind, randomised controlled study comparing the 
effect of IFT and TENS on cold induced pain. A convenience sample of 21 was used in the 
study. The sample was split into three groups, with the first group receiving IFT as the 
treatment, the second receiving TENS, and the third receiving sham treatment. All subjects 
had to place their hand in warm water for five minutes, then into ice cold water. The time
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taken for the subject to say ‘pain’ was used as their pain threshold. The subject then had to 
keep their hand in the water for a further 30 seconds before removing their hand. On 
removal they were asked to rate the pain and unpleasantness of the sensation on a scale of 
0-10. This constituted one cycle. All subjects completed six cycles, with the intervention 
being applied for the third and fourth cycles. IFT delivered in the study was bipolar at a 
modulated frequency of 100Hz and at a strong, but comfortable intensity. This setting was 
based on previous work carried out by the authors. Sham IFT was used to maintain blinding 
in the study. Additionally, TENS was delivered at 100Hz. Subjects in the sham group 
received no stimulation but watched an oscilloscope display which changed frequently 
giving the impression that a current was being delivered.
The study found that subjects in the IFT and TENS groups demonstrated significantly 
higher pain thresholds than those in the sham group (p=<0.05). However, there were no 
significant differences between these two groups. None of the groups demonstrated any 
significant changes in pain intensity or unpleasantness rating. Even so, this study does 
demonstrate that both electrotherapeutic modalities seem to have an effect on pain 
threshold, even though this study failed to demonstrate whether one modality is more 
effective than the other. The study also adds to the varying types of pain that IFT appears to 
have analgesic effects on when used at a frequency of 100Hz. The following study again 
examines the effect of IFT delivered at 100Hz on various types of pain.
Mcmanus (2006) examined the analgesic effects of IFT on pain induced by different 
methods; through temperature variation and mechanical irritation. Twenty subjects were 
used in a cross-over randomised, controlled trial. Subjects were split into two groups of 10 
and were randomly assigned to receive mechanical pain or cold-induced pain initially, then 
to receive the opposite pain type in the following phase of the study. For cold-induced pain, 
subjects had to immerse their hand in a bowl of ice cold water, after having the hand in 
warm water. The subject had to say when they felt pain after immersion in cold water; the 
time it took for the subject to say ‘pain’ was taken as their cold-pain threshold. Thirty 
seconds after this, the subject removed their hand from the cold water and rated the 
intensity and unpleasantness of the pain on a scale of 0-10. The subjects then rested for the
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remainder of the 10-minute cycle, before repeating the procedure 6 times. During cycles 3 
and 4 of the process, IFT was applied for 20minutes at a frequency of 100Hz.
Mechanical pain was applied via a clamp with an electrode measuring the amount of force 
placed through the clamp. Subjects in this group had the clamp applied to the webspace of 
their index finger and thumb. The subjects manually tightened the clamp, and on 
experiencing pain, said the word “pain”. The amount of pressure was recorded and the 
subject then gradually increased the pain to a maximal sustainable level. This level was 
recorded and the subject was free to gradually release the pressure. The subject rated their 
unpleasantness of pain on a scale of 0-10, and then rested for the remainder of the cycle. As 
with the cold-induced pain, there were six cycles of pain application, with the IFT being 
applied for the 3rd and 4th cycles for 20minutes in total. IFT was applied via two electrodes 
placed on the anterior and posterior aspect of the forearm, midway between the wrist and 
elbow for both pain inducing procedures.
The study reports that IFT had a significant effect on the pain threshold in both aspects of 
pain induction (p=0.017- cold, p=0.041- mechanical). In addition, it was demonstrated that 
it took a significantly greater amount of time for subjects to report pain in the cold-induced 
pain model, and the amount of pressure needed to induce pain was significantly greater in 
the pressure model when subjects were receiving IFT. However, in the study subjects will 
have known when the IFT was being applied, and therefore, it could be questioned as to 
whether they would be more likely to alter their behaviour. The conditions during whichthe 
subjects were receiving the IFT were not commented on. The setup of the trial was very 
experimental, thus the ‘clinical’ relevance of the trial could be questioned. The sample size 
of the population studied could be considered as being limited, and this in conjunction with 
the fact that the sample population were of convenience in a university population, may 
reduce the ability to generalise the results of the study. However, the study does add to the 
body of evidence concerning IFT and pain relief.
Summary Table of Laboratory Based Trials (See Table 5)
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2.2.5.2 Clinical Trials
Cheing (2002) examined the effect of exercise and/or TENS on knee OA with pain as the 
main outcome measure. Sixty-two patients with knee OA were split into four groups; one 
receiving TENS, one receiving placebo TENS, one receiving exercise therapy, and the final 
group receiving TENS and exercise. The main outcome measure was the visual analogue 
scale (VAS), which is a subjective measure of pain. Subjects in the study received 
treatment five days a week for four weeks, which consisted of 60 minutes of TENS each 
treatment session at a frequency of 80Hz.. Those in the placebo group had electrodes placed 
in the same place, and had TENS units with lights on, but with no internal unit to ensure 
that no stimulation was provided via the unit. Subjects in the exercise group received 
quadriceps and hamstring strengthening exercises on an isokinetic dynamometer. Those in 
the combination group received 60 minutes of TENS followed by 20 minutes of exercise.
The study reported that all groups had a significant reduction in pain during the four week 
period of the study. However, in the period between the final treatment and the final data 
collection (four weeks), there was a significant increase in pain in the exercise only and 
placebo groups, which suggests a limited carry-over of pain relief effect for these groups. 
This study adds to the evidence suggesting that combinations of electrotherapy and 
exercise, as well as TENS alone can have a significant effect on pain experienced with knee 
OA. However, in the study, only one outcome measure was used, and the reliability of this 
measure has been questioned (Carlsson 1983). The amount of treatment subjects received 
in the study may also be questioned as it is not common practice to treat patients as often or 
for as long.
In a later study, Cheing (2004) examined the effect of the same procedure on different 
outcome measures. In this study, 66 subjects with radiographically confirmed knee OA 
were randomly assigned to receive TENS, placebo TENS, exercise or a combination of
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TENS and exercise. In this study, the functional effects of the four treatments modalities 
were assessed. Overall the study found that those receiving TENS produced improvements 
in gait parameters (p=0.053). Furthermore, those in the TENS group and exercise group 
produced significantly improved force of knee extensors with the knee at 60 or 90 degrees 
flexion (p=0.013, p=0.001). The group receiving a combination of treatments produced the 
greatest improvements in force generation (p=0.002), gait parameters (p=0.006) and range 
of movement (p<0.001) of all the groups, and greater improvements than those receiving 
each treatment in isolation. Therefore, this study again demonstrates the positive effect of 
combined electrotherapy and exercise treatment on the functional difficulties experienced 
with knee OA. However, the study does employ treatment methods/approaches that would 
be uncharacteristic for traditional physiotherapy departments due to the equipment used for 
treatment, and frequency and length of treatment. Another study that examined the use of 
combination therapy in the treatment of a musculoskeletal complaint was the following 
study by Hurley et al. (2004).
Hurley (2004) compared the individual and combined effects of manipulative therapy and 
IFT on Low Back Pain (LBP). In this study, a large number of subjects presenting with 
acute LBP were randomly assigned to receive manipulative therapy (MT), IFT or both. 
There was no control group used. All subjects received The Back Book, as well as their 
randomised intervention. Subjects in the MT group were treated with mobilisation or 
manipulation at the discretion of the treating physiotherapist. The study ensured that all 
treating physiotherapists were of a high standard by only including those with post­
graduate study. Subjects in the IFT group received 30 minutes of IFT at a frequency of 140 
Hz constant. Subjects were treated an average of five times, over five weeks. Outcomes 
used measured pain, function, and quality of life and subjects were followed up for a period 
of twelve months. The study found that there was a ‘clinical improvement’ in all groups, in 
all outcome measures, although there was no significant difference between groups. The 
combined therapy group showed a significant improvement when compared to manual 
therapy for physical functioning (p=0.04) and bodily pain (p=0.036).
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It was stated in a previous study by the same authors, that the same IFT method when 
compared to The Back Book yielded significantly better results in terms of functional 
disability, even though this was a preliminary study (Hurley 2001). Therefore, overall this 
study, along with those previously reviewed, add to the body of evidence supporting the 
use of combined therapy involving IFT in the clinical environment when the goal is pain 
relief. The study also adds to those using IFT at a frequency above 140Hz and according to 
theories stated in section 1.5, possibly utilizing the physiological pain block or pain gate 
mechanisms.
Walker (2006) looked at the effects of IFT on psoriatic arthritis. The outcome measures 
utilised in this study were pain, morning stiffness, physician and patient assessed disease 
activities, function, blood sedimentation rates (BSR) and C-reactive protein (CRP). 
Radiological investigation in the form of X-ray and MRI were also carried out on the hands 
and feet of subjects and scored on different criteria indicating joint inflammation and 
degeneration. Nine patients were treated with home-use, bipolar IFT units. They were 
advised to place the electrodes on their hands and feet, while immersed in water. Subjects 
were told to apply the IFT for 5 minutes in the morning at a frequency of 100Hz, and 5 
minutes in the evening at 10Hz, at a comfortable intensity. This treatment protocol was 
carried out daily for 16 weeks. Results found that there was a high adherence to treatment, 
although there were minimal significant changes. It was found that in the SF-36 (a function 
scale), the sub-group for pain showed a significant improvement (p=0.03), although the 
VAS scales used failed to show this. There was a significant improvement found in 
morning stiffness (p=0.02), as this reduced from a mean of 38 minutes to 4 minutes. Joint 
tenderness was the only other significant improvement found in the study (p=0.04). Further 
outcome measure changes were not to a significant level. This study was a pilot-study, thus 
had a small sample group, and therefore the findings cannot be applied generally. However, 
the study does seem to add to the argument that IFT can have a significant effect on pain 
even though the subjects were only using the IFT for 10 minutes a day, and for half of that 
time, at a frequency that is not known to produce analgesia.
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Jarit (2003) examined the effect of IFT on pain, swelling and movement on post-operative 
knees. The study was a double-blinded RCT and found that IFT had a significantly positive 
effect on all three outcomes measured. The study did not include a functional assessment as 
an outcome. Outcome measures were looked at from the stage immediately post- 
operatively up until nine weeks post surgery. In the study, all patients had undergone knee 
surgery, however the type of surgery and the surgeon varied, thus reducing the validity of 
the study. The types of surgery included either: Anterior Cruciate Ligament (ACL) 
reconstruction, meniscectomy, or knee chondroplasty. Within each type of surgery, patients 
were randomly assigned to either receive home IFT or sham IFT (placebo). All subjects 
received a standard physiotherapy protocol, as well as their allocated treatment during their 
post-op recovery period. Subjects were instructed to use the IFT units three times a day, for 
28 minutes each session for 7-9 weeks. This amount of treatment would be realistic if 
patients were to use home IFT units, however in the majority of hospital departments in the 
UK, IFT units are for department use only, thus this amount of treatment would be 
unrealistic. The placebo group was advised to turn on the unit for 30 minutes, three times 
per day. They were advised not to be alarmed if no sensation was felt.
This study claims to show a significant benefit of using IFT on post-operative knee surgery 
patients. However, in the study there was no confidence interval stated, and no p values 
given for any results. There is no statistical analysis section published and this makes 
analysis of the results difficult. Due to the fact that the overall group was essentially split 
into the three sub-groups of surgery type, the number of subjects is greatly reduced, thus 
reducing the external validity of the study, and thus the ability to accurately predict these 
values in the general population. Furthermore, there was no functional outcome used 
however all other outcomes were appropriate and commonly used in the clinical 
environment. The method of placebo application in the study has to be questioned , as over 
a period of nine weeks a subject is likely to suspect that they would be receiving a placebo. 
A superior model of control might have used a stimulus that would be unlikely to affect 
pain or swelling, even though this would also constitute a method of intervention. The 
study followed up the effects for a relatively long period, and therefore this study could add
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to the body of evidence for the use of IFT to reduce inflammatory pain, however due to the 
lack of key information it is difficult to interpret its results with any amount of accuracy.
The effect of IFT on knee OA has been studied by (Adedoyin 2002; Adedoyin 2005). In the 
former, the effect of IFT on knee OA in an African population was studied in isolation. 
Subjects were recruited if they had radiologically confirmed knee OA. All subjects did 
underwent a screening of their lower quarter to ensure the pain did not originate in any 
other major joint of the lower limb. Thirty subjects were recruited to the study and were 
allocated to an IFT group or a placebo group. Allocation was not randomised, although 
stratification of patients did take place to ensure equal distribution of age, height, weight 
and BMI. All patients were asked to change their diet prior to the study, although the reason 
for this was not explained. Subjects in the IFT group received treatment twice a week for 4 
weeks. IFT was applied at a frequency of 100Hz for the first 15minutes of treatment, 
followed by 5 minutes of treatment at 80Hz at a comfortable intensity. IFT was applied via 
a quadrapolar method ensuring that current was directed at the centre of the knee joint. In 
the placebo group, subjects were attached to the IFT machines in the same way, although 
instead of the intensity being at a comfortable intensity, the machine was not turned up at 
all. The main outcome measure used in the study was pain rating with the Visual Analogue 
Scale (VAS), and this was assessed before every treatment. Although this scale has been 
proven to be a reliable outcome measure (Scrimshaw 2001; Geier 2007), by asking subjects 
prior to every treatment session, there could be seen to be an increased pressure on the 
subject to ‘get better’, as they would be more likely to remember the answer they gave to 
the same question previously, furthermore it has been proven that the VAS is less 
responsive than other measures when used to rate current pain in comparison with over the 
last 24 hours (Scrimshaw 2001). There was no functional measure used as an outcome, 
although this was recognised in the discussion. Overall, the study stated a significant 
improvement in pain in both the IFT and placebo groups, however no p-values are 
published, and therefore the results of this study must be interpreted with caution. 
Furthermore, the placebo could be questioned as a method of control, as the patient could 
still be experiencing some sort of stimulation, albeit at a very low intensity. It is also stated 
that subjects received a morning treatment, and a twice weekly exercise regime, although it
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is not explained what this treatment was, or what exercises were used, therefore any 
improvement could be due to other interventions. This study does not really add to the 
argument that IFT is beneficial for pain relief as the significance of the result is unknown, 
and also contributes minimally to the mechanism of the action of IFT.
In the second study by the same author (Adedoyin 2005) forty-six subjects with 
radiological ly confirmed knee OA were recruited to compare the effects of IFT and TENS 
on knee OA. The sample size was based on a power calculation done prior to the study. 
However, when calculating, an assumption was made that a significant change in VAS 
score would be 30%. This could be questioned, as there appears to be no scientific basis for 
this assumption. In the study, the WOMAC scale of function was used as the main outcome 
measure, with pain as a secondary measure. The same assessor was used throughout the 
study to assess both outcomes, increasing the validity of the study. To reduce any possible 
psychological effect on patients, a machine that delivered TENS and IFT was used to 
deliver the allocated treatment. This was a positive aspect of the study as it has been 
claimed by other authors that the more impressive appearance of an IFT machine could be a 
possible reason for the effect of treatment (DeDomenico 1987). In the study, subjects were 
randomly allocated to one of three groups. One group received IFT and exercise, one 
received TENS and exercise, with the remaining group receiving exercise alone. Each 
subject had their own exercise programme in the study as the weight that they were 
required to lift progressed according to their own maximum repetition. In the IFT group, 
subjects were treated twice a week, for 4 weeks. IFT was applied at 80Hz continuous for 20 
minutes at a comfortable level. TENS was applied for the same amount of time, with the 
same treatment frequency (80Hz) and a phase duration of 200ms. The study found that 
there were statistically significant improvements for all groups in pain (p=0.001) and 
WOMAC scores (p=0.001) for all groups, however, there were no statistically significant 
differences between groups. The study adds to the evidence that IFT at or above 80Hz 
appears to have a significant affect on pain, however this study suggests that it is no more 
effective than exercise alone or exercise combined with TENS.
For Summary Table of Clinical Based IFT Trials, see Table 6
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2.2.7 Summary of IFT Studies
In summary, studies evaluating the effect of IFT are low in number and methodological 
quality. However, the studies reviewed appear to show a positive effect of IFT on pain 
relief when used at frequencies above 80Hz. Mechanisms that are thought to take place 
when IFT is applied to pain seem to be poorly understood and seem to be based more on 
opinion of experts in the field than fact (Johnson 1999), however due to the positive results 
of studies reviewed that utilized frequencies above 80Hz, it may be postulated that 
physiological pain block or pain gate mechanisms may be accessed with IFT at these 
frequencies.The research methodologies utilised make it difficult for an overall consensus 
of opinion to be achieved as many of the studies use different treatment parameters, such as 
varying timescales o f application, and measure different outcomes.
However, the research that has been carried out seems to be in favor of IFT when treating 
pain for a variety of pathologies, and there appears to be a need for more randomised 
controlled trials to evaluate the true effectiveness of IFT (Johnson 1999). The following 
section of the review chapter will examine the use of exercise therapy in the treatment of 
OA knee.
2.3 Exercise Therapy Review
2.3.1 Introduction
OA of the knee is a major contributor to functional impairment and reduced independence 
in older adults, commonly affecting adults over the age of 45 (Peat et al., 2001). 
Osteoarthritis most commonly affects the joints of the lower limb, in particular the hip and 
the knee, with the knee being the most commonly affected (Felson 1987; Mcalindon 1992; 
Sisto 2006). Due to the average age of the population gradually increasing the number of 
people suffering with the disease, along with the cost of treatment is also likely to increase 
(Rat 2005).
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There are many surgical options for the treatment of knee OA including arthroscopy, joint 
lavage and knee replacement, however these methods are costly and tend to be used as a 
‘last resort’(Zhang 2007). Therefore, a commonly used method of treating OA, due to its 
relatively low cost and convenience is physiotherapy, and one of the main forms of 
physiotherapeutic treatment that is utilised is exercise therapy (Holden 2008).
Various reviews have been carried out on exercise therapy in the treatment of knee OA 
(Fransen 2001; Roddy 2005; Holden 2008), and various others have recommended exercise 
be used in the management of the knee OA (Jordan 2003; Zhang 2007). The benefits of 
exercise to those with knee OA are said to include improved function, reduced pain, 
improved walking speed and improved strength (Ytterberg 1994; Van Baar 1999; Vad 
2002; Thorstensson 2005). However, although many benefits of exercise have been agreed, 
there is less consensus on frequency of exercise, exact types of exercise and exercise 
dosage (Holden 2008). A recent study (Roddy 2005) did outline the benefits of specific 
types of exercise, the benefits of different exercise situations (group vs home), the 
importance of adherence and different strategies to improve this. The review was based on 
research evidence and on recommendations of a panel of ten experts in the area. The study 
highlighted the need for further research on the practicalities of carrying out exercise as a 
treatment, i.e. exact modes of exercise, contraindications etc.
2.3.1.1 Objective
The aim of this review is to outline the studies that have been done in this area in the 
context of the overall thesis and to add to the database of knowledge on the area by 
updating with reviews recently carried out, with the overall aim being to establish the effect 
o f exercise therapy on knee OA, and the most beneficial methods o f application to guide a 
future clinical study into the area.
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2.3.2 Method
In order to understand the current level of knowledge of the potential clinical benefits of 
exercise therapy programmes for the effective treatment of osteoarthritis of the knee, a 
number of methods were employed to identify the relevant literature. Electronic searches, 
hand searches and a quality criterion were employed in order to perform a rigorous and 
expansive search of all the available and relevant peer-reviewed literature. Furthermore, 
non-peer reviewed information was collected and reviewed for relevance to the overall 
discussion.
2.3.2.1 Search Strategy and Electronic searches
Relevant trials and reviews were identified by conducting electronic searches through 
Medline/PubMed, ISI Web of Knowledge, and CINAHL databases. A preliminary search 
of electrotherapy literature was conducted in order to highlight key phrases to facilitate a 
more categorical search; these included:
• Osteoarthritis (and any deviation of it such as OA)
• Exercise
• Exercise therapy
• Rehabilitation
• Active rehabilitation
• Physical therapy
• Physiotherapy
• Physical activity
Due to the large number of papers retrieved from the databases, the searches were limited
to studies of human subjects, published in the English language and in the last 40 years.
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Keywords were individually searched, and then combined in order to locate a number of 
the most relevant trials.
The same process (i.e. combining keywords and limiting searches) was conducted on the all 
electronic databases between the search dates of 1970 and 2009, the results of which are in 
table 1 which shows the number of papers retrieved from all electronic databases, with each 
keyword and their combinations.
The abstracts of the papers yielded by searches using the different keyword combinations 
were read and appraised to decide the two final search phrases (i.e. eligibility and quality 
assessment). It ensured that the papers were relevant to the overall objective of the project, 
which is to explore the research evidence for the therapeutic benefits of exercise therapy in 
people living with osteoarthritis of the knee, within the context of the existing evidence 
base.
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2.3.2.2 Inclusion Criteria
Papers were included if they were published in the date ranges identified, they compared 
land based exercise with any other intervention in the treatment with OA of the knee, and if 
the full-text of the paper was available.
2.3.2.3 Hand searching
The reference lists of the relevant papers found through the electronic database searches 
were then checked for further relevant papers. A number of relevant Cochrane library 
publications were found amongst the appraised papers’ references. Efforts were therefore 
made to retrieve these papers through the Cochrane database.
2.3.2.4 Quality criterion
The ‘PEDro scale’ was used to appraise the papers as a further criteria for inclusion in order 
to consider the internal validity of the trials, and to discover if there was sufficient 
statistical information to make the results interpretable. The PEDro scale consists of a 
checklist of 11 conditions and gives a total possible score of 10 if all 11 conditions are 
fulfilled. Criterion numbers 1 to 8 assess internal validity and give a score out of 8. 
Criterion numbers 9 and 10 assess statistical reporting and give a score out of 2. Criterion 
number 11 is not used to calculate the PEDro score, but has been included in the PEDro 
scale so that all items of the Delphi scale are represented. Papers were only included if a 
combined score of 7 or above was prescribed, ensuring that only robust papers conducted to 
a high quality were included in the systematic review.
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Tables 2 and 3 show the PEDro scale and marking criteria with which papers were 
appraised.
Table 2:- Criteria and explanations
1. Subjects were randomly allocated to groups
Explanation Random allocation ensures that (within the constraints provided 
by chance) treatment and control groups are comparable.
no/yes
2. Allocation was concealed.
Explanation “Concealment” ensures that there is no systematic bias due to 
the person who determined if subjects were eligible for inclusion in the trial 
being aware, at the time he or she made this decision, which group the next 
subject would be allocated to.
no/yes
3. The groups were similar at baseline regarding the most important 
prognostic indicators.
Explanation This criterion may provide an indication of potential bias arising 
by chance with random allocation. Gross discrepancies between groups may 
be indicative of inadequate randomisation procedures and lead to bias 
treatment outcomes.
no/yes
4. There was blinding of all Subjects
Explanation Blinding of subjects involves ensuring that they are unable to 
distinguish whether they received or did not receive the treatment. When 
subjects have been blinded, the reader can be satisfied that the apparent effect 
(or lack of effect) of treatment was not due to placebo effects or Hawthorne 
effects (whereby participants responses are distorted by being observed and 
how they expect the experimenters want them to respond).
no/yes
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5. There was blinding of all therapists who administered the therapy
Explanation Blinding of therapists involves ensuring that they are unable to 
distinguish whether individual subjects received or did not receive the 
treatment. When therapists have been blinded, the reader can be satisfied that 
the apparent effect (or lack of effect) of treatment was not due to the 
therapists' enthusiasm or lack of enthusiasm for the treatment or control 
conditions.
no/yes
6. There was blinding of all assessors who measured at least one key outcome.
Explanation Blinding of assessors involves ensuring that assessors were 
unable to distinguish whether individual subjects received or did not receive 
the treatment. In trials in which key outcomes are self-reported, visual 
analogue scale or pain diary for example, the assessor is considered to be 
blind if the participant was blind. When assessors have been blinded, the 
reader can be satisfied that the apparent effect (or lack of effect) of treatment 
was not due to the assessors' biases impinging on their measures of outcomes.
no/yes
7. Measures of at least one key outcome were obtained from more than 85% 
of the subjects initially allocated to groups.
Explanation It is important that measurement of outcome is from as many 
subjects who are randomised to groups as possible. Subjects who are not 
followed up may potentially introduce bias since they may differ 
systematically from those who remain in the study. The magnitude of the 
potential bias increases with the proportion of subjects not followed up.
no/yes
8. All subjects for whom outcome measures were available received the 
treatment or control condition as allocated or, where this was not the case, 
data for at least one key outcome was analysed by “intention to treat”.
Explanation Almost inevitably there are protocol violations in clinical trials, 
which may involve subjects not receiving treatment as planned or receiving 
treatment when they should not have. Biases may be produced by analysis of 
data according to how subjects were treated (rather than according to how 
subjects should have been treated). It is important that, when the data are 
analysed, analysis is done as if each subject received the treatment or control 
condition as planned. This is usually referred to as “analysis by intention to 
treat”.
no/yes
9. The results of between-group statistical comparisons are reported for at no/yes
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least one key outcome.
Explanation In clinical trials, statistical tests are performed to determine if 
the difference between groups is greater than can plausibly be attributed to 
chance.
10. The study provides both point measures and measures of variability for at 
least one key outcome.
Explanation Clinical trials potentially provide relatively unbiased estimates 
of the size of treatment effects. The best estimate (point estimate) of the 
treatment effect is the difference between (or ratio of) the outcomes of 
treatment and control groups. A measure of the degree of uncertainty 
associated with this estimate can only be calculated if the study provides 
measures of variability.
no/yes
11. Eligibility criteria were specified.
Explanation This criterion influences external validity, but not the internal or 
statistical validity of the trial. It has been included in the PEDro scale so that 
al l items of the Delphi sGale are represented on the PEDro scale, but is not 
used to calculate the PEDro score.
no/yes
fhttp://www.otseeker.com/PDF/PEDroScalePartitionedGuidelinesExplanations.pdf)
Table 3;- Scoring Criteria:
All Criteria Points are only awarded when a criterion is clearly satisfied. If on a 
literal reading of the trial report it is possible that a criterion was not 
satisfied, a point should not be awarded for that criterion.
Criterion 1 A study is considered to have used random allocation if the report states 
that allocation was random. The precise method of randomisation need 
not be specified. Procedures such as coin-tossing and dice-rolling 
should be considered random. Quasi-randomised allocation procedures 
such as allocation by hospital record number or birth date, or 
alternation, do not satisfy this criterion.
Criterion 2 Concealed allocation means that the person who determined if a subject 
was eligible for inclusion in the trial was unaware, when this decision 
was made, of which group the subject would be allocated to. A point is 
awarded for this criterion, even if it is not stated that allocation was 
concealed, when the report states that allocation was by sealed opaque 
envelopes or that allocation involved contacting the holder of the 
allocation schedule who was “off-site”.
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Criterion 3 At a minimum, in studies of therapeutic interventions, the report must 
describe at least one measure of the severity of the condition being 
treated and at least one (different) key outcome measure at baseline. The 
rater must be satisfied that the groups’ outcomes would not be expected 
to differ, on the basis of baseline differences in prognostic variables 
alone, by a clinically significant amount. This criterion is satisfied even 
if only baseline data of study completers are presented.
Criterion 3, 6-10 Key outcomes are those outcomes that provide the primary measure of 
the effectiveness (or lack of effectiveness) of the therapy. In most 
studies, more than one variable is used as an outcome measure.
Criterion 4-6 Blinding means the person in question (subject, therapist or assessor) 
did not know which group the subject had been allocated to. In addition, 
subjects and therapists are only considered to be "blind" if it could be 
expected that they would have been unable to distinguish between the 
treatments applied to different groups. In trials in which key outcomes 
are self-reported (eg, visual analogue scale, pain diary), the assessor is 
considered to be blind if the subject was blind.
Criterion 7 This criterion is only satisfied if the report explicitly states both the 
number of subjects initially allocated to groups and the number of 
subjects from whom key outcome measures were obtained. In trials in 
which outcomes are measured at several points in time, a key outcome 
must have been measured in more than 85% of subjects at one of those 
points in time.
Criterion 8 An intention to treat analysis means that, where subjects did not receive 
treatment (or the control condition) as allocated, and where measures of 
outcomes were available. The analysis was performed as if subjects 
received the treatment (or control condition) they were allocated to. This 
criterion is satisfied, even if there is no mention of analysis by intention 
to treat, if the report explicitly states that all subjects received treatment 
or control conditions as allocated.
Criterion 9 A between-group statistical comparison involves statistical comparison 
of one group with another. Depending on the design of the study, this 
may involve comparison of two or more treatments, or comparison of 
treatment with a control condition. The analysis may be a simple 
comparison of outcomes measured after the treatment was administered, 
or a comparison of the change in one group with the change in another 
(when a factorial analysis of variance has been used to analyse the data, 
the latter is often reported as a group x time interaction). The
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comparison may be in the form of hypothesis testing (which provides a 
"p" value, describing the probability that the groups differed only by 
chance) or in the form of an estimate (for example, the mean or median 
difference, or a difference in proportions, or number needed to treat, or a 
relative risk or hazard ratio) and its confidence interval.
Criterion 10 A point measure is a measure of the size of the treatment effect. The 
treatment effect may be described as a difference in group outcomes, or 
as the outcome in (each of) all groups. Measures of variability include 
standard deviations, standard errors, confidence intervals, interquartile 
ranges (or other quantile ranges), and ranges. Point measures and/or 
measures of variability may be provided graphically (for example, 
Standard Deviations may be given as error bars in a figure) as long as it 
is clear what is being graphed (for example, as long as it is clear 
whether error bars represent Standard Deviations or Standard Errors). 
Where outcomes are categorical, this criterion is considered to have 
been met if the number of subjects in each category is given for each 
group.
Criterion 11 This criterion is satisfied if the report describes the source of subjects 
and a list of criteria used to determine who was eligible to participate in 
the study.
2.3.3 Results
Below are the tables showing the number of papers retrieved, with each keyword and their 
combinations, from the PubMed database, ISI Web of Knowledge database, and CINAHL 
between the search dates of 1970 and 2009 (For full search results, please refer to Appendix 
1).
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Search Flow Chart 1; PUBM ED database:
Papers obtained (n=44)
PUBMED database
Total Hits (n=565,897)
Search Terms Entered
Search Flow Chart 2; Web o f  K now ledge Database
Web of Knowledge 
database
Search Terms 
Entered
Total Hits 
(n=370988)
Papers obtained 
(n=39)
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Search Flow Chart 3; M edline Database
Cinahl/Medline database
♦
Search Terms Entered
♦
Total Hits (n=534640)
♦
Papers obtained (n=41)
Additionally , two reviewers scored papers using the scale and any disagreem ents were 
resolved by consensus. Papers scoring seven out o f  ten, or above were deemed eligible for 
inclusion in the systematic review.
The table below (Table 4) outlines the papers included in the review  and the PEDro scores 
achieved during the scoring process:
Table 4: PEDro scoring table
Authors Title PEDro Score
Williamson, L. et al. (2007) Severe knee osteoarthritis: a random ized  
controlled  trial o f  acupuncture, 
physiotherapy and standard m anagem ent 
for patients aw aiting knee replacem ent
8/10
Bennell, K.L. et al. (2005) E fficacy  o f  physiotherapy m anagem ent o f  
knee jo in t osteoarthritis: a random ised, 
double blind, p laceb o  controlled trial
8 /10
Chaipinyo, K. and 
Karoonsupcharoen, O. (2009)
N o  difference betw een  hom e-based  
strength training and hom e-based balance  
training on pain in patients w ith knee  
osteoarthritis: a random ised trial
7 /10
Deyle, G.D. et al. (2000) E ffectiv en ess o f  manual physical therapy 9 /10
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and exercise in osteoarthritis o f the knee
Deyle, G.D. et al. (2005) Physical therapy treatment effectiveness 
for osteoarthritis o f the knee: A 
randomized comparison o f supervised 
clinical exercise and manual therapy 
procedures versus a home exercise 
programme
9/10
Doi, T. et al. (2008) Effect o f  home exercise o f  quadriceps on 
knee osteoarthritis compared with non­
steroidal anti-inflammatory drugs
7/10
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In agreement with the paper inclusion criteria outlined in methodology section above, the 
original 35 papers yielded by the various searches, were narrowed to 17 when reviewed 
against the PEDro scale. The following eighteen papers were not included following 
scoring according to the PEDro scale: (Hurley 1998; Cheing 2002; Evcik 2002; Gur 2002;
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T opp  2002; Cheing 2004; Eyigor 2004; Adedoyin  2005; Sekir 2005; Thorstensson 2005; 
A ndersson  2006; M ikesky 2006; V een h o f 2006; Iwamoto 2007; Thorstensson 2007; King 
2008; Shakoor 2008; Tsauo 2008)
Search Flow Chart 4; Overall search
Articles Scoring 7 or 
above
According to PEDro scale 
N=17
Title and abstract
Scanned
N=35
Databases searched 
Using key terms 
N=124
2.3.4 Discussion
W illiam son et al. (2007) carried out an assessor-blinded and randomised controlled trial 
that com pared the therapeutic effects o f  acupuncture, supervised exercise and ‘standard 
m an ag em en t’ on a cohort o f  patients (n= 181) aw aiting knee arthroplasty (total, unilateral 
and bilateral). As a result, subjects were recruited from waiting lists and the dem ographic 
characteristics indicated little difference between participants in each o f  the groups. In this 
study, the acupuncture cohort (n=60) received once per w eek  m usculoskeletal acupuncture 
at defined points for 20m ins for a total o f  6 weeks; whilst the physiotherapy group (n=60) 
received a group based exercise  based intervention; defined as static quadriceps 
contractions, inner range quadriceps contractions; straight leg raises, sit to stand, stair
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climbing, calf stretches, theraband resisted knee extensions, balance training, knee 
flexion/extension and freestanding peddle revolutions. The control group (n=61) received a 
purposefully designed exercise and advice leaflet. The authors utilised a number of 
validated and reliable outcome measures that aimed to explore physical function (i.e. 
Oxford Knee Score questionnaire, the 50m timed walk test and WOMAC), pain (i.e. VAS), 
depression (i.e. HADS) and impact upon patient recovery and hospital resources (i.e. total 
length of stay post -operation) at repeated times for a period of baseline, 7 weeks, 12 weeks 
and 3 months post-operatively. The main results of the study indicated that acupuncture 
produced a significant short-term therapeutic reduction in the Oxford Knee Score for 
acupuncture at the 7 week time measurement only (p = 0.0497). Therefore, suggesting that 
the physiotherapy led group exercise intervention did not produce any statistically 
significant impact upon any of the outcome measures. The PEDro assessment of this paper 
indicated a 7 out of 10 score, which highlighted that this study was a randomised control 
trial with a power calculated sample size with blinded assessment with the outcome 
measure data being appropriately and robustly analysed. However, the blinding of the 
outcome measures was only single blinded (i.e. assessor only) and that could introduce a 
source of bias that affects the interpretation of the findings. The authors further indicated 
that there was patient loss throughout the time period of the study that reduced from 181 at 
baseline to 69 patients at the 12 week and 3 month assessment points. The authors did 
detail the main reasons for this dramatic decrease in sample size, which included 
dissatisfaction with treatment allocation, inability to remain in contact with patients and 
medical reasons. This reduction in sample size could explain why no significant results 
were reported and the authors did not include an intention to treat calculation to take this 
into consideration. Additionally, the authors did not report exactly how they defined and 
confirmed that the patient had osteoarthritis of the knee joint, which is important to ensure 
that patients with non-OA knee conditions were not included within the sample.
In contrast, Bennell et al (2005) conducted a study to determine the efficacy of a 
physiotherapy programme that included an exercise component that recruited 140 
participants with knee joint osteoarthritis as defined using the American College of 
Rheumatology, of which 119 completed the 12 week therapist led intervention and 12 week
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self management period. Furthermore, this randomised, doubled-blinded and placebo 
controlled study included an intention to treat analysis. The physiotherapy programme 
included taping and massage as well as exercise therapy; whilst the placebo group received 
sham ultrasound and light application. The exercise therapy component of this study was 
defined as retraining of the quadriceps, hip and back muscles as well as balance exercise. In 
addition to these components, all participants allocated into this group received 
proprioceptive knee taping, thoracic spine mobilisation and soft tissue massage lasting a 
maximum of 45mins (of which includes the 1 Omins allocated for the mobilisation and 
massage interventions) once per week for four weeks and repeated fortnightly for an 
additional 8 weeks. The intervention was delivered by 10 different physiotherapists and the 
authors do not detail how they ensured standardisation of care, which could influence the 
results of the study. At the end of the treatment period, the participants that received 
physiotherapy were provided with exercises and taping instructions to complete an 
additional 12 weeks of self management that was monitored for patient compliance. Those 
patients allocated to the placebo intervention did not receive an additional 12 week self 
management treatment period. With regards to outcome measures used, the authors used 
primary outcomes of pain and patient global change, with secondary outcomes consisting 
o f WOMAC, knee pain scale, SF-36, Quality of Life, quadriceps strength and balance. All 
of these measures are recognised as being reliable and valid for outcomes they are 
measuring. The results of the study indicated that there were no significant improvements 
between groups, whilst there was a slight reduction in reported pain scores (p = 0.069) and 
increases in global improvement (p = 0.309) in the physiotherapy group. Therefore, 
indicating that the physiotherapy intervention was no more effective than regular contact 
with a therapist. When considering that the physiotherapy intervention contained multiple 
components, it is possible that one or more of those components masked any potential 
influence that any single component could have (especially the exercise therapy 
component). Furthermore with the lack o f reporting on how standardisation of therapy was 
monitored and maintained this could explain the results reported.
Similarly to the previous study that included a home based self-management programme, 
Chaipinyo and Karoonsupcharoen (2009) conducted a double blinded randomised study
- 5 4 -
that focused entirely on home based interventions that compared strength training to 
balance training in a cohort of patients with knee osteoarthritis to ascertain their impact 
upon on the preserving of muscle strength. However, the authors state that the primary 
outcome measure used within the study was pain and not muscle strength. Additionally, in 
contrast to the Bennell et al study, this study consisted of only 48 participants with knee 
OA, as defined by the American College of Rheumatology criteria, which were split 
equally between the two intervention groups. The study did not include any control or 
placebo groups to aid with comparison based analysis. The interventions were defined by 
the authors, which indicated that the strength training programme consisted of 30 
repetitions of isometric knee extension with a 10 second maximal contraction for each leg,
5 days a week for a total of 4 weeks and the balance programme consisted of 30 repetitions 
of stepping and 10 repetitions bilateral mini squats repeated the same amount of times as 
the strength training programme. Whilst the results indicated that there were between group 
differences in quality of life and time to walk downstairs in favour of the strength training 
group, these were not significant. Additionally, for the main primary outcome measure of 
pain there was no significant decrease or difference between groups, however both groups 
did show a significant improvement in all outcomes other than knee extension strength in 
the unaffected knee which indicated that there may be therapeutic benefit of strength and 
balance exercise programmes. One area identified by the PEDro scale criteria that 
influences the robustness of the results that should be considered when interpreting the 
results of this study highlighted that there are differences between participants allocated 
into the groups, for example there were more males in the balance group compared to the 
strength group.
In 2000, Deyle et al. conducted a placebo-controlled research study to assess the 
therapeutic effects o f exercise therapy combined with another standard of physiotherapy 
treatment for knee osteoarthritis, manual therapy. In contrast to previous studies, the 83 
participants that were recruited onto the study were determined to have knee OA as defined 
by the Altman criteria that were randomised between the two experimental groups with the 
authors ensuring that the patient characteristics were similar in both groups. The 
intervention group received manual therapy determined by clinical need that consisted of
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passive physiological and accessory joint movements, muscle stretching and soft tissue 
mobilisations that targeted the knee, lumbar spine, hip and ankle. Additionally, the authors 
explicitly defined the exercise therapy, which consisted of stretching, range of movement 
and strengthening exercises that was adjusted based upon patient tolerance. The placebo 
intervention comprised of sub-therapeutic ultrasound for 1 Omins applied to area of knee 
symptoms. Both groups received 30mins of total therapist delivered intervention, whilst the 
treatment group received additional 30-45mins to perform the exercises, twice weekly for 4 
weeks. Furthermore, the participants who were allocated to the exercise treatment group 
performed the exercise programme on days they received no clinic based treatment at 
home. Therefore, there was a potentially significant difference between the two 
experimental groups in regards to total treatment time that may have influenced the study’s 
results. Similar to the previous studies outlined above, one of the outcome measures utilised 
to determine treatment efficacy was WOMAC, pain and physical functioning as determined 
using the 6min walk test. In contrast to the previous papers, this study that attained a 9 out 
of 10 PEDro score, demonstrated a clinically and statistically significant improvement in 
WOMAC scores and 6min walk test at the end of the intervention and at the 4 week follow- 
up measurement time point for the manual therapy and exercise programme when 
compared to the placebo group. Therefore, suggesting that a combined physiotherapy 
programme does produce functional benefits in people with knee OA.
In a study, Deyle et al (2005) continued with the exploration of the clinical benefits 
indicated in the previous study, by comparing an exercise and manual therapy based 
intervention to a home based exercise program. Within this study, they utilised the same 
primary outcome measures (i.e. WOMAC and the 6min Walk Test), same combined 
intervention programme for the same length of time and used a randomised, blinded 
approach but without any placebo-controlled group. The home based exercise programme 
received verbal information sheets contained photographs o f the exercises and physical 
demonstration of the same exercise regime as the combined intervention group that was 
reinforced with a clinic visit at 2 weeks. The sample size for this study was increased to 134 
patients who were randomised into the two groups (i.e. combined and home based, n=66 
and 68, respectively). This study that attained a 9 out of 10 PEDro score, had an extended
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follow-up period of 1 year compared to their earlier study and reported that there were 
improvements in physical functioning at the end of treatment and the 8 week follow-up 
measurement, with those in the clinic based combined intervention gaining double benefit 
to those in the home based exercise group. Additionally, the authors reported that at the one 
year follow-up, both groups had substantial improvement when compared to baseline 
values. Therefore, this study reinforced the findings from their 2000 paper for the 
therapeutic benefits of combining manual therapy and exercise therapy, whilst indicating 
that if the exercise programme is structured and well supported can be effectively delivered 
and provide clinical benefit via a home based self management programme.
In a more recent publication, Doi et al. (2008) reported a similar conclusion to Deyle et al. 
(2005) that indicated that a home exercise programme can produce significant clinical 
benefits for people with knee OA. Doi et al. (2008) compared a home based exercise 
programme that targeted the quadriceps muscle group via knee extension movements 
(n=63) to Non-steroidal Anti-inflammatory Drugs (NSAIDs; n=58), used the universally 
accepted outcome measures of WOMAC, Japanese Knee Osteoarthritis Measure, SF-36 
and Pain (i.e. VAS) and had no significant differences in patient characteristics at baseline. 
This randomised study demonstrated that there was an improvement in the outcome 
measures for both groups which was statistically significant (p = <0.001 for exercise group 
vs p = 0.03 for NSAID group) but it should be noted that the authors did not detail whether 
or not the outcome measure assessment was blinded and did not include an explicitly 
defined control group, which reduced its PEDro score to 7 out of 10.
Thomas et al (2005) further explored the effectiveness of home based exercise therapy for 
knee pain and knee OA using a pragmatic randomised controlled trial with a 2 year study 
duration. The study randomly allocated the 600 participants into one of four groups; (i) 
Exercise therapy (with Dolomite supplement), (ii) self management supported via monthly 
telephone contact, (iii) Exercise therapy (with Dolomite (Magnesium and 
Calcium)supplement) plus telephone contact and (iv) no intervention or contact but they 
were still required to take a prescription of a placebo herbal based medication (i.e. 
Dolomite). The outcomes used were WOMAC, SF-36, Hospital Anxiety and Depression
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Scale (HADS) and isometric muscle strength and where administrated via a blinded 
assessor every 6 months. The exercise therapy programme was designed to be reflective of 
the individuals’ condition and progression by increasing muscle resistance, whilst aiming to 
maintain and improve the strength of muscles that act to support the knee. However, the 
precise detail of the exercise therapy component was not fully described by the authors, 
hence it is difficult to ascertain how the objective of the exercise therapy was designed. The 
authors concluded that exercise decreased reported pain levels at 6, 12 and 18 months but 
was only statistically significant at 6 months (p = 0.001), especially when compared to the 
two non-exercise groups. Additionally, in regards to physical functioning as measured by 
WOMAC, exercise therapy was demonstrated to significantly increase functioning in 
comparison to the non-exercise groups (p = 0.002). Therefore, the authors concluded that 
exercise therapy for 30min sessions delivered daily via a home based approach can produce 
reductions in pain scores and can influence physical functioning. One of the strengths of the 
research design used in this study is the stratified randomisation based upon sex and age to 
ensure each group had similar patient characteristics at baseline and included power 
calculation to determine sample size and the analysis of results included an intention to 
treat basis. However, the lack of explicit details regarding the actual exercise therapy 
programme used makes the reproducibility of the methodology difficult.
In an earlier paper by O’Reilly et al. (1999) additional information regarding the exercise 
therapy protocol is provided. In this study that evaluated the effectiveness of home based 
exercise therapy on pain and disability (i.e. physical functioning as measured by WOMAC 
which was the primary outcome measure) the exercise programme that comprised of 
isometric quadriceps contraction held in full extension held for 20secs, and mid flexion for 
5secs; isotonic quadriceps and hamstring contractions, as well as a dynamic stepping 
exercise is described. Each exercise component was repeated to a maximum number of 20 
repetitions daily at home by those participants randomly allocated to the exercise therapy 
group (n=l 13). These participants were compared to a non-intervention group (n=78) who 
received no exercise based treatment intervention or any additional support of therapist 
visits between assessment time points. The authors reported that the exercise based group 
had statistically significant reductions in WOMAC pain scores (p = 0.02), VAS pain scores
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(p = 0.03) and WOMAC physical functioning (p = 0.01) when compared to the control 
group. One of the strengths of this study is in the sample size (n=191) which is supported 
by a power calculation. However, the lack of double blinding as highlighted by the authors 
is a possible limitation.
Previous papers that examined the effects of exercise therapy delivered via a home based 
approach have provided conflicting results, and McCarthy et al. (2004) designed a research 
study that explored the potential of supplementing the home exercise programme with an 
additional class based exercise programme to determine whether or not the clinical 
outcomes for people with knee OA would be improved. All 151 participants (as determined 
by a power calculation) that completed the entire 12 month trial, were included in the study 
if they had knee OA as defined using the American College of Rheumatology, were 
randomly allocated equally into either home exercise only (n=71) or class supplemented 
home exercise group (n=80). Regardless of which group the patient was allocated into, all 
participants received advice and education guidance derived from the UK Arthritis 
Research Campaign’s publications. However, no control or placebo group was included 
within the research design, thus limiting the scope of the comparative statistical analysis. 
The exercise programme was designed to include muscle strengthening, muscular 
endurance (to improve fatigue levels), balance and proprioception. However, the precise 
details of the exercise protocol are not included in the paper, which limits the 
reproducibility of the methodology used but the readers are directed to the publication by 
Hurley and Scott (1998). Those in the supplemented exercise group received a twice 
weekly 45 minute group based and clinician led clinic session for a total of 8 weeks. As 
with previous studies included in this review, the study utilised the reliable and valid 
outcome measures of WOMAC and VAS pain scores but also included Aggregate 
Locomotor Function score, 8 metre walk test and stair ascent and descent time as well as sit 
to stand time. However, the lack of full blinding of outcome measures is a weakness of the 
research design. Conversely, one of the strengths of this paper is its inclusion of an 
intention to treat approach in the statistical analysis of the outcome measures. Statistically, 
the authors demonstrated significant improvements in locomotive functioning (p = 0.006) 
and decrease in walking related pain (p = 0.001) for the class supplemented exercise group.
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The authors concluded that home-based exercise therapy programmes that include therapist 
led clinic sessions can significantly improve the clinical outcomes for people with knee OA 
and that this improvement remained for 12 months, when compared to only home based 
exercise therapy programmes.
Maurer et al. (1999) further explored the use of isokinetic quadriceps exercise therapy 
targeting to increase muscle strengthening and comparing its potential therapeutic effects to 
an intensive educational based intervention with regards knee OA related pain and physical 
functioning in 113 participants (which was supported by an appropriate sample size 
calculation). All participants recruited on the study had a confirmed diagnosis of knee OA 
as determined using the American College of Rheumatology criteria, at least a 3 month 
presence of mild to moderate knee pain and a Kellgran X-ray score of 3 or less, and were 
randomly allocated into either the exercise or education group. There was no control group 
condition that did not receive any additional interventions above normal care to aid 
comparative statistical analysis of treatment effects. Whilst initial clinical baseline 
assessments of muscle strength (as determined by isometric peak torque) were obtained for 
each participant under blinded assessor conditions, the authors do not state whether 
subsequent measures (such WOMAC, SF-36 and pain) were obtained under single-blinded 
conditions, which could be a source of potential experimental bias affecting the 
interpretation of their results. The exercise intervention received strength training of the 
knee extensor muscle groups, three times a week for a total of 8 weeks. During each 
exercise therapy session, the participants were required to complete a total of 27 repetitions 
separated in to three sets of extensions of 90/sec, 120/sec and 150/sec angular velocities 
using a dynamometer. The participants in the educational intervention group received 
educational leaflets, a series o f 4 lectures that explored the disease process, self 
management, nutrition and coping strategies. The authors concluded that both 
interventions had statistically significant strength gains (p = <0.001) and demonstrated 
improvements in physical functioning which were not significant (p = 0.08). Furthermore, 
only participants in the exercise therapy intervention group had any improvement in pain 
reduction (p = 0.007). Whilst these results are encouraging in their support of isometric 
strength training improving physical functioning and pain reduction, the lack of specific
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methodological detail and justifications for not including a control group or blinding 
processes, may influence the robustness of their findings.
In contrast to the above study, Ettinger et al. (1997) further compared exercise therapy to a 
structured health education program using a total sample size of 365 patients with 
radiographically confirmed presence of knee OA. In this study, the participants were 
randomly allocated into one of three groups; (i) aerobic exercise, (ii) resistance exercise or 
(iii) a nurse led structured health education program. The aerobic exercise group received 
an intervention that consisted of a small group and clinic based walking program for the 
first 3 months of the study, followed by a 15 month home-based walking regimen. The 
clinic based sessions consisted of a thrice weekly 1 hour session that incorporated a warm 
up period, with 40min walking at 50-70% of resting heart rate reserve (ascertained by a pre­
trial treadmill test) and finished with a cool down period. Participants in the resistance (or 
strength training) exercise group followed the same 3 month clinic based and 15 month 
home based protocol. The resistance training consisted of the same warm up and cool down 
procedures but with an exercise protocol that contained 2 sets of 12 repetitions of 9 specific 
weight resisted exercises (i.e. leg extension, leg curl, step up, heel raise, chest fly, upright 
row, military press, biceps curl and pelvic tilt) with the objective of improving overall 
muscle strength and fitness. The health education programme comprised o f a once monthly
1.5 hour education sessions for the first 3 months, which explored physical activity, issues 
related to arthritis and a social period. For the following 15 month period, these participants 
were supported via telephone sessions where they were encouraged to discuss their current 
health status and medication usage. The primary outcome measure used within the study 
was a self-reported measure o f physical disability questions, which was generated as a 
result of work previously published by the research team. The secondary outcomes focused 
on physical performance (i.e. 6min walk test and timed activities), oxygen uptake during a 
treadmill test, isokinetic strength o f knee flexion and extension, knee X-rays and knee pain 
scores (as derived from the research team’s previous research). All outcome measurements 
were obtained with assessor blindness and repeated at regular time intervals (3, 9 and 18 
months). The authors concluded that those participants that completed the aerobic exercise 
protocol (n=l 17) had significant improvements on the physical disability (p = <0.001) and
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functioning scores (p = 0.001) when compared to the health education group (n=127). 
Additionally, the participants in the resistance exercise protocol group had significant 
improvements in the physical functioning (p = 0.02) outcomes when compared to the health 
education intervention but this was accompanied by a significant reduction in pain scores. 
Furthermore, in regards to disease progression as determined by knee X-rays, the authors 
demonstrated that there were no significant differences between any of the intervention 
groups. This randomised, controlled, single blinded clinical trial with a respectively large 
sample size (which was supported by a power calculation) and robust clinical outcomes 
provides arguably strong research evidence for the symptom management benefits of 
exercise therapy that would improve physical functioning levels for people with knee OA, 
which is reflective of its 9 out of 10 PEDro score.
However, in contrast to the above study, Rogind et al (1998) assessed the effects of a 
physical training programme that consisted of exercises that targeted general fitness, 
balance, coordination, stretching, lower limb strengthening and a daily home based 
programme, using only a consecutive (but random) sample of 23 patients with American 
College of Rheumatology defined knee OA. All participants were randomly allocated into 
either the exercise intervention group or control group (i.e. no intervention). The exercise 
intervention group consisted of a 3 month training programme delivered twice a week by a 
physiotherapist and comprised of well defined exercises that focused on mobility, venous 
therapy, lower limb muscle strength and flexibility as well as balance and coordination. The 
home based programme consisted of exercises familiar to the participants during the clinic 
based sessions and that further targeted the strengthening of the quadriceps as well as 
stretching the hamstrings, lower back and hip adductors. The potential long-term benefit of 
this intensive 3 month protocol (clinic and home based exercises) was assessed at the end 
of a 1 year follow-up measurement. The outcome measures used in this study were the 
main ones replicated in the other studies included within this review (i.e. pain and muscle 
strength) but the authors included a general evaluation using the Algofunctional Index, a 
physical clinical assessment o f the knee joint and postural sway. These outcomes provide a 
mix of objective and subjective outcomes. The results from this study, although they could 
be decreased in possible robustness due to the lack of a power calculated sample size,
- 6 2 -
blinding and unequal baseline characteristics (i.e. significantly more females than males), 
does support previous research outlined in this review that exercise therapy may be able to 
significantly improve physical functioning (p = <0.05), increase muscle strength (p = 0.05) 
and reduce pain (p = <0.05) in people with knee OA.
One of the common features of the exercise programmes evaluated in the studies outlined 
above is the inclusion of strengthening exercises to improve physical functioning. Jan et al. 
(2008) explored a different aspect of examining muscle strength training for patients with 
knee OA, by comparing high resistance training to low resistance training in elderly 
subjects instead of young people, which is more reflective of the clinical knee OA 
population. As with most of the other papers included in this review, the confirmed 
diagnosis of knee OA in the patients recruited onto the study complied with the American 
College of Rheumatology criteria which included clinical history, presence of grade 3 
bilateral radiographic changes and clinical assessment by an orthopaedic surgeon. The 
authors provide CONSORT (Moher at al., 2010) flow diagram to illustrate participant flow 
from the 133 initial contacts to the 112 participants that completed the study, which were 
randomly allocated into one of three experimental groups: (i) High resistance 
exercise(n=34), which consisted of 60% of the weight required for 1 repetition maximum 
(RM) repeated 8 times in three complete sets, (ii) Low resistance exercise (n=34), which 
comprised of 10% of 1RM repeated 15 times in three complete sets and (iii) control (n=30), 
which consisted of no intervention. The authors concluded that both high and low 
resistance muscle strengthening exercise therapies produced significant improvement for all 
outcome measures (i.e. WOMAC (pain and physical functioning) (p = <0.008), walking 
times (p = <0.05) and knee extensor and flexor torque (p = <0.008)). Whilst this study 
provides further evidence for the clinical benefit of exercise therapy that targets muscle 
strengthening in reducing the key characteristics of knee OA, the lack of details regarding 
the blinding processes included in the research design is a weakness of the study. However, 
this paper still attained an 8 out of 10 PEDro score.
In 2003, Huang et al. conducted a randomised trial exploring the therapeutic effects of 3 
strengthening exercise (i.e. isokinetic (n=33), isotonic (n=33) and isometric (n=33))
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approaches when compared to a control group (n=33). The 132 participants recruited onto 
the study had knee OA as defined by the Altman criteria, which had to be a bilateral 
presentation and all received additional home based exercise programme that comprised of 
15mins cycling for the isokinetic and isotonic exercise groups and those in the isometric 
group were instructed to complete 30 repetitions of 5sec isometric contractions of the 
quadriceps and biceps femoris (hamstrings) with the knee in full extension. Muscle power 
of the leg at flexion and extension was the primary outcome measure, which needs to be 
standardised in order to increase its reliability and validity. Secondary measures included 
measures of physical function via VAS, ambulation speed and Lequesne Index (i.e. level of 
disability). The authors suggested that for all exercise therapy groups there were significant 
improvements in pain and disability scores as well as ambulation speed when compared to 
the control group (all p = <0.05). However, these positive results may be criticised based 
upon the lack of double blinding in obtaining outcome measures to ensure that the apparent 
effect (or lack of effect) of treatment was not due to the assessors’ biases impinging on their 
measures of outcomes. Additionally, with the limited description of the baseline patient 
characteristics it is not possible to determine whether or not the research design used 
attempted to ensure that the groups contained similar types of patients to limit the potential 
bias arising by chance with random allocation. Furthermore, the sample size of the study 
was not explained or justified by the inclusion of a power calculation.
In a later study, Huang et al. continued the previous study utilising a similar research design 
in 140 patients with bilateral knee OA as classified by the Altman criteria. The 
experimental groups included an integrated therapy approach, whereby group 1 received 
the same isokinetic exercise protocol only, group 2 received isokinetic exercise combined 
with pulsed ultrasound designed to treat soft tissue pain (i.e. 1MHz frequency, 2.5 
watts/cm2 and a 25% pulse rate, 3 times per week for a total of 8 weeks) and group 3 
received isokinetic exercise, pulsed ultrasound and intraarticular 20mg hyaluronan (an anti­
inflammatory agent) injection therapy every day for 7 days for a total of 5 weeks. Outcome 
measures included in the study are the same as the ones used in the 2003 study. The authors 
concluded that an integrated therapy approach should be recommended for the effective 
management of knee OA, as all groups showed significant improvements in muscle peak
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torque, pain and disability scores with the group 3 participants showing the greatest level of 
improvements between all exercise groups.
The therapeutic benefit of intra-articular hyaluranic acid injections was further compared to 
exercise therapy in the study completed by Karatosun et al in 2006. In this prospective non­
controlled but assessor blinded clinical trial, the exercise therapy protocol used was a series 
of progressive, resistance based exercises that incorporated range of movement. The 
progressive exercise protocol included isometric exercises that targeted the quadriceps 
femoris muscles (week 1), stretching of the hamstrings, active range of movement, and 
strengthening exercises (from week 2 to 5) and proprioceptive exercises with closed kinetic 
chain exercises at week 6. The intra-articular hyaluranic therapy consisted of once weekly 
injections over a 3 week period. The authors reported that both interventions significantly 
improved clinical outcome in the 105 participants, (i.e. n=52 for the intra-articular 
hyaluranic acid therapy group and n=53 for the progressive exercise therapy group), 
comparing baseline to end of trial assessments as measured via the Hospital for Special 
Surgery Knee Score (p = 0.0002). However, there was no significant difference between 
groups indicating the exercise therapy protocol is as effective as intra-articular hyaluranic 
acid therapy in improving the level of physical functioning in patients with knee OA.
Whilst these results are encouraging and support previously discussed papers in this review, 
it is important to note that this was a progressive clinical study that did not include a control 
group and only had assessor blinding rather than double blinding but it still achieved an 8 
out of 10 PEDro score.
Whilst some of the previous papers included in this review explore the delivery of exercise 
therapy via small group classes, van Baar et al (2001) examined the effectiveness of 
exercise therapy delivered individually in patients with osteoarthritis of the hip or knee. 
Additionally, this single-blinded and controlled study of 201 participants (with 183 
participants completing the trial) who were randomly allocated into either the exercise 
invention or control group provides evidence that the benefits of exercise therapy for 
osteoarthritis may not fully affect the patients’ level of physical functioning, as the authors 
conclude that that any beneficial effects of exercise they demonstrated immediately post
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intervention may actually decline and return to baseline values over time. The exercise 
protocol used in this study focused on muscle functioning (i.e. strength), mobility (i.e. 
physical functioning) and coordination (i.e. balance). Each exercise therapy session lasted 
30min once to three times per week for a maximal total of 12 weeks, which was determined 
by the physiotherapist assessment of the participants’ pain levels and whether or not they 
had received their treatment goals. In addition, the participants received further advice and 
guidance to support the participants’ activities of daily living and they were prescribed a 
home based exercise regime. The primary outcomes used in this study focused upon pain 
scores and observed disability, which is a common feature to all studies included in this 
review. In contrast to other studies, the authors included a measurement of NSAIDs usage 
by the participant. Furthermore, the authors included a series of subjective self reported 
secondary outcome measures that explored global perceived effort, level of disability and 
level of physical activity. Whilst the findings from this study indicated that exercise therapy 
can produce moderate reductions in osteoarthritis related pain in the short term, these 
benefits are lost over time. However, it should be highlighted that whilst this study was 
well designed (i.e. randomised, justified sample size, single blinding, valid outcome 
measures etc) it did include two different clinical OA populations and this could have had 
impact upon the interpretation of the study’s overall results.
For a summary of systematic reviews, see Table 7.
2.3.5 Rationale for Present Study
The studies evaluated appear to show a general support of the use of exercise therapy in the 
treatment of knee OA. The majority of papers demonstrate an improvement in pain function 
and strength (Ettinger 1997; Rogind 1998; Maurer 1999; Deyle 2000; Thomas 2002; Huang 
2003; Deyle 2005; Huang 2005; Karatosun 2006; Doi 2008; Jan 2008; Chaipinyo 2009), 
with few studies reporting no statistically significant changes following exercise therapy 
(Bennell 2005; Williamson 2007). However, due to the wide variety o f exercise methods 
and exercise frequency used it is difficult to draw a definite conclusion with regards to the 
most effective methods. The studies highlighted appear to suggest that the quadriceps and 
hamstring muscle groups are the most important groups to concentrate on when designing
- 6 6 -
exercise programmes to have an effect on knee OA. Furthermore, it appears that clinic- 
based programmes that are supplemented by home exercises appear to yield favourable 
results. These findings are in agreement with previous reviews carried out by Fransen 
(2001) and Alkhazim (2004). Common outcome measures used appear to be the WOMAC 
and VAS pain scales, therefore if future studies are to be designed to assess exercise 
intervention, these outcome measures should be used primarily to maintain continuity 
throughout the studies.
Future studies should concentrate on the use of clinically applicable exercises that 
concentrate on quadriceps and hamstring strengthening that can be delivered in the clinic 
and home based setting.
The following chapter will present a single blind randomised controlled pilot study that will 
evaluate the effect of IFT and exercise therapy in isolation and in combination. An attempt 
will be made to answer the null hypothesis of whether the combination of treatments leads 
to a greater improvement than either intervention in isolation.
- 6 7 -
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3,0 Clinical Trial: Assessing the effect of IFT and Exercise Therapy on
KneeOsteoarthritis: A Pilot Study
3.1 Summary
BACKGROUND:
Osteo-Arthritis (OA) is one of the most prevalent diseases that affects the major joints of 
the musculoskeletal system. Osteo-Arthritis of the knee is particularly disabling due to 
symptoms such as pain, stiffness and muscle weakness (Mcalindon et al. 1992, O’Reilly et 
al. 1998). One aspect of the care of people living with Osteo-Arthritis of the knee involves 
the referral to a physiotherapist for symptom management. The mainstay of 
physiotherapeutic intervention is exercise therapy targeting the muscles that surround the 
knee to improve function. One modality also used to address pain felt during exacerbations 
of OA is Interferential Therapy (IFT).
OBJECTIVE:
The Objective of this MPhil study was to explore the current concepts and research base 
surrounding the use of exercise therapy and IFT in the treatment of OA knee and to 
compare the effects of the two different treatment methods on OA of the knee, and to 
ascertain whether the effects of the modalities are increased when used together.
METHODS:
36 subjects suffering with OA of the knee were randomly split into 3 groups. Group 1 
received Exercise Therapy treatment only. Group 2 received Interferential Therapy only. 
Group 3 received both treatments. All subjects acted as their own control. Outcome 
measures used were VAS pain scale, WOMAC, and ROM using goniometer.
- 7 3 -
RESULTS:
Changes in the combination treatment group were found to be most significant of the 
treatments used. Significant improvements were found in the exercise therapy group on all 
outcome measures. Interferential Therapy did not produce any significant changes when 
used in isolation.
CONCLUSION:
Combination treatment is clinically effective for the treatment of Osteo-Arthritis of the 
knee, however exercise therapy in isolation is also an effective and suitable treatment. More 
studies need to be carried out to evaluate the most effective settings to be used in the 
treatment of Osteo-Arthritis of the knee when using Interferential Therapy, and to assess 
the true financial implication of using combination treatments.
- 7 4 -
3.2 Introduction
Knee OA is a common pathology in the western world (Sisto 2006). It becomes 
increasingly common as the population ages and can become a burden to the sufferer 
leading to worsening physical function and disability (Peat 2001). It is thought that as many 
as 10% of people over the age of 65 in the US suffer with the disease (Felson, 1982) 
leading to an economical cost of around $86 billion (Abell 2005). Therefore the best ways 
to manage the condition are important to keep the physical functioning of the individual 
sufferer high and the cost to the economy low.
Previous chapters have commented on research that has looked the effect of exercise 
therapy and IFT on OA of the knee in isolation. This work has demonstrated positive 
results and suggested that the use of both modalities could be useful in addressing the 
muscle weakness, reduced function and pain that usually affects the OA knee sufferer. 
However, few studies have looked at the effect of both modalities in combination and it 
could be hypothesized that the use o f both modalities may lead to a greater overall 
treatment effect than either intervention alone.
This pilot study plans to look at the effects of each intervention in isolation and in 
combination to assess the effect of both IFT and exercise therapy on OA knee in the clinical 
environment. The study plans to produce data that may be used to plan a larger scale study 
to more accurately assess the effect o f the combination of treatment techniques to treat OA 
knee in the future.
3.3 Methodology
3.3.1 Study Design
As was seen in the previous review chapter, the methods of clinical design differ quite 
considerably, however, based on the majority of the studies reviewed, and guidance 
following ethics review, the present pilot study was designed. The aim of the present pilot 
study was to test the trial design to guide a future larger scale study.
- 7 5 -
Following guidance from the ethics review panel, it was decided that a single blind 
randomized controlled trial would be the most efficient way to carry out the study. The 
novel method of having subjects act as their own control would avoid any symptomatic 
subjects receiving no treatment, yet still enable comparison of the same subject following a 
period of no treatment. Ideally, the design would have been double blinded but subjects 
were required to be made aware of the various treatment options and therefore, the blinding 
of the subjects to their treatment group would have been unrealistic. One of the main 
researchers (Craig Dyson) was used to deliver the treatment in that phase of the study, and 
it could be justifiably questioned as to whether the involvement of one of the main 
researchers in treatment delivery could impart an element of bias, however due to financial 
restraints it was decided to involve him in this stage of the study and have a blinded 
member of staff (Ron van Heeswijk) carry out the data collection and assessment of 
subjects pre-control, pre-treatment and post-treatment. The staff member that was used to 
take measurements had over 20 years experience and was tested for reliability in taking 
measurements according to a protocol using consistent anatomical landmarks for ROM 
using the goniometer.
Randomised controlled studies are used to test an association between an intervention and 
an outcome, with the effort made to randomize subjects ruling out any confounding 
differences in the groups (Sibbald and Roland, 1998). The present pilot study tested 
subjects over a period of six weeks in total with no follow-up period. This was done due to 
financial constraint as ideally subjects would have been followed up for a longer period. 
Subjects were treated over six sessions as this was the average number of treatments in the 
clinical setting based on the clinical experience of the author, however following review of 
previous studies, had finances allowed, up to 12 treatments could have been considered. 
Outcomes used were WOMAC (Bellamy, 1982), NRS for pain and joint ROM measuring 
flexion. These outcomes were used as WOMAC (Bellamy, 1982) is a commonly used 
outcome when assessing this type of condition according to previous studies reviewed in 
earlier chapters. NRS for pain and joint ROM are also commonly used in clinical 
departments, and this was the main factor in their use in the present study.
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Flow Chart 5: Study Design
Outcome Measures 
Assessed pre-treatm ent
n=36
IFT Group 
n=12
Exercise Therapy Group 
n=12
Combination Group 
n=12
Outcome Measures 
Reassessed
n=36
Subject consent and 
data baseline collected 
pre-control
n=36
Subjects Recruited 
n=36
Control period 
(3 weeks) 
Random allocation
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3.3.2 Subjects
Thirty-six subjects, aged 45-70 years old all suffering with knee OA were recruited from 
specialist GP, physiotherapy and consultant clinics around Abertawe Bro-Morgannwg 
University NHS Trust. Subjects were referred into these clinics by their GP.
3.3.3 Inclusion Criteria
Inclusion Criteria were as follows:
1. Age 45-70 years
2. Confirmed osteo-arthritis (OA) of the knee by way of radiological investigation (X- 
Ray).
3. Osteo-arthritis as defined by Altman (1986), i.e. the patient experiences pain and 
any five of the following:
1. Over 50 years of age,
2. Less than 30 minutes of morning stiffness,
3. Crepitus (noisy, grating sound) on active motion,
4. Bony tenderness,
5. Bony enlargement,
6. No palpable warmth of synovium,
7. Erythrocyte sedimentation rate (ESR) less than 40 mm/hr,
8. Rheumatoid factor less than 1:40 titer (agglutination method),
9. Synovial fluid signs.
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3.3.4 Exclusion Criteria
Patients were excluded from the study if they:
1. Had had any other treatment in the previous six weeks
2. Had any other medical condition which could explain their current complaints.
3. Kellgren Grade IV OA (large osteophytes (bony growths), marked joint space 
narrowing, severe sclerosis (hardening of the cartilage) and definite deformity of bone ends. 
This is applied when X-Ray shows a very high level of OA presence)(Kellgren 1957).
4. Were suffering with patello-femoral joint OA (Osteo-arthritis of another joint)
5. Were contra-indicated for exercise treatment or Interferential Treatment (IFT)
Contraindications for IFT are as follows:
• Subjects whose skin is easily damaged or bruised
• Subjects who are on anti-coagulation therapy
• Subjects with pacemakers,
• Subjects who have active malignancy.
Contraindications to exercise therapy are as follows:
• Any uncontrolled cardiac conditions (aortic stenosis,cardiac
enlargement,dysrhythmias,ventricular aneurysm,cardiomyopathy,congestive heart failure)
• Any uncontrolled metabolic disorders (Diabetes, thyrotoxicosis,
myxedema).
6. Are unable to read and understand English.
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3.3.5 Procedure
Subjects were assessed for their suitability for the study in the specialist clinic and if 
suitable, were given an information sheet about the study. The information sheet 
(Appendix2) contained details of the investigation and stated that subjects had the right to 
withdraw from the study at any time. The information sheet also contained the contact 
details of the Chief Investigator (Craig Dyson). Subjects were instructed to contact the 
Chief investigator if they wished to be included in the study. On contact with the Chief 
Investigator, subject name and contact details were taken, and allocated to a subject 
number and then an appointment was made to meet a physiotherapist (Ron van Heeswijk) 
who acted as the assessor of subject outcomes. The physiotherapist was blinded to the 
subject treatment. Informed consent was obtained via a consent form (See Appendix 3) 
issued prior to the start o f the data collection process by the blinded physiotherapist. The 
blinded physiotherapist carried out the following outcome measures during the initial 
assessment:
1. WOMAC Scale which consists of 24 questions, each corresponding to a visual 
analogue scale, designed to measure subjects perceptions’ of pain, stiffness and 
dysfunction. This has been shown to be a valid and reliable measure of function in patients 
with orthopaedic problems (Bellamy et. al, 1988; Bellamy et al., 1988). The WOMAC scale 
is a rating of function that uses a participants rating of difficulty of a number of functional 
tasks on a scale of 0 (No pain) to 5 (Unable to do). Therefore, a higher score indicates 
worsening functional ability.
2. Numerical Rating Scale (NRS) pain score. This is a numerical rating scale between 
0-10. The subject is asked to rate their current pain on a scale of 0-10 with 0 meaning no 
pain and 10 meaning the worst pain imaginable. This has been shown to be a valid measure 
of changes in chronic pain (Price et al., 1983)
3. Range of Movement. This will be a measurement of the subjects knee flexion
and extension by the blinded physiotherapist. This will be measured using a standard AMS 
protractor goniometer. It was decided to use this type of goniometer as this type of 
equipment is low-cost and commonly used in physiotherapy departments in the UK.
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Measurements were taken with the subject in supine, using lateral joint line of the knee as 
the fulcrum point, and the femur and fibula as the other points of reference.
Following collection of the data, subjects were given another appointment three weeks 
following the initial assessment. This three week period acted as the control period. After 
three weeks, subjects were again assessed by the blinded physiotherapist using the same 
outcome measures, and were commenced on the treatment procedure to which they were 
randomly allocated.
Subjects were randomly allocated into one of three intervention groups:
1. Interferential Therapy only group
2. Exercise Therapy only Group
3. Combined therapy group
3.3.5.1 IFT Group
Subjects in the IFT group received IFT twice a week, for three weeks, i.e. six sessions in 
total. Each session lasted for twenty-five minutes and IFT was concentrated on the 
symptomatic knee. Standardized IFT stimulation parameters for pain relief were used: 
carrier frequency 3.85kHz; 80-120Hz sweep; pulse duration 130^s. Four electrodes were 
placed around the knee joint so as to concentrate the effect of the IFT into the centre of the 
joint and were attached via a velcro strap to ensure maximum skin contact.
IFT was administered by the chief investigator.
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3.3.5.2 Exercise Therapy Group
Subjects in the exercise therapy group were treated twice a week for twenty minutes. The 
session was broken up into the following format:
1. Warm up using static exercise bike x 3min at slow pace.
2. 6 exercise stations. Subjects exercised at each station for 40sec with 20 sec for 
change of station. Subjects completed the circuit 3 times.
3. Warm down using static bike x 3min at slow pace
For example, each subject did a warm up followed by the following circuit three times. 
After doing the circuit three times the subjects did the warm down.
Participants did the following commonly used exercises:
1. Inner Range Quads in long sitting (sitting with legs on plinth and contracting quads 
muscle).
2. Single Leg Balance. (Balancing on one leg)
3. Straight Leg Raise (sitting with legs on plinth and, keeping the leg straight, lifting 
the leg 2-3” off the bed).
4. Step Up Exercise (stepping up onto a step)
5. Passive Knee Flexion (the participant pulls their knee into a bent position)
6. Hamstring Curl (the participant lies on their front and bends their knee against 
gravity).
Exercises used primarily target the quadriceps and hamstrings muscle groups as suggested 
in previous trials reviewed (see Section 2.3.5). Subjects in the exercise group were 
supervised by the chief investigator. Subjects were encouraged to continue with the 
exercises at home, but, in keeping with clinical practice, this was not supervised.
3.3.5.3 Combined Group
Subjects in the IFT and Exercise group did the above exercise regime and then received 25 
minutes of IFT set at the above parameters.
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3.3.5.4 Control Group
Subjects acted as their own control as they were assessed following initial recruitment, then 
they waited three weeks to simulate a control period, with a further assessment again prior 
to starting the treatment. Any subjects that complained of increased symptoms following an 
exercise period, their exercise protocol were modified accordingly on the opinion of the 
supervising physiotherapist.
Following completion of the study, subjects were offered conventional physiotherapy.
The second set of outcome measures were recorded at least 48 hours after the last set of 
exercises to allow for any post-exercise stiffness to dissipate.
Subjects were advised to continue using any medication prescribed prior to the start of the 
study, but were excluded if any changes in analgesic medication occurred during the study. 
Subject name and contact details were allocated to a reference number on allocation to the 
study. This data was stored on password controlled university computers at Swansea 
University. This data was only be accessed by the Chief investigator and the research team. 
All assessment data recorded during the study was kept in a sealed container in a lockable 
cabinet in Singleton Hospital. This was be accessed by the blinded physiotherapist carrying 
out the assessment, and the Chief investigator. Following completion of the study, all data 
will be stored at Swansea University for 10 years in compliance with the Data Protection 
Act 1998.
3.3.6 Data Analysis
Normality tests were carried out on patient demographics using the Shapiro-Wilks test 
(Shapiro and Wilk, 1965). Height, weight and time since diagnosis was all proved to be 
normal and therefore, further analysis was done using the ANOVA test.
Outcomes measured were function, using the WOMAC scale (Bellamy, 1982), pain using 
the NRS, and ROM of the knee joint. Shapiro-Wilks proved the data on pain and extension 
ROM to be not normal. WOMAC data is measured on a likert scale, thus non-parametric 
tests were used for further analysis and flexion ROM was proved to be normal and
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therefore A N O V A  tests were used for further analysis. Data proved to be not normal w as 
analysed using the Kruskal-W allis test (Kruskal and Wallis, 1952).
3.3.7 Ethics
Ethical approval for the study has been granted by the South West Wales Research Ethics 
Com mittee. Please refer to appendix  4 for a copy o f  the application and confirm ation letter.
3.4 Results
3.5 Patient Demographics
Table 8: Patient D em ographics
G roup n Time since
Diagnosis
(Months)
Gender 
Male Female
Height
(Inches)
mean±sem
Weight (lbs) 
mean±sem
BMI
All 36 9.36 14 22 65.79 ± 0 .8 181.86 ± 7.33 29.2
IFT Only 12 9.67 5 7 66.33 ± 0 .9 9 177.89 ± 7.86 28.7
Exercise 
Therapy only
12 10.83 5 7 66.2 ± 1.55 199.4 ± 16.03 32.1
Com bination
G roup
12 7.58 4 8 64.78 ± 1.62 166.33 ± 10.33 27.7
Subject dem ographics  are outlined above. Thirty-six subjects were included in the study. 
Tim e since diagnosis details were obtained from date o f  diagnostic study (X-ray, MRI) 
until date o f  starting intervention process. Height and weight details were ob tained for 
twenty-eight subjects as eight subjects did not reply to questionnaires. BMI was calculated 
according to average height and weight values for the group.
Mean time since diagnosis  for subjects within the study was 9.37±1.83 m onths (mean ±
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S.E.M.). Therefore, on average, subjects were referred to physiotherapy from specialist care 
within 9-10 months.
The study group was made up of fourteen male subjects and twenty-two female subjects. 
Average height within the group was 65.79 inches (5’6”) and the average weight was 
181.861bs (12 stone and 13lbs). This gave an average Body Mass Index (BMI) of 29.2 
which is classed as overweight in the BMI categorising system.
3.5.1 Between Group Demographics 
Exercise Therapy Group
The exercise therapy group contained five male subjects and seven female subjects. 
Average time since diagnosis was 10.82 months. Average height for patients within the 
exercise therapy group was 66.2 inches (5’6”) and average weight was 199.41bs (14 stone 
3lbs), giving an average group BMI of 32.1, which is classed as obese on the BMI 
classification system.
Interferential Therapy Group
The IFT group contained five male subjects and seven female subjects. Average time since 
diagnosis was 9.67 months. Average height for patients within the IFT group was 66.3 
inches (5’6”) and average weight was 177.891bs (12 stone 9.91bs), giving an average group 
BMI of 28.7, which is classed as overweight on the BMI classification system.
Combination Group
The combination group contained four male subjects and eight female subjects. Average 
time since diagnosis was 7.58 months. Average height for patients within the combination 
group was 64.78 inches (5’5”) and average weight was 166.331bs (11 stone 12.31bs), giving 
an average group BMI of 27.7, which is classed as overweight on the BMI classification 
system.
Analysis of between group demographics
Data collected from each group for height, weight and time since diagnosis were each 
tested for normality using the Shapiro-Wilks test (Shapiro and Wilk, 1965). These tests 
proved the data to be normal and thus between group tests were done using the ANOVA 
test. Following these tests it was proved that there were no significant differences between 
groups for height (p= 0.861), weight (p=0.164) or for time since diagnosis (p=0.773) at 
baseline.
3.6 WOMAC
The primary outcome measure used in the study was the The Western Ontario and 
Mcmaster Universities Arthritis Index (WOMAC).
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Graph 1. Changes in WOMAC score during the intervention period across all groups.
The graph above outlines the changes o f  W O M A C  scores in subjects in each o f  the three 
different treatment groups. Subjects m easurem ents were taken at baseline prior to control 
period (0 weeks), prior to intervention (3 weeks), and after the intervention period (6 
weeks). The graph shows that over the initial period, the exercise therapy group appears to 
deteriorate in terms o f  W O M A C  score over the control period, thus increasing W O M A C  
scores by 7.83 ± 4.83 SEM , as opposed to the o ther two groups which appear to improve 
slightly, decreasing the score in the IFT group by 7.83 ± 4.31 SEM  and in the combination 
group by 0.67 ± 8.85 SEM. Every group appeared to improve over the second three week 
period. The exercise (32.5 ±12 . 1  SEM ) and com bination group (41.91 ± 16.53) show 
greatest im provem ent over the intervention period, whereas the IFT seems to show a 
relatively constant im provem ent from the initial baseline to post intervention (25.67 ±
12.46 SEM).
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The W O M A C  scale is scored using a Likert scale and therefore is not interval/ratio data. As 
a result, the Kruskal Wallis (Kruskal and Wallis, 1952) test was used to analyse data. 
A nalysis showed that there was no significant im provem ent between groups at any point 
during the study.
However, when testing within group differences, significant changes were identified. To 
com pare within group differences a W ilcoxon Signed Ranked test w as used. The exercise 
therapy group improved significantly over the 0-6 week period (p=0.034), and over the 3-6 
w eek  intervention period (p=0.01). The IFT group showed no significant within group 
im provem ent over any period, how ever the combination group dem onstrated  a significant 
im provem ent over the 0-6 w eek period (/?=0.041) and over the 3-6 w eek  intervention 
period (y?=0.026).
3.7 Pain
Pain was assessed using a 10-point pain scale ranging from no pain at all to worst pain 
imaginable.
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Graph 2. Changes in pain over the intervention period across all groups 
The graph above outlines the changes in pain in subjects throughout the study. Over the 
control period, pain appears to increase in both the exercise (increase of 0.33 ± 0.79 SEM) 
and IFT groups (increase of 0.58 ± 0.53 SEM). However, over the same period pain in the 
combination group appears to decrease (0.17 ± 0.56 SEM). During the intervention period, 
every group appears to improve in terms of pain, leading to an overall decrease in every 
group in terms of pain. The exercise group improved by 1.41 ± 0.63 SEM, the IFT group by 
0.83 ± 0.66 SEM, and the combination group by 2.53 ± 0.77 SEM.
On statistical testing, initial tests using the Shapiro-Wilks test (Shapiro and Wilk, 1965) 
proved the data to be not normal and therefore, the Kruskal-Wallis (Kruskal and Wallis, 
1952) test was used to analyse the data. There was a significant difference demonstrated 
between the IFT and combination groups in terms of pain over the 6 week period using the 
post-hoc Kruskal-Wallis test (p=0.05).
Within group tests were carried out using the Wilcoxon Signed Ranked test. Only the 
exercise therapy group demonstrated a significant decrease over the intervention period 
(p=0.021; Pre-treatment 0.33 ± 0.79 SEM vs post-treatment -1.08 ± 0.63 SEM). Although 
the other groups appear to show a positive trend, this was the only demonstrable significant 
improvement within groups for pain.
3.8 Range of Motion
Range of motion at the knee joint was measured using a standard AMS protractor 
goniometer following the procedure described in section 3.3.5. Flexion and extension at the 
knee was measured.
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3.8.1 Reliability Analysis for Errors in Range o f  Movement (ROM) Measurement
To examine the  level of agreement ,  magni tude and reliability of the ROM measurement  of 
knee flexion and extension; the measures  obtained at the start  of the trial (i.e. initial 
assessment  at the start  of the control period) and pre-intervention (i.e. the  end of the 
control period) were analyzed using correlational analysis and Spearmans Rho (Spearman, 
1904). These tes ts  explored the level of relationship between the measures at the two 
time points. Additionally, a Bland Altman Plot was generated to determine the level of 
agreement  within 95% Confidence Intervals (i.e. 2 standard deviations).
The table 9 below summarises the findings from a number of approaches to assess the 
level of error in measurem ent  and how this relates to reliability and levels of agreement  in 
obtaining that  measurem ent  relating to range of movement .
Table 9: Level of Agreement between Range of Movement Scores for initial and pre­
treatment measures (i.e. control period)
Outcome Correlation Spearmans
Rho
Flexion r=0.78
(p<0.00)
r=0.75
(p<0.00)
Extension r=0.36
(p=0.03)
r=0.38
(p=0.03)
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A Bland Altman plot analysis was conducted to explore the level of agreement  for the 2 
measures  of flexion and extension range of movements;  this is illustrated in Figures 2 and 
3 below, with a summary of the data used in the plots in table 10.
35
30
25
20
15
10
5
0
-5
-10
-15
-20
-25
-30
-35
-40
Mean +2sd
♦
♦
♦
♦ 
♦
♦
♦
♦
♦
♦  ♦ ♦ ♦
♦  0
♦
Mean
♦ * ♦ $ ♦ ♦ ♦  
♦ ♦
♦
Mean - 2sd
♦
20 40  60 80 100
M ean Flexion Scores (degrees)
120 140 160
Figure 2: Bland Altman plot for flexion difference scores versus mean flexion scores to 
demonstrate the clustering of values between 2 standard deviations.
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Figure 3: Bland Altman plot for extension difference scores versus mean extension 
scores to demonstrate the clustering of values between 2 standard deviations.
Table 10: Bland Altman summary data table.
Outcome Mean
Difference
Score
Difference
Score
Standard
Deviation
(sd)
Sd x 2 Mean + 
2sd
Mean -  
2sd
Percentage 
of scores 
within 
±2sd
Flexion 3.7 13.02 26.04 30.01 -22.34 97.3%
Extension 1.27 5.63 11.26 12.53 -9.99 94.5%
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The figures and tables above demons tra te  that  measurements  of flexion and extension of 
the knee fall within 95% confidence interval limits, thus demonstrat ing a high level of 
agreement  be tween  measures  and therefore  a high level of reliability.
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Graph 3. Changes in knee flexion during the intervention period across all groups
The graph above shows changes in flexion across the study period for each o f  the 
intervention groups. O ver the initial three week period (control), the IFT (10.25 ± 2.44 
SEM ) and combination group (2.25 ± 2.67 SEM ) appeared to im prove in degrees o f  knee 
flexion. H owever in the sam e period, the exercise therapy group appeared  to decrease 
flexion range o f  motion (1.42 ± 5.04 SEM).
Over the intervention period both the exercise therapy group (10.25 ±  3.52 SE M ) and the 
combination group (4.48 ± 3.66 SEM ) appeared to increase flexion range o f  motion.
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However, over the same period the IFT decreased in flexion range of motion (3.42 ± 3.52 
SEM).
Over the study period all groups demonstrated an improvement in flexion range of motion. 
Statistically, normality tests proved the data collected for flexion range of motion to be 
parametric, thus ANOVA tests were used to analyse the data. For between group 
differences, Bonferroni post-hoc tests were used.
Between group analysis demonstrated that there was a significant difference (p=0.015) 
found between the exercise therapy and IFT groups over the intervention period. No other 
significant between group differences were found.
A one-way repeated ANOVA was conducted to compare flexion ROM before the control 
period, prior to treatment and following treatment. Significant improvements in flexion 
ROM, in the exercise therapy group were found in both the intervention period (p=0.015) 
and in the overall study period (p=0.05).
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Graph 4. Changes in knee extension during the intervention period across all groups.
The graph above show s changes in knee extension range o f  motion in subjects over the 
study period. All groups appear to have dem onstrated im provem ents over all periods during 
the study.
Statistically, norm ality  tests proved the data collected for extension range o f  motion to be 
significantly d ifferent from normal distribution therefore Kruskal-W illis  and W ilcoxon tests 
were used for betw een  group and within group analysis respectively. Following statistical 
testing, no significant between group differences were found.
Within group analysis  using W ilcoxon tests dem onstrated a significant im provem ent 
(p=0.009) in the exercise  therapy group over the study period. A significant im provem ent
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(p=0.007) was also dem onstrated over the sam e period in the com bination group. The 
com bination group also dem onstrated a significant im provem ent (p=0.027) over the 
intervention period.
3.9 Summary
Overall, there appeared to be a general im provem ent across all outcom es in all groups (see 
Fable 10 below), o ther than in ROM  flexion in the IFT group. However, significant 
im provem ents w ere dem onstrated  for all outcom es in the exercise therapy group. T he IFT 
group did not dem onstra te  any significant im provem ent in any o f  the outcom es measured. 
Furthermore, it does appear that the addition o f  IFT to exercise therapy does have relevance 
as the com bination  group appeared to be o f  most benefit to subjects in the study when 
assessing extension ROM.
Table 10: Sum m ary  Table o f  Results
Outcome Pre
Treatment
score
Post
Treatment
score
Improvement P  value
Combination
Group
WOMAC -0.67 -41.91 Improvement  
of 41.24
P=0.026
Pain -0.17 -2.36 Improvement  
of 2.19
P>0.05
ROM Flexion 2.25 6.73 Improvement  
of 4.48
P=0.05
ROM
Extension
1.42 6.45 Improvement  
of 5.03
P=0.027
IFT Group WOMAC -7.83 -25.67 Improvement  
of 17.84
P> 0.05
Pain 0.58 -0.25 Improvement  
of 0.83
P> 0.05
ROM Flexion 10.25 6.83 Worsened by 
3.42
P> 0.05
ROM
Extension
0.67 1.33 Improvement  
of 0.66
P>0.05
Exercise
Therapy
Group
WOMAC 7.83 -32.5 Improvement  
of 40.33
P=0.01
Pain 0.33 -1.08 Improvement  
of 1.41
P=0.021
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ROM Flexion -1.42 8.83 Improvement 
of 10.25
P=0.015
ROM
Extension
1.75 4.17 Improvement 
of 2.42
P=0.009
3.10 Discussion
In the current trial the effect of different interventions on subjects with OA of the knee has 
been examined. Originally, the aim of the study was to evaluate whether the combination of 
exercise therapy and IFT would have a greater benefit to sufferers of OA knee than either 
intervention alone. Following completion of the trial, it appears that for function (when 
measured by WOMAC), pain and flexion ROM, that the addition of IFT to an exercise 
therapy programme increased the benefit when compared to treatment using an exercise 
therapy programme in isolation.
Previously, combination treatments involving IFT on knee OA had not been tested on this 
type of population . This may be in keeping with the relatively little amount research done 
on IFT as a modality (Johnson 1999), or due to the increased complexity of examining 
numerous interventions in a single study. There is one other study known to the authors 
that has examined the effect of these combination treatments on an African population 
(Adedoyin 2005), and therefore the current trial planned to add knowledge to an area of 
relatively scant information, and test the methodology to plan a larger a scale study. 
Outcomes used to evaluate effectiveness of the interventions were the WOMAC scale, 
verbal pain scale and range of motion (ROM) measured with standard AMS goniometer. 
These outcomes were chosen as they have been proven to be reliable measures (Carlsson A 
1983; Clapper 1988; Angst F 2001; Cibere 2004; Faucher M 2004), are regularly used 
within clinical practice, and have been commonly used in studies assessing similar 
measures as the current study (Adedoyin 2005; Walker 2006).
It was found that exercise therapy in isolation had a significant effect on pain (Pre­
treatment 0.33 ± 0.79 (mean ± SEM) vs post-treatment -1.08 ± 0.63), flexion ROM (-1.42 
± 5.04 vs 8.83 ± 4.07), extension ROM (1.75 ± 1.34 vs 4.17 ± 1.13) and function (7.83
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± 4.36 vs -32.5 ± 12.1) at various points of the study. IFT was found to have no significant 
effects on any outcome in isolation, however when used in combination with exercise 
therapy, significant improvements were found on function (0.67 ± 8.85 SEM vs -41.91 
± 16.53 SEM) and extension ROM (1.42 ± 1.53 SEM vs 6.45 ± 1.45 SEM). Improvements 
were greatest in the combination group.
3.11 Conclusion
The pilot study carried out appears to show that both exercise therapy and the combination 
of IFT to exercise therapy improves the outcomes measured when compared to either 
intervention in isolation. IFT in isolation did not demonstrate any significant changes in 
any of the outcomes measured. The trial carried out also planned to test the methodological 
process as a plan for any larger scale future trial. As the trial was carried out successfully, 
the trial does offer a valuable method of assessing these interventions in the treatment of 
OA knee.
The following chapter will examine the review and trial chapters, with comparison to any 
previous studies in the area and offer any possible explanation for the observed changes in 
the clinical trial study and to determine possible implications for future clinical practice.
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4.0 Thesis Discussion
4.1 Introduction
Knee OA is a common disorder that affects millions o f people worldwide (Naredo 2005). 
The disease is linked to an increase in age and with the age of the population set to 
increase, the prevalence of this condition is also likely to increase (Hamerman 1995). 
Furthermore the social cost of the condition is likely to increase and therefore it is 
important that a variety of methods are investigated so that society is able to adequately 
tackle the problems that this condition will present.
4.1.1 Aims and Objectives
The aim of the current thesis was to examine the current literature on the use of IFT and 
exercise therapy in the treatment of knee OA. Current trends were used to guide the design 
of a clinical trial which attempted to test the methodological design to guide a larger scale 
study which could answer whether the combination of IFT and exercise therapy would lead 
to greater improvements than either intervention alone.
4.2 Main Findings
This thesis has examined the existing literature on some of the possible methods that could 
be used to address some of the common symptoms that knee OA is likely to present. The 
review chapter presented some of the possible mechanisms of IFT and highlighted that it 
may be a viable option to decrease pain caused by inflammatory disorders such as knee OA 
and to aid in function. The review also highlighted the need for more structured research in 
the area, and into the exact mechanisms that caused IFT to have its effects.
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The review chapter also described the use of exercise therapy on knee OA and presented 
encouraging signs that this method is a useful and easily applicable method with which to 
address many of the common symptoms of knee OA. The majority of studies encouraged 
the further use of exercise therapy and also highlighted potential problems in this body of 
research. The review highlighted difficulties in comparisons of studies due to the wide 
varieties of exercise methods, repetitions; frequencies used and suggested the need for 
some parity when designing studies to assess the modality.
As part o f the thesis a pilot study was designed to assess whether the combination of the 
two aforementioned treatments would have significant effects when compared to either 
treatment modality in isolation, and to test the viability of a similar larger scale study. 
Although the pilot-study did demonstrate a small benefit of combination therapy, the effect 
was minimally more beneficial than exercise therapy in isolation and therefore it could be 
questioned as to the cost effectiveness of the addition of IFT to an exercise programme for 
knee OA.
4.2.1 Hvpoalgesia of IFT
When compared to other studies that have examined the effect of IFT on pain, the current 
study was unable to demonstrate any significant improvement in pain, although a clinical 
improvement in pain was observed, thus in agreement with other studies (Adedoyin 2002; 
Hurley 2004). As in other studies (Hurley 2004) a clinical improvement is one that is 
insignificant post analysis, but keeps with a positive trend and is one that may be viewed by 
the subject to be worthwhile, i.e. from a mean rating of 0.58 at the end of the control period 
to -0.25 post intervention as illustrated in Graph 2. In contrast to the current study however, 
improvement with regards to pain in other studies was proved to be significant (Johnson 
1999; Jarit 2003; Johnson 2003; Adedoyin 2005; Jorge 2006; Mcmanus 2006).
In the present study, IFT was used for 20 minutes with a sweep setting between 80Hz and 
120Hz beat frequency. These settings are in keeping with previous authors’ work, as 
outlined in the narrative review chapter of the current study. Most other studies used 100Hz 
at a constant beat frequency (Johnson 1999; Johnson 2003; Mcmanus 2006; Walker 2006), 
therefore it may be that 100Hz is the optimum frequency for pain relief, as most studies
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reviewed that used this frequency appeared to find significant improvements on pain relief 
Other authors propose that frequencies of 100Hz or above selectively stimulate large 
diameter nerve fibres, inducing segmental inhibition of nociceptive nerve impulses in the 
substantia gelatinosa of the dorsal horn (De Domenico 1981; Savage 1992; Walsh 1997). It 
is interesting to note that a significant effect on pain was found in a similar study 
(Adedoyin 2005) using 80Hz frequency as this is contradictory to the supposed mechanism 
of action in terms of inhibition of large diameter fibres, which supposedly occurs above 
100Hz. However, it has been postulated that frequencies above 40Hz may cause a 
physiological pain block (De Domenico 1982; Brown 1985; Goats 1990). The Adedoyin 
(2005) study used IFT as often as the current study, and also applied the intervention using 
a quadrapolar method. The main differences being the beat frequency used and every 
subject in the intervention group in the Adedoyin (2005) study received exercise therapy 
treatment. There are a number of other treatment variables that need to be considered when 
analysing the effects demonstrated in the present study. Frequency of application, duration 
of treatment, electrode placement and length of intervention period may all affect the ability 
of IFT to have a significant effect on pain. In the current study, IFT was applied twice a 
week, whereas in other studies IFT has been applied two or three times a day (Jarit 2003; 
Walker 2006) . This frequency of treatment may be considered unrealistic in any setting 
other than in a home setting due to resources of staff and equipment, thus would be 
therefore clinically inapplicable. The present study used a treatment duration of 20 minutes 
as this is considered as the average treatment duration in clinical practice, however in some 
of the studies reviewed, IFT was applied for up to one hour (Jorge 2006). This may be 
considered as unrealistic in the clinical environment as the average physiotherapy treatment 
lasts about 30 minutes.
Some of the studies reviewed treated subjects for up to sixteen weeks (Walker 2006) 
whereas the current study had no follow up period, with the intervention period lasting 
three weeks. This was mainly down to resources available to the current authors, and is an 
aspect that any future study would look to address.
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4.2.2 IFT Effect on Function
IFT studies that examined the effect on function found similar findings to that of the 
present study. Hurley et al. (2004) found a clinical improvement in function, although this 
was not proved to be significant. In contrast, Adedoyin et al. (2005) found a significant 
improvement in WOMAC score following use of IFT at 80Hz beat frequency for 20 
minutes, twice a week for four weeks. However, the fact that every intervention group in 
this study received exercise therapy meant that the IFT group in the Adedoyin (2005) study 
was in effect, a combination treatment group. In the study, functional improvement was 
attributed to the effect of IFT, however it could be argued that the improvement in function 
could be attributable to the effect of the exercises used in the study.
However, Hurley (2004) found that the addition of manipulative therapy to an IFT 
programme yielded significantly better results than the manual therapy group, thus in 
contradiction to the present study. Hurley (2004) used IFT at a constant frequency of 
140Hz, for 30 minutes per treatment session but only gave an average of five treatment 
sessions. Thus, it may be that constant frequencies yield better results when using IFT for 
functional improvement.
4.2.3 IFT Effect on Range of motion
The remaining outcome measure used in the current study was ROM using goniometer. 
None of the studies examining IFT used ROM as an outcome measure, thus comparison in 
respect of this outcome is made difficult. The measurement of ROM is much more common 
when analysing the effect of exercise therapy on knee OA.
4.2.4 Exercise Therapy on Hvpoalgesia
In the present study, the exercise therapy group was the only intervention group that 
demonstrated a statistical improvement in pain over the intervention period. Although the 
other groups appeared to demonstrate an improvement, only the exercise therapy group
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showed a significant change. This finding was in agreement with other studies mentioned 
previously in chapter 2 (Ettinger 1997; Rogind 1998; O'Reilly 1999; Deyle 2000; Thomas 
2002; Huang 2003; McCarthy 2004; Deyle GD 2005; Huang 2005; Doi 2008; Jan 2008). 
However although there seems to be a favourable effect of exercise therapy, the types of 
exercise used in the various studies ranges from high resistance, low repetition exercise to 
aerobic, class based exercise. The muscle groups that are targeted with the exercises used 
also varies from quadriceps to lumbar region. Therefore, due to the wide variety of exercise 
used, clear comparison is difficult. The present study used easily applicable exercises that 
are commonly used in practise in a circuit method at an intensity that was comfortable for 
the subjects in the study. Subjects were encouraged to continue with the exercises at home 
if they wished. This was also aimed to replicate clinical practise as patients often have to 
continue with exercises at home as part of a treatment plan.
The present study found a significant reduction in pain, however, a number of other studies 
found no significant difference in osteoarthritic knee pain when treating subjects with 
exercise. Williamson et al (2007) demonstrated an improvement in pain scores which was 
not significant. The exercises used in this study were similar to the ones used in the present 
study, as they used clinically applicable exercises that concentrated on quadriceps and 
hamstring exercises such as straight leg raise, balance exercises, sit-to-stand, stair climbing 
and resisted knee extension. This exercise group exercised under supervision for one hour 
per week over six weeks but did not exercise at home. It may be considered that if this 
group were allowed to exercise at home, then a significant reduction similar to the present 
study may have been achieved.
Bennell et al. (2005) compared ‘physiotherapy’ management which included exercise 
against a placebo in the treatment of knee OA. The exercises used were devised to retrain 
the quadriceps, hip, back and thoracic spine. Compliance with the exercises was monitored 
with log book however as the exercise detail in the study is relatively scant and due to the 
exercises being combined with a number of different interventions, it is difficult to compare 
the current study accurately. The Bennell study reported that 53% of the physiotherapy
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group reported a significant reduction in pain, compared with 47% in the placebo group, 
thus there being no significant between group differences.
4.2.5 Exercise Therapy effect on function
Function in the present study was measured using the WOMAC scale which is a scale used 
in a number of the studies compared earlier in chapter 2. (Maurer 1999; O'Reilly 1999; 
Deyle 2000; Thomas 2002; McCarthy 2004; Bennell 2005; Deyle GD 2005; Doi 2008; Jan 
2008). The present study found that both the exercise therapy group and the combination 
group found a significant improvement in WOMAC score during the intervention period. 
This significant improvement in WOMAC score is in keeping with the findings of a 
number of other studies (O’Reilly 1999; Deyle 2000; Thomas 2002; Deyle GD 2005; Jan 
2008) regardless of exercise type used. This suggests that general exercise, regardless of 
fine detail can lead to a significant improvement in activities of daily living and overall 
function.
4.2.6 Exercise Therapy effect on range of movement
In the present study, subjects in the exercise therapy group improved in flexion and 
extension range of motion significantly. Between group analysis also demonstrated a 
significant difference in the exercise therapy group over the IFT group. The only other 
similar study (Huang 2005) to examine the effect of exercise therapy on ROM found that 
flexion and extension ROM increased significantly in all treated groups. Exercises used in 
this study involved the used of a Kin-Kom machine which helps strengthen the knee at 
different degrees of knee flexion. Although the exercise programme used in this study 
differs to that used in the present study, it could be that the prolonged positioning of the 
affected knee in differing degrees of flexion led to stretching of the knee joint capsule. This 
may have occurred in the present study as a number of the exercises used could feasibly 
have had this affect (hamstring curl, passive knee flexion, cycling).
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4.2.7 Effect o f Combination Treatment on outcome measures
The only studies known to the authors that have used the same combination treatments are 
those carried out by Adedoyin et al. (2002) and (2005). In the former study, IFT was used 
as the treatment and this was compared to a ‘placebo’ group, although all participants, 
including those in the placebo group received eight, 20 minute exercise sessions over four 
weeks. The IFT in the study was set at 100Hz for the first fifteen minutes and then reduced 
to 80Hz for the final five minutes and participants in the IFT group underwent this 
treatment following the exercise. The study found that both groups found a significant 
reduction in pain, and furthermore there was a significant difference between groups. This 
result suggests that both the IFT and exercise therapy is effective at reducing pain, although 
details of the exercises that subjects undertook are not documented in the study.
In the 2005 study, the author assessed the effect of IFT, TENS, and exercise on knee OA. 
However, in the study all groups received exercises which consisted of eight sessions of 
quadriceps strengthening exercises and cycling for a total of approximately 25 minutes. The 
IFT used in the study consisted of a continuous beat frequency at 80Hz at a strong but 
comfortable intensity. In the 2005 study, WOMAC was added to pain rating as an outcome 
measure and the study found that all groups had a significant improvement in pain and 
WOMAC score over the four week period which is in agreement with the present study. 
However, the present study was not able to demonstrate a significant reduction in pain in 
the combination group, although this was adjudged to be clinically significant.
4.2.8 Outcome Measures
The current study used WOMAC as the main outcome measure. This outcome has been 
proven to be reliable (Angst F 2001; Faucher M 2004) and is commonly used in arthrogenic 
studies to detect any change in function. However, it may be argued that although it is a 
commonly used measure in clinical trials, it is not commonly used in clinical practice, and
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it is suspected that this may be due to the overall cost of the scale. It could also be argued 
that another less common functional scale such as ‘timed get up and go’ or 100m walk test 
could have been used. It was therefore decided that due to limited time resources, and in 
keeping with studies within the area that the main functional outcome would be the 
WOMAC scale.
A verbal pain rating scale was used in the study to evaluate pain as this is a scale commonly 
used in clinical practice. Subjects were asked to rate their pain at worst between 0-10 over 
the past 24 hours. Although it has been proved that this is a valid and reliable measure to 
use (Geier 2007), one could argue that the outcome may not be as sensitive as a rating 
between 0-100, which may allow for a more accurate detection of any change in pain 
rating. It may also be argued that other pain specific questionnaires such as the Mcgill pain 
questionnaire (Melzack and Torgerson, 1971) could have been used in place of, or in 
addition to the NRS. This was considered, however in keeping with clinical practice and 
due to limited resources, the NRS was the only pain measure used.
The final outcome used was ROM of the knee as measured by goniometer. This measure is 
a commonly used measure in physiotherapy and the reliability has been confirmed by other 
authors in previous studies (Rothstein 1983; Clapper 1988; Cibere 2004). The measurement 
is used within clinical practice to give the examiner an idea of the flexibility of the joint, 
and thus the overall health of the joint being tested. Reliability measures of data showed 
that measurements for flexion and extension fell within 95% confidence limits, thus were of 
high reliability.
Overall the outcomes used are all outcomes that are easily able to be used in clinical 
practice in any outpatient department. It could be argued that the outcomes may not be as 
sensitive as other more expensive outcome measures (Kin-kom to measure muscle strength 
or electro-goniometry) and it could also be argued that the study could have used more 
outcomes to measure function, such as the SF-36 scale, or timed lOmetre walk test. 
However, based on the time available the study ensured that the most common clinical 
measures were assessed using reliable formats. Although the study did aim to try and
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replicate similar treatments and outcomes used in the clinical setting, it is recognised that 
there were limitations to the study.
4.3 Limitations
Overall, the present study has found similar results to previous studies when examining the 
effects of exercise therapy and IFT on knee OA. However, the present study is one of two 
known to the authors that has trialled combination therapy on the chosen condition. There 
are many studies that have examined each intervention in isolation, however the 
examination of combination therapies is less common and the possible reasons for this have 
been discussed earlier. The design of the present study is also less common. In the present 
study, each subject acted as their own control over the initial three week period. This meant 
that the authors were able to include a control group without the clinical loss to the patient 
of not receiving any treatment. It could be argued that due to subjects acting as their own 
control, the disadvantage of intervention subjects being compared to control subjects with 
other potentially confounding variables is not a concern. It may also be argued that as all 
subjects knew that they were to receive treatment in the second three week period of the 
study, that a ‘cognitive-dissonance effect’ may have caused the subjects to behave in a 
manner that would not have been keeping with their normal behaviour had they not been 
due to receive treatment. With a linear control group throughout a study, it is possible to 
evaluate the effect of no intervention across the whole study period, and due to restrictions 
following ethical review, this was not possible during the current study.
The present study evaluated the interventions over a six week period and there was no 
follow up done on subjects on completion of the intervention period. This denies the 
authors potentially valuable information on the longer term effect of the intervention. Had 
resources been available to the authors, subjects would have been evaluated over a six 
month period following completion of the intervention phase.
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The study was a pilot study; therefore any findings must be viewed with caution as they 
may not be applicable to the general population. Due to time and staffing resources, it was 
decided that this would be the most realistic option when compared to the option of starting 
with a multi-centre trial. No power calculation was done prior to subject allocation, and 
subject number was based on similar studies that had examined similar interventions 
(Adedoyin 2002, 2005). There was no follow up period on subjects following completion 
of the trial. This means that any longer term effects of interventions were not assessed and 
this makes true evaluation of cost-effectiveness of each intervention difficult. Although the 
combination intervention group showed most improvement, it could be questioned as to 
whether the degree of improvement is cost effective when the extra treatment time of the 
therapist is also considered, and this could be a question of future research. However, even 
though it is recognised that there were limitations to the study, it is possible that the study 
can shape future research into the area, as the study does demonstrate that combination 
treatments on OA knee can have beneficial effects.
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4.4 Conclusion
The results of the study show that the interventions tested can have a positive effect on 
people living with knee OA. This is largely in agreement with other studies done in the 
area, as reviewed in chapter 2. It was also demonstrated that the largest effect took place in 
the combination group for the improvement of extension ROM. The effect of combination 
therapy needs to be studied in more detail, possibly using a multi-centre trial and group 
exercise classes. This would improve cost-effectiveness and hopefully maintain effect of 
intervention. It appears from past research that the most effective frequency for IFT use is 
100Hz, and therefore, it may be that any future study uses this frequency when assessing 
the effect of IFT on knee OA. The exercises used in the current study are simple to apply 
and are commonly used in clinical practice, thus it would be appropriate to continue their 
use in any future study.
The effect of exercise therapy on knee OA has previously been examined by a number of 
studies, and therefore the current study adds little to the work on this area However, the use 
of IFT on OA knee is relatively scant therefore the study adds to the work done on 
examining the effect of IFT on knee OA.As far as the author is aware, this is the first study 
that has looked at the effect of each of these modalities in isolation and in combination in 
this population, and as a result contributes originally to the body of knowledge on the area. 
The results from the clinical suggest that exercise therapy should be the mainstay of future 
treatment, with combination treatment used if available. The study also suggests further 
ways in which future research may be structured in order to make comparison more viable 
and thus more valuable. The thesis has addressed its initial aims through evaluation of the 
current research and the presentation of a repeatable pilot study.
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Study Title
Patient Information Sheet
Comparing the effect of two different types of physiotherapy treatment on knee pain. 
Your Invitation to the Study
You are invited to take part in a research study, but before you do, it is important you 
read the information below to understand what the research involves so you can 
decide if you wish to be involved. Please take some time to read the information and 
feel free to contact one of the investigators to ask any questions you may have.
Purpose of the Study
The purpose of the study is to see whether the combination of two commonly used 
physiotherapy treatments work better than one alone. The reason for the study is to 
see if there is any particular treatment that is best for knee pain.
Why have I been asked to take part?
You have been chosen to take part in this study as you have been diagnosed with a 
certain type of knee pain (arthritis) by your doctor.
Do I have to take part?
No, you do not have to take part. If you choose to take part in the study it is at your 
own free will. Also, if you do choose to take part, you do have the right to pull out of 
the study at any time, without giving a reason.
What will happen if I take part?
If you decide to take part you will need to contact the investigator using the contact 
details given below.
When you make contact, you will be asked for your contact details and be given an 
appointment to see a physiotherapist at Singleton Hospital.
During the first appointment at Singleton hospital you will be given the chance to ask 
any questions and asked to sign a consent form. When you sign the consent form, it 
means you are giving consent for the researchers to randomly allocate (put you into a 
group at random) you to receive one of three different types of treatment. You are also 
giving consent for us to contact your GP to make them aware of your taking part in 
the study, and for the researchers to collect some personal information for the purpose 
of the study. After signing the form you will have a simple assessment by a 
physiotherapist that will last about 20 minutes.
You will then be given another appointment for 3 weeks after that initial assessment. 
At this appointment you will have the same assessment to check for any changes, but 
then you will start your treatment.
You could have any of the following types of treatment:
1. A pain relieving treatment called Interferential Therapy
2. Exercises
3. A combination of the above treatments.
The type of treatment that you receive will be decided randomly so you will not have 
the ability to decide on which treatment you have. The type of treatment is decided 
randomly to try and keep the study fair and free from any effect that could alter the 
results.
Depending on what treatment you have, the time you are treated for could be between 
25 and 50 minutes. You will need to attend Singleton Hospital for treatment twice a 
week for three weeks.
Following the three week treatment period you will be assessed again. This will 
complete your involvement in the study. At the end of this period, if you are not 
happy with the treatment you have received or wish to have more physiotherapy 
treatment, you can be placed on the physiotherapy waiting list.
What do I have to do?
All you need to do is read this sheet and if you wish to take part in the study, then 
contact an investigator whose contact details are given below.
What are the possible disadvantages and risks of taking part?
There are no common or expected risks by taking part.
What are the possible benefits of taking part?
It is hoped that by taking part in this study you could have less pain in your knee, 
have more strength in the muscles around your knee, have more movement at your 
knee and improve your ability to carry out daily tasks.
Will my taking part in this study be kept confidential?
Yes. As soon as you provide details, these will be given a number. The only people
who will see these details are the people carrying out the study and they have to keep
them safe.
Who will have access to the information I have provided?
Only the people carrying out the study will have access to the information you have
provided.
What will happen to the results of this study?
The results will be stored at Swansea University for 10 years, as instructed by law.
You will be able to see the results of the study if you wish to do so.
Will I receive travel costs?
Yes, travel costs will be paid. You will receive 23p per mile, up to a total of 10 miles 
per return journey (5 miles each way) to Singleton Hospital. Any travel costs will be 
paid at the end of your involvement within the study. To claim the travel costs you 
will need to fill in an expense form which one of the researchers will be happy to help 
you with.
Who has funded the study?
Sponsorship and funding of this study has been supplied by University of Wales, 
Swansea.
Who has reviewed this study?
This study has been reviewed by the student research committee and supervisors 
within the School of Health Science at the University of Wales, Swansea. It has also 
been presented to fellow researchers and physiotherapists for feedback.
This study has been reviewed by The South-West Wales Research Ethics Committee.
Contact for further information
Thank you for taking time to read about this study. To take part or for any further 
questions please contact:
Craig Dyson
E-Mail: 491747@swansea.ac.uk 
Tel: 01792 543564
Gareth Noble (Supervisor)
E-Mail: j.g.noble@swansea.ac.uk 
Tel: (01792) 602026
Appendix 3
Consent Form
Title of Project: Assessing the Effect of Interferential Therapy and Exercise therapy 
on OA Knee.
Name(s) of Researcher(s): Craig Dyson, Gareth Noble, Ron van Heeswijk
Please initial box
1. I confirm that I have read and understand the information ------
sheet dated.................for the above study. I have had the
opportunity to consider the information, ask questions and
have had these answered satisfactorily.
2. I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, 
without my medical care or legal rights being affected.
3. I understand that relevant sections of my medical notes and 
data collected during the study, may be looked at by the 
individuals outlined above, where it is relevant to my taking 
part in the research. I give permission for these individuals to 
have access to my records.
4. I agree to take part in the above study.
Name of Patient Signature Date
Name of person 
Taking consent
Signature Date
Appendix 4
D ate: 2 1 /0 8 /2 0 0 8 Reference: 08/W M W 02/76 Online Form
All studies except clinical trials of investigational medicinal products
REC Ref: 08/WMW02/76
Short Title of Study: Assessing the effect of Exercise Therapy and I FT on 0 A Knee
Cl Name: Mr Jonathan C Dyson
Sponsor: Sw ansea University
Please com plete this checklist and send it with your application
♦ Send ONE copy of each document (except where stated)
♦ ALL accompanying documents must bear version numbers and dates (except where stated)
♦ When collating p lease do NOT staple documents a s  they will need to be photocopied.
Document Enclosed? Date Version Office u se
Covering letter on headed paper O Y es O No
NHS REC Application Form, Parts A&B Mandatory
Site-Specific Information Form (for SSA) O Y es O No
Research protocol or project proposal (6 copies) Mandatory
Summary C.V. for Chief Investigator (Cl) Mandatory
Summary C.V. for supervisor (student research) O Y es O No
Research participant information sheet (PIS) O Y es O No
Research participant consent form O Y es O No
Letters of invitation to participants O Y es O No
GP/Consultant information sheets or letters O Y es O No
Statement of indemnity arrangements O Y es O No
Letter from sponsor O Y es O No
Letter from statistician O Y es O No
Letter from funder O Y es O No
Referees' or other scientific critique report O Y es O No
Summary, synopsis or diagram (flowchart) of 
protocol in non-technical language O Y es O No
Interview schedules or topic guides for 
participants O Y es O No
Validated questionnaire O Y es O No
Non-validated questionnaire O Y es O No
Copies of advertisement material for research 
participants, e.g. posters, newspaper adverts, 
website. For video or audio cassettes, please also 
provide the printed script.
O Y es O No
NHS REC Application Form -  Version 5.6 1 AB/132691/1
Date: 21/08/2008 Reference: 08/WMW02/76 Online Form
}Z " : f ; &],m iife^ ^ -■ ■*:0*5-g iV»ITQ i
An application form specific to your project will be created from the answers you give to the following questions.
1. Is your project an audit or service evaluation?
O Yes 0 No
2. Select one research category from the list below:
O  Clinical trials of investigational medicinal products 
O  Clinical investigations or other studies of medical devices 
0 Other clinical trial or clinical investigation
O  Research administering questionnaires/interviews for quantitative analysis, or using mixed quantitative/qualitative 
methodology
O  Research involving qualitative methods only
O  Research limited to working with human tissue sam ples and/or data
O  Research tissue bank
If your work does not fit any of these categories, se lect the option below:
O  Other research
2a . P lease answer the following questions:
a) D oes the study involve the use of any ionising radiation? O Yes 0 No
b) Will you be taking new human tissue sam ples? O Yes 0 No
c) Will you be using existing human tissue sam ples? O Yes 0 No
3. Is your research confined to one site?
0 Yes O No
4. Does your research involve work with prisoners?
O  Yes 0 No
5. Do you plan to include in this research adults unable to consent for them selves through physical or mental 
incapacity?
O  Yes 0 No
6. Is the study, or any part of the study, being undertaken a s an educational project?
0 Yes O No
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6a. Is the project being undertaken in part fulfilment of a PhD or other doctorate?
O Y es 0  No
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N H fi  R o c o a r r h  F t h i r c  r n m m i t f p o
Application form_____________________
This form should be com pleted by the Chief Investigator, after reading the guidance notes. S ee glossary for clarification 
of different term s in the application form.
Short title and version number: (maximum 70 characters -  this will be inserted a s header on all forms)
A ssessin g  the effect of Exercise Therapy and I FT on OA Knee
Name of NHS Research Ethics Committee to which application for ethical review is being made:
Project reference number from above REC: 08/WMW02/76 
Subm ission date: 21/08/2008
A1. Title of the research
Full title: A ssessing the effect of Exercise Therapy and Interferential Therapy on OA Knee: A feasability study.
Key words: Osteoarthritis
OA
Arthritis
Exercise
Exercise Therapy
Rehabilitation
Active Rehabilitation
Physical Therapy
Physiotherapy
Physical Activity
Electrotherapy
Electrical Stimulation
TENS
I FT
US
Ultrasound 
PSWD 
Knee OA
A2. Chief Investigator
Title: Mr
Forename/Initials: Jonathan C
Surname: Dyson
Post: Physiotherapist
Qualifications: BSc(Hons) Physiotherapy
Organisation: Vale Clinic
Work Address: Vale Clinic
Hensol
Post Code: CF72 8JY
E-mail: jc_dyson@hotmail.co.uk
Telephone: 01792204546
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Fax:
Mobile: 07789394082
A copy of a current CV (maximum 2  pages of A4) for the Chief Investigator must be  submitted with the application
A3. Proposed study dates and duration
Start date: 01/10/2008
End date: 01/09/2009
Duration: Years: 1 ; Months: 0
A4. Primary purpose of the research: (Tick as appropriate)
[U  Commercial product development and/or licensing
□  Publicly funded trial or scientific investigation 
0  Educational qualification
□  Establishing a database/data storage facility
□  Other
Question(s) 5 disabled.
A6. Does this research require site-sp ecific  assessm en t (SSA)? (Advice can be found in the guidance notes on this topic.) 
O Yes ®  No 
If No, please justify:
Data Collection will take place in the Physiotherapy Department of Singleton Hospital (Abertawe 
Bro-Morgannwg University Trust). Data collection will only utilise equipment currently held in the department for 
its intended use. Investigation falls within routine clinical com petence, a s  the methods being investigated are 
part of routine physiotherapy practice.
If Yes, an application for SSA should be made for each research site on the Site-Specific Information Form and submitted to 
the relevant local Research Ethics Committee. Do not apply for SSA at sites other than the lead site until the main 
application has been booked for review and validated by  the main Research Ethics Committee.
Management approval to proceed with the research will be  required from the R&D office for each NHS care organisation in 
which research procedures are undertaken. This applies whether or not the research is exem pt from SSA. R&D applications in 
England, Wales and Scotland should be  made using the Site-Specific Information Form.
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A7. What is the principal research question/objective? (Must be in language comprehensible to a layperson.)
The primary objective of the proposed study is to evaluate the effectiveness of exercise therapy and 
interferential therapy in the management of OA knee a s determined by pain, range of motion, physical 
function and Quality of Life m easures. Baseline measurements using standardised objective tests would be 
taken pre and post treatments and effectiveness of treatments would then be evaluated.
A8. What are the secondary research questions/objectives? (If applicable, must be in language comprehensible to a lay 
person.)
Secondarily, it is to ascertain whether these treatment options would be more or less effective as a 
combination therapy.
A9. What is the scientific justification for the research? What is the background? Why is this an area of 
importance?(M ustbe in language comprehensible to a layperson.)
Osteo-Arthritis (OA) is one of the most prevalent d isease  associated with significant disability as well a s a 
common cause of functional limitation and dependency (Devos-Com by et al. 2006) that affects the major 
joints of the musculoskeletal system  (especially the hip and knee joints) and has a high prevalence in the 
older population due to the ‘wear and tear’ component in its pathogenesis, in the United States, OA w as the 
leading cause of disability, with the indirect cost estimated to be $68.4 billion in 1992 (Yelin and Callaghan, 
1995). It has been projected that 59.4 million in the U.S. (or 18.2% of the population) will suffer from OA by 
2020 (MMWR, 1994). As a condition, OA of the knee is particularly disabling due to symptoms such as pain, 
stiffness and muscle w eakness (Mcalindon et al. 1992, O’Reilly et al. 1998). As the population ages, the cost 
of this public health burden is expected to increase. Increased treatment efforts and appropriate clinical and 
self-m anagem ent are needed to reduce the impact of arthritis and chronic joint symptoms (MMWR, 2002). 
One aspect of the care of people living with OA of the knee involves the referral to a physiotherapist for 
symptom management aiming to decrease pain levels, muscle stiffness and w eakness to ultimately improve 
their ability to carry out day to day activities(physical function) and quality of life (QoL). The mainstay of 
physiotherapy treatment is exercise therapy targeting the m uscles that surround the knee to improve 
function. Furthermore, it is thought that if there is appropriate pain management via another physiotherapy 
treatment (i.e. interferential therapy), the persons’ physical function and QoL may further increase. However, 
the strength of research evidence to support the use of both exercise therapy and interferential therapy is 
limited. Therefore, this research project would be aimed at improving the evidence base behind currently 
used treatment techniques within the realm of physiotherapy. The primary objective of the proposed study is 
to evaluate the effectiveness of exercise therapy and interferential therapy in the management of OA knee as  
determined by pain, range of motion, physical function and QoL measures. Secondarily, it is to ascertain 
whether these treatment options would be more or less  effective as a combination therapy. Subjects would 
be split into one of four treatment groups; 1. Exercise Therapy, 2. Interferential Therapy, 3. A combination of
1. and 2., and 4. Control Group. Baseline m easurements using standardised objective tests would be taken 
pre and post treatments and effectiveness of treatments would then be evaluated. The results of this study 
would inform physiotherapy practice with the aim of improving the management of OA knee for all people 
living with OA knee.
A10-1. Give a full summary of the purpose, design and m ethodology of the planned research, including a brief 
explanation of the theoretical framework that informs it. It should be clear exactly what will happen to the research 
participant, how many times and in what order.
This section must be completed in language comprehensible to the lay person. It must also be self-standing as it will be 
replicated in any applications for site-specific assessm ent on the Site-Specific Information Form. Do not simply reproduce or 
refer to the protocol. Further guidance is available in the guidance notes.
The purpose of the planned study is to s e e  whether the combination of exercise therapy and interferential 
therapy is more beneficial than either intervention alone when treating patient with osteo-arthritis of the knee.
It is planned to take thirty-six subjects, aged 4 5 -7 0  all suffering with Osteo-arthritis (OA) of the knee who will 
be recruited from specialist GP clinics and consultant clinics around Abertawe Bro-Morgannwg University
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NHS Trust. Subjects will have been referred into these clinics by their GP.
Inclusion Criteria are a s follows:
1. Age 4 5 -7 0
2. Confirmed osteo-arthritis (OA) of the knee by way of radiological investigation (X-Ray).
3. Osteo-arthritis a s defined by (Altman 1986), i.e. the patient experiences pain and any five of the following:
1. Over 50 years of age,
2. Less than 30 minutes of morning stiffness,
3. Crepitus (noisy, grating sound) on active motion,
4. Bony tenderness,
5. Bony enlargement,
6. No palpable warmth of synovium,
7. Erythrocyte sedimentation rate (ESR) less than 40 mm/hr,
8. Rheumatoid factor less than 1:40 titer (agglutination method),
9. Synovial fluid signs.
Patients will be excluded from the study if they:
1. Have had any other treatment in the previous six w eeks
2. Have any other medical condition which could explain their current complaints.
3. Have Kellgren Grade IV OA (large osteophytes (bony growths), marked joint space narrowing, severe  
sclerosis (hardening of the cartilage) and definite deformity of bone ends. This is applied when X -Ray show s 
a very high level of OA presence)(Kellgren 1957).
4. Are primarily suffering with patello-femoral joint OA (Osteo-arthritis of another joint)
5. Are contra-indicated for exercise treatment or Interferential Treatment (IFT). Contraindications for I FT are 
as follows: Patients w hose skin are easily damaged or bruised, patients who are on anti-coagulation therapy, 
patients with pacemakers, patients who have active malignancy. Contraindications to exercise therapy are as  
follows: Any uncontrolled cardiac conditions(aortic stenosis,cardiac enlargement,dysrhythmias,ventricular 
aneurysm,cardiomyopathy,congestive heart failure) or uncontrolled metabolic disorders (Diabetes, 
thyrotoxicosis, myxedema.)
6. Are unable to read and understand English.
Procedure
Patients will be a sse sse d  for their suitability for the study in the GP/consultant clinic. If suitable, subjects will 
be given an information sheet about the study s e e  attached). The information sh eet will contain details of the 
investigation and state that they have the right to withdraw from the study at any time. The information sheet 
will also contain the contact details of the Chief Investigator. Subjects will be instructed to contact the Chief 
investigator if they wish to be included in the study. On contact with the Chief Investigator, patient name and 
contact details will be taken, and these details will be allocated to a number for randomisation. An 
appointment will be made to meet a physiotherapist who will act a s the a ssesso r  of patient outcome. The 
physiotherapist will be blinded to the patient treatment. Informed consent will b e  obtained via a consent form 
issued prior to the start of the data collection process by the blinded physiotherapist. The blinded 
physiotherapist will carry out the following outcome m easures during the initial assessm ent:
1. WOMAC Scale which consists of 24 questions, each corresponding to a visual analogue scale, designed  
to measure patients perceptions’ of pain, stiffness and dysfunction.
2. Numerical Rating Scale (NRS) pain score. This is a numerical rating scale between 0 -1 0 . The patient is 
asked to rate their current pain on a scale of 0 -1 0  with 0 meaning no pain and 10 meaning the worst pain 
imaginable.
3. Range of Movement. This will be a measurement of the patients knee flexion 
and extension by the blinded physiotherapist.
This collection of data should take 20 minutes.
Following collection of the data, patients will be given another appointment three w eeks following the initial 
assessm ent. This three week period will act a s the control period. After three w eeks, patients will again be 
assessed  by the sam e blinded physiotherapist using the sam e outcome m easures, and will com m ence the 
treatment procedure that they will have been randomly allocated.
Patients will be randomly allocated into one of three groups:
1. Interferential Therapy only group
2. Exercise Therapy only Group
3. Combined therapy group
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IFT Group
Patients in the IFT group will receive IFT twice a week, for three weeks, i.e. six session s in total. Each 
session  will last for twenty-five minutes and IFT will be concentrated on the painful knee. Standardized IFT 
stimulation parameters for pain relief will be used: carrier frequency 3.85kHz; 8 0 -1 20Hz sweep; pulse 
duration 130V4S. Four electrodes will be placed around the knee joint so  a s to concentrate the effect of the 
IFT into the centre of the joint and will be attached via a velcro strap to ensure maximum skin contact.
IFT will be administered by the chief investigator.
Exercise Therapy Group
Patients in the exercise therapy group will also be treated twice a w eek for twenty minutes. The session  will 
be broken up into the following format:
1. Warm up using static exercise bike x 3min at slow pace.
2. 6 exercise stations. Patient to exercise at each station for 40sec  with 30 se c  for change of station. Patient 
to complete circuit 3 times.
3. Warm down using static bike x 3min at slow pace
For example, each patient will do a warm up followed by the following circuit three times. After doing the 
circuit three times the patient will do the warm down.
Participants will carryout the following commonly used exercises:
1. Inner Range Quads in long sitting (sitting with legs on plinth and contracting thigh muscle).
2. Single Leg Balance. (Balancing on one leg)
3. Straight Leg Raise (sitting with legs on plinth and, keeping the leg straight, lifting the leg 2 -3 ” off the bed).
4. Step Up Exercise (stepping up onto a step)
5. Passive Knee Flexion (the participant pulls their knee into a bent position)
6. Hamstring Curl (the participant lies on their front and bends their knee against gravity).
Patients in the Exercise group will be supervised by the chief investigator. Patients will be encouraged to 
continue with the exercises at home.
Combined Group
Patients in the IFT and Exercise group will do the above exercise regime and then receive 25 minutes of IFT 
set at the above parameters.
Control Group
Patients will act as their own control as they will be a ssessed  following initial recruitment, wait three w eeks to 
simulate a control period, then be a ssessed  again prior to starting the treatment. For any patients 
complaining of increased symptoms following an exercise period, their exercise protocol would be modified 
accordingly on the opinion of the supervising physiotherapist.
Following completion of the study, patients will be offered conventional physiotherapy.
The second set of outcom e m easures will be recorded at least 48 hours after the last set of exercises to allow 
for any post-exercise  stiffness.
Patients will be advised to continue using any medication prescribed prior to the start of the study, but will be  
excluded if any changes in analgesic medication occur during the study.
Patient name and contact details will be allocated to a reference number on allocation to the study. This data 
will be stored on password controlled university computers at Sw ansea University. This data will only be 
accessed  by the Chief investigator and the research team. All assessm ent data recorded during the study will 
be kept in a sealed  container in a lockable cabinet in Singleton Hospital. This will be accessed  by the blinded 
physiotherapist carrying out the assessm ent, and the Chief investigator. Following completion of the study, all 
data will be stored at Sw ansea University for 10 years in compliance with the Data Protection Act 1998.
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A10-2. In which parts of the research have patients, members of the public or service users been involved?
Q  As user-researchers 
O  As members of a research project group 
CH As advisor to a project
IH As members of a departmental or other wider research strategy group 
0  None of the above
Please provide brief details if applicable:
A10-3. Could the research lead to the development of a new product/process or the generation of intellectual property?
O  Y es 0  No O  Not sure
A11. Will any intervention or procedure, which would normally be considered a part of routine care, be withheld from 
the research participants?
O Y e s  0 N o
A12. Give details of any clinical intervention(s) or procedure(s) to be received by research participants over and above 
those which would normally be considered a part of routine clinical care.(These include uses of medicinal products or 
devices, other medical treatments or assessm ents, mental health interventions, imaging investigations and taking samples of 
human biological material.)
Additional
Intervention Average number per participant
Average time 
taken
(mins/hours/days)
Details of additional intervention or 
procedure, who will undertake it, and 
what training they have received.
Routine Care Research
Other 0 6 25mins
Intervention is exercise therapy to be 
delivered over 6 stations, each lasting for 
40secon ds per station. Participants will 
exercise at each station 3 times per 
session  and do 2 session s per w eek over 
3 weeks.Therefore the total treatment time 
will be 150mins.
Other 0 6 25mins
Interferential Therapy (IFT) which will be 
delivered for 25minutes, twice a w eek over 
three w eeks. Therefore total treatment 
time will be 150mins
A13. Give details of any non-clinical research-related intervention(s) or procedure(s).(These include interviews, 
non-clinical observations and use of questionnaires.)
Additional Intervention
Average 
number per 
participant
Average time 
taken
(mins/hours/days)
Details of additional intervention or procedure, who 
will undertake it, and what training they have 
received.
A14. Will individual or group interviews/questionnaires d iscu ss any topics or is su e s  that might be sensitive, 
embarrassing or upsetting, or is it possible that criminal or other d isclosures requiring action could take place during 
the study (e.g. during interviews/group d iscu ssion s, or u se of screening tests  for drugs)?
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The Information Sheet should make it clear under what circumstances action may be taken
A15. What is the expected total duration of participation in the study for each participant?
The participants will be recruited from the primary sector (GP clinic)or from consultant led, hospital based  
clinics. Participants will then be given information on the study in the form of an information sheet. After 
voluntary participation in the study, baseline measurements using the Numerical Rating pain questionnaire, 
WOMAC function scale, and Range of Motion will be taken. These participants will wait for three w eeks (to 
simulate waiting list times) and then be re -a ssessed  using the sam e m easures. After this, participants will be 
randomly allocated into one of three groups outlined earlier. This treatment will last for three w eeks, with 
participants receiving treatment twice a w eek for up to one hour per session . Following the three w eek  
period, measurements using the outcome measures mentioned earlier will be repeated. At this stage the 
participants involvement in the study will end. They will then be offered further physiotherapy treatment if 
necessary.
Participants will undergo three sets of assessm ent lasting 15-20m inutes per assessm en t. Participants in the 
exercise or IFT only group will receive treatments lasting for a total of 150minutes, split over 6 treatment 
session s over a 3 w eek period. Participants in the combined treatment group(those receiving IFT and 
exercise therapy) will receive treatments lasting 300 minutes split over 6 treatment session s over a 3 w eek  
period.
A16. What are the potential adverse effects, risks or hazards for research participants either from giving or withholding 
m edications, devices, ionising radiation, or from other interventions (including non-clinical)?
All participants in this stduy will continue with routine treatment and medication.
A17. What is the potential for pain, discomfort, distress, inconvenience or changes to lifestyle for research  
participants?
There is no increased risk for any of these factors, other than those that may be experienced due to 
conventional physiotherapy treatment.
A18. What is the potential for benefit to research participants?
Potential benefit to research participants include decreased pain, increased range of motion at the knee joint, 
improved function and quality of life.
A19. What is the potential for adverse effects, risks or hazards, pain, discomfort, d istress, or inconvenience to the 
researchers them selves? (if any)
None
A20. How will potential participants in the study be (i) identified, (ii) approached and (iii) recruited?
Give details for cases and controls separately if appropriate:
Potential participants for the study will be identified via specialist GP musculoskeletal clinics, and 
consultant-led hospital-based clinics. Patients will be informed of the study by the GP/consultant responsible 
for patient treatment. Patients will also be given an information sheet about the study with contact details of 
the chief investigator. If patients would like to be involved with the study they will contact the lead 
researcher/physiotherapy department that data collection will take place via telephone. An appointment will 
be made with a physiotherapist who will answer any questions and obtain written consent. This will complete 
the recruitment process.
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A21. Where research participants will be recruited via advertisement, give specific details.
0  Not Applicable
If applicable, enclose a copy of the advertisement/radio script/website/video for television (with a version number and date).
A22. What are the principal inclusion criteria?(Please justify)
1. Patients aged 4 5 -7 0
2. Confirmed Knee Osteo-arthritis by way of Radiological investigation.
Patient age range chosen so  as to include those most likely to suffer with OA knee. Confirmed Knee OA by 
way of radiological investigation to ensure diagnosis of condition being studied.
A23. What are the principal exclusion criteria 1 (Please justify)
1. Kellgren Grade IV Knee Osteo-arthritis of the knee
2. Patello-Femoral Joint Osteo-arthritis
3. Inability to read and understand English.
4. Patients suffering with pain from another source.
5. Exercise therapy or IFT in previous six w eeks.
6. Any Contra-indications to Interferential Therapy/Exercise Therapy.
Patients with Kellgren grade IV osteo-arthritis have been excluded a s physiotherapeutic intervention has 
been shown to be ineffective at this stage due to the advanced stage of degeneration of the affected joint. 
Those patients with Patello-femoral OA have been excluded a s this could reduce the validity and power of 
the study.
Those patients who are unable to read and understand English have been excluded as the patient 
information sheet and questionnaires issued (WOMAC) will be worded in English. Therefore if the patient is 
unable to understand this could decrease the validity of the study and reduce patient safety.
Patients with pain from another source and those who have received other treatment (exercise therapy or 
IFT) have been excluded as this could decrease validity of the study.
Those with any contra-indications to the treatments being studied have been excluded to ensure patient 
safety.
A24. Will the participants be from any of the following groups?(T/'c/c as appropriate)
Q  Children under 16
□  Adults with learning disabilities
□  Adults who are unconscious or very severely ill 
C l Adults who have a terminal illness
f~l Adults in emergency situations
□  Adults with mental illness (particularly if detained under Mental Health Legislation)
□  Adults with dementia
□  Prisoners
I~1 Young Offenders
□  Adults in Scotland who are unable to consent for them selves
□  Healthy Volunteers
□  Those who could be considered to have a particularly dependent relationship with the investigator, e.g . those in care 
homes, medica( students
□  Other vulnerable groups
Justify their inclusion.
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A25. Will any research participants be recruited who are involved in existing research or have recently been involved in 
any research prior to recruitment?
O Y es ®  No O Not Known
If Yes, give details and justify their inclusion. If Not Known, what steps will you take to find out?
A26. Will informed consent be obtained from the research participants?
® Y e s  O N o
If Yes, give details of who will take consent and how it will be done. Give details of any particular steps to provide information 
(in addition to a written information sheet) e.g. videos, interactive material.
If participants are to be recruited from any of the potentially vulnerable groups listed in A24, give details of extra steps taken 
to assure their protection. Describe any arrangements to be made for obtaining consent from a legal representative.
If consent is not to be obtained, please explain why not.
Patients will be issued with a consent form with the patient information sheet. The patients will be given the 
information sheet after being a ssessed  for their suitability for the study by a consultant/GP/specialist 
physiotherapist. The patient will be required to sign and bring their consent form to the initial assessm ent.
Copies of the written information and all other explanatory material should accompany this application.
A27. Will a signed record of consent be obtained?
®  Y es O  No
If Yes, attach a copy of the information sheet to be used, with a version number and date.
A28. How long will the participant have to decide whether to take part in the research?
Patients will have the time from their being handed the information sheet in the clinic that they are initially 
assessed , up to the time they choose to be included and meet the physiotherapist for the first time. This 
period could be up to six months.
A29. What arrangements have been made for participants who might not adequately understand verbal explanations or 
written information given in English, or who have special communication needs? (e.g. translation, use of interpreters etc.)
Patients who do not understand English will be excluded from the study.
A30. What arrangements are in place to ensure participants receive any information that b ecom es available during the 
course of the research that may be relevant to their continued participation?
If any such information becom es available, patients will be informed and at all times and be offered the 
opportunity to exclude them selves from the study.
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A30-1. What step s would you take if a participant, who has given informed consent, lo se s  capacity to consent during 
the study? Tick one option only.
O  The participant would be withdrawn from the study. Data or tissue which is not identifiable to the research team may be 
retained. Any identifiable data or tissue would be anonymised or disposed of.
®  The participant would be withdrawn from the study. Identifiable data or tissue already collected with consent would be 
retained and used in the study.
O  The participant would continue to be included in the study.
O  Not applicable -  informed consent will not be sought from any participants in this research.
Further details:
Participants should be informed when seeking initial consent if it is planned to retain and make further use of identifiable 
data/tissue in the event of loss of capacity.
A31. Does this study have or require approval of the Patient Information Advisory Group (PIAG) or other bodies with a 
similar remit?(see the guidance notes)
O Y e s  ® N o
A32a. Will the research participants' General Practitioner (and/or any other health professional responsible for their 
care) be informed that they are taking part in the study?
O  Y es ®  No
If Yes, enclose a copy of the information sheet/letter for the GP/health professional with a  version number and date.
A32b. Will permission be sought from the research participants to inform their GP or other health professional before 
this is done?
O Y e s  ® N o
If No to either question, explain why not
If the participants GP refers to a specialist GP clinic or consultant clinic, responsibility of patients care p a sses  to 
the specialist GP or consultant involved. Therefore, whoever refers the participant into the study will be the 
person responsible for the participants' care, thus the person responsible for participant care is informed.
it should be made clear in the patient information sheet if the research participant's GP/health professional will be informed.
A33. Will individual research participants receive any payments for taking part in this research?
O Yes ®  No
A34. Will individual research participants receive reim bursem ent o f expenses or any other incentives or benefits  for 
taking part in this research?
O Y e s  ® N o
A35. Insurance/indemnity to meet potential legal liabilities
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Note: References in this question to NHS indemnity schemes include equivalent schemes provided by Health and Personal 
Social Services (HPSS) in Northern Ireland.
A35-1. What arrangements will be made for insurance and/or indemnity to meet the potential legal liability of the 
sponsorfs) for harm to participants arising from the management of the research?
Note: Where a NHS organisation has agreed to act as the sponsor, indemnity is provided through NHS schemes. Indicate if this 
applies (there is no need to provide documentary evidence). For all other sponsors, describe the arrangements and provide 
evidence.
O NHS indemnity schem e will apply
0 Other insurance or indemnity arrangements will apply (give details below)
This project is part of Sw ansea University educational qualification and therefore, they will act as sponsor and 
provide indemnity cover (see attached documents).
Please enclose a copy of relevant documents.
A35-2. What arrangements will be made for insurance and/or indemnity to meet the potential legal liability of the 
sponsorfs) or emploverfs) for harm to participants arising from the design of the research?
Note: Where researchers with substantive NHS employment contracts have designed the research, indemnity is provided 
through NHS schemes. Indicate if this applies (there is no need to provide documentary evidence). For other protocol authors 
(e.g. company employees, university members), describe the arrangements and provide evidence.
O  NHS indemnity schem e will apply to all protocol authors 
0 Other insurance or indemnity arrangements will apply (give details below)
This project is part of Sw ansea University educational qualification and therefore, they will act as sponsor and 
provide indemnity cover (see attached documents).
Please enclose a copy of relevant documents.
A35-3. What arrangements will be made for insurance and/or indemnity to meet the potential legal liability of 
investigators/collaborators and, where applicable, Site Management Organisations, arising from harm to participants in 
the conduct of the research?
Note: Where the participants are NHS patients, indemnity is provided through NHS schemes or through professional indemnity. 
Indicate if this applies to the whole of the study (there is no need to provide documentary evidence). Where non-NHS sites are 
to be included in the research, including private practices, describe the arrangements which will be made at these sites and 
provide evidence.
0 All participants will be recruited at NHS sites and NHS indemnity schem e or professional indemnity will apply 
O  Research includes non-NHS sites (give details of insurance/indemnity arrangements for these sites below)
Please enclose a copy of relevant documents.
A36. Has the sponsor(s) made arrangements for payment of com pensation in the event of harm to the research  
participants where no legal liability arises?
0 Yes O  No
If Yes, give details of the compensation policy:
This project is part of Sw ansea University educational qualification and therefore, they will act a s sponsor and 
provide indemnity cover (see attached documents).
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Please enclose a copy of relevant documents.
A37. How is it intended the results of the study will be reported and disseminated? (Tick as appropriate)
0  Peer reviewed scientific journals 
0  Internal report 
0  Conference presentation
□  Other publication
□  Submission to regulatory authorities
□  A ccess to raw data and right to publish freely by all investigators in study or by Independent Steering Committee on 
behalf of all investigators
0  Written feedback to research participants
l~~l Presentation to participants or relevant community groups
CD Other/none e.g. Cochrane Review, University Library
A38. How will the results of research be made available to research participants and communities from which they are 
drawn?
Research participants will receive a copy of the extended summary of the research findings and a copy will 
be supplied to a patient representation group, i.e. Arthritis Care so  that all people living with OA knee will be 
informed of the outcomes.
A39. Will the research involve any of the following activities at any stage (including identification of potential research 
participants)?(Tick as appropriate)
l~1 Examination of medical records by those outside the NHS, or within the NHS by those who would not normally have 
access
□  Electronic transfer by magnetic or optical media, e-m ail or computer networks
CD Sharing of data with other organisations
□  Export of data outside the European Union
0  U se of personal addresses, postcodes, faxes, e-m ails or telephone numbers
□  Publication of direct quotations from respondents
CD Publication of data that might allow identification of individuals
CD Use of audio/visual recording devices
0 Storage of personal data on any of the following:
CD Manual files including X-rays 
CD NHS computers 
CD Home or other personal computers 
0 University computers 
CD Private company computers 
CD Laptop computers
Further details:
All information gathered from this study will be held on a password protected University computer.
NHS REC Application Form -  Version 5.6 15 AB/132691/1
Date: 21/08/2008 Reference: 08/WMW02/76 Online Form
A40. What measures have been put in place to ensure confidentiality of personal data? Give details of whether any 
encryption or other anonymisation procedures have been used and at what stage:
On recruitment, participant details will be allocated a number. Patient details will only be accessib le by the 
researchers involved.
A41. Where will the analysis of the data from the study take place and by whom will it be undertaken?
Analysis of data will take place in Sw ansea University by the chief investigator.
A42. Who will have control of and act as the custodian for the data generated by the study?
As the study is part of an educational project, chief custodian will be the supervisor working alongside the 
chief investigator.
A43. Who will have a ccess  to research participants' or potential research participants' health records or other personal 
information? Where access is by individuals outside the normal clinical team, justify and say whether consent will be  sought.
N/A
A44. For how long will data from the study be stored?
10 Years Months
Give details of where they will be stored, who will have access and the custodial arrangements for the data:
Data will be stored in an electronic archive which is password protected held on a password protected computer 
at Sw ansea University. Data will be held in accordance with the Data protection act 1998
A45-1. How has the scientific quality of the research been a sse sse d ?  (Tick as appropriate)
□  Independent external review
□  Review within a company
CU Review within a multi-centre research group 
0  Review within the Chief Investigator's institution or host organisation 
0  Review within the research team  
0 Review by educational supervisor
□  Other
A45-2. How have the statistical a sp ects of the research been reviewed? (Tick as appropriate)
□  Review by independent statistician commissioned by funder or sponsor
□  Other review by independent statistician 
O  Review by company statistician
0  Review by a statistician within the Chief Investigator’s  institution 
0 Review by a statistician within the research team or multi-centre group 
0 Review by educational supervisor
□  Other review by individual with relevant statistical expertise
In all cases give details below of the individual responsible for reviewing the statistical aspects. If advice has been provided
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in confidence, give details of the department and institution concerned.
Department: 
Institution: 
Work Address:
Postcode:
Telephone:
Fax:
Mobile:
E-mail:
Title:
Dr
Forename/Initials:
Gareth
School of Health Science 
Sw ansea University 
Sw ansea University 
Glyndwr Building 
Singleton Park, Sw ansea  
SA2 8PP  
01792602026
j.g.noble@ swansea.ac.uk
Surname:
Noble
Please enclose a copy of any available comments or reports from a statistician.
Question(s) 4 6 -4 7  disabled.
A48. What is the primary outcom e m easure for the study?
WOMAC Scale
A49. What are the secondary outcom e m easu res?///any)
Knee Range of Movement, Numerical Rating scale for pain.
A50. How many participants will be recruited?
If there is more than one group, state how many participants will be recruited in each group. For international studies, say how 
many participants will be recruited in the UK and in total.
Three groups of twelve participants. Therefore 36 participants in total.
A51. How w as the number of participants decided upon?
Due the limitation in the amount of previously published research in the area of combined exercise therapy and 
interferential therapy; this research project is designed to be a feasbility based study, as described by the 
Medical Research Council. Feasibility studies, pilot studies and phase II trials are viewed as preparatory studies 
essential for determining the most appropriate questions for the next generation of phase III trials. Therefore, we 
are testing the protocol in order to generate the information needed to complete a sam ple size calculation for the 
next phase of the clinical study.
If a formal sample size calculation was used, indicate how this was done, giving sufficient information to justify and 
reproduce the calculation.
A52. Will participants be allocated to groups at random?
® Y e s  O  No
If yes, give details of the intended method of randomisation:
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A randomisation list will be generated on participants inclusion in the study. Patient details will be allocated to a 
number on inclusion to the study. Numbers 1 -3 6  will be placed in an envelope and randomly assigned to a 
treatment group.
A53. Describe the m ethods of analysis (statistical or other appropriate m ethods, e .g . for qualitative research) by which 
the data will be evaluated to meet the study objectives.
The primary analysis for this study is to examine 'cause and effect' by comparing each of the experimental 
groups individually to the control. In this research design, each of the participants in the separate 
experimental groups will be the sam e participant, thus making this a sam e-subject design. The statistical 
analysis for this would either be McNemar for ordinal level data, (e.g. Quality of Life) and for the interval/ratio 
level data, (eg. Range of Movement) it would be the Wilcoxon test (if the data is considered non-parametric) 
or the related t test (if considered parametric). In order for an overal comparison between all groups, an 
O ne-w ay ANVOA with appropriate post-hoc tests will be utilised due to the comparisons of groups 
consisting of different participants.
A54. Where will the research take p lace?(Tick as appropriate) 
0  UK
□  Other states in European Union
I~1 Other countries in European Economic Area
□  Other
If Other, give details:
A55. Has this or a similar application been previously rejected by a Research Ethics Committee in the UK, the European 
Union or the European Economic Area?
O Yes ®  No
A56. In how many and what type of host organisations (NHS or other) in the UK is it intended the proposed study will 
take place?
Indicate the type of organisation by ticking the box and give approximate numbers if known:
Number of 
organisations
0  Acute teaching NHS Trusts 1
□  Acute NHS Trusts
□  NHS Primary Care Trusts or Local Health Boards in W ales
□  NHS Trusts providing mental healthcare 
ED NHS Health Boards in Scotland
ED HPSS Trusts in Northern Ireland 
ED GP Practices 
ED NHS Care Trusts
□  Social care organisations
□  Prisons
EH Independent hospitals
□  Educational establishments
□  Independent research units
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Other:
A57. What arrangements are in place for monitoring and auditing the conduct of the research?
Sw ansea  University, by acting as sponsor has a monitoring and auditing procedure for all post graduate 
research via the research student committee.
A57a. Will a data monitoring committee be convened?
O Y es ®  No
If Yes, details of membership of the data monitoring committee (DMC), its standard operating procedures and summaries of 
reports of interim analyses to the DMC must be  forwarded to the NHS Research Ethics Committee which g ives a favourable 
opinion of the study.
What are the criteria for eiectively stopping the trial or other research prematurely?
A58. Has external funding for the research been secured?
®  Y es O  No
If Yes, give details of funding organisation(s) and amount secured and duration:
Organisation: Sw ansea University
Address: Singleton Park 
Sw ansea
Post Code: SA2 8PP
UK contact: Deborah Fitzsimions
Telephone: 01792 518531
Fax:
Mobile:
E-mail:
Amount (£): 2240 Duration: 18 Months
A59. Has the funder of the research agreed to act as sponsor a s se t out in the Research Governance Framework?
®  Y es O  No
Has the employer of the Chief Investigator agreed to act as sponsor of the research?
(•)  Y es O  No
Lead sponsor (must be completed in all cases)
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Naime of organisation which will act as the lead sponsor for the research:
S w an sea  University
Status:
O  NHS or HPSS care organisation ®  Academic O  Pharmaceutical industry 0  Medical device industry O  Other
If Other, please specify:
Address: Sw ansea University, Singleton Park, Sw ansea
Post Code: SA 28P P
Telephone: 01792205678
Fax.- +44 (0) 1792 295157
Mobile:
E-mail:
S ponsor's UK contact point for correspondence with the main REC (must be completed in all cases)
Title: Dr Forename/Initials: Gareth Surname: Noble
Work Address: Sw ansea University
Glyndwr Building
Singleton Park, Sw ansea
Post Code: SA 28P P
Telephone: 01792 602026
Fax:
Mobile:
E-mail: j.g.noble@ swansea.ac.uk
C o-sp on sors
Are there any co -sp o n so r s  for this research?
O  Yes ®  No
A60. Has any responsibility for the research been delegated to a subcontractor?
O Yes ®  No
A61. Will individual researchers receive any personal payment over and above normal salary for undertaking this 
research?
O  Yes ®  No
A62. Will individual researchers  receive any other benefits or incentives for taking part in this research?
Q Y e s  ® N o
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A63. Will the h o st organisation  or the researcher's departm ent(s) or institution(s) receive  any paym ent or b en efits  in 
e x c e s s  o f th e  c o s t s  of undertaking the research?
O Y es 0  No
A64. D o e s  the Chief Investigator or any other investigator/collaborator have any direct personal involvem ent (e .g . 
financiial, sh are-h o ld in g , personal relationship etc.) in the organisations sp on sor in g  or funding the research  that m ay  
g iv e  r ise  to  a p o ss ib le  con flict of interest?
Q Y es 0 No
A65. R esearch  reference num bers: (give any relevant references for your study):
Applicant's/organisation's own reference number, e.g. R&D (if available): 
Sponsor's/protocol number:
Funder's reference number:
International Standard Randomised Controlled Trial Number (ISRCTN): 
CliinicalTrials.gov Identifier (NCT number):
Project website:
A66. O ther key investigators/collaborators (all grant co-applicants or protocol co-authors should be listed)
Tittle: Forename/Initials: Surname:
Post:
Qualifications:
Organisation:
Work Address:
Postcode:
Telephone:
Fax:
Mobile:
E-mail:
A67. W hat arrangem ents are being m ade for continued provision of the intervention for participants, if appropriate, 
o n ce  the research  h as fin ish ed ?  May apply to any clinical intervention, including a drug, medical device, mental health 
intervention, complementary therapy, physiotherapy, dietary manipulation, lifestyle change, etc.
On completion of the research, participants will be offered conventional physiotherapy within Abertawe 
Bro-Morgannwg University Trust.
A68. O verview  of the research
To provide all the information required by the REC, we ask a number of specific questions. This section invites you to give an 
overview using language comprehensible to lay reviewers and members of the public. Please read the guidance notes for 
advice on this section.
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A 68-1I. Lay sum m ary. Please provide a brief summary of the research (maximum 300 words) in lay language. This summary 
will b e ? published on the website of the National Research Ethics Service following the ethical review.
Osteo-Arthritis (OA) of the knee is a very common m usculo-skeletal disorder suffered by millions of people 
throughout the world. The most common type of OA is that affecting the knee. Treatment includes the use of 
medication, physiotherapy and surgery. Physiotherapy treatment is a common form of treatment used to treat 
OA of the knee. Two commonly used treatment techniques used by physiotherapists are exercise therapy and a 
type of treatment called Interferential therapy (IFT). IFT u ses electrical im pulses to block pain transmission in the 
painful joint. The evidence behind the use of exercise therapy to treat OA Knee is fairly substantial, however the 
research behind the use of IFT is fairly limited, and research supporting the u se  of combined exercise therapy 
and IFT is even more sparse. The aim of this pilot study is to a s s e s s  the effectiveness of the combined use of 
exercise therapy and IFT in the treatment of OA knee. The effectiveness of the treatments will be evaluated 
using commonly used outcome measures. Patients will undergo three w eeks of treatment, with outcome 
m easures being taken before and after the treatment intervention.
It is hoped that the results of this study will drive future treatment protocols and add to the body of research 
supporting the u se of combination therapies.
A 6 8 -2 . Summ ary of main is su e s . Please summarise the main ethical and design issues arising from the study and sa y  how 
you hiave addressed them.
If participants percieve a benefit of treatment, participants will be offered extended treatment on completion of 
the study.
Questiion(s) 69 disabled.
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A70. G ive details of the educational cou rse  or degree for w hich th is research is  bein g  undertaken:
Name of student: 
Craig Dyson
Name and level of course/degree: 
MPhil
Name of educational establishment:
School of Health Sciences, Sw ansea University
Name and contact details of educational supervisor:
Dr Gareth Noble,
Glyndwr Building,
Singleton Park,
Sw ansea University,
Sw ansea,
SA 28P P
A71. Declaration of educational supervisor
I have read and approved both the research proposal and this application for the ethical review. I am satisfied that the scientific 
content of the research is satisfactory for an educational qualification at this level. I undertake to fulfil the responsibilities of a 
supervisor as set out in the Research Governance Framework for Health and Social Care.
Signature: ...........................
Print Name:
Date: (dd/mm/yyyy)
A one-page summary of the supervisor's CV should be submitted with the application
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Declaration by Chief Investigator
1. The information in this form is accurate to the best of my knowledge and belief and I take full responsibility for it.
2 . 1 undertake to abide by the ethical principles underlying the Declaration of Helsinki and good practice guidelines on 
the proper conduct of research.
3. If the research is approved I undertake to adhere to the study protocol, the terms of the full application of which the 
main REC has given a favourable opinion and any conditions set out by the main REC in giving its favourable 
opinion.
4 . 1 undertake to seek  an ethical opinion from the main REC before implementing substantial amendments to the 
protocol or to the terms of the full application of which the main REC has given a favourable opinion.
5 . 1 undertake to submit annual progress reports setting out the progress of the research.
6 . 1 am aware of my responsibility to be up to date and comply with the requirements of the law and relevant 
guidelines relating to security and confidentiality of patient or other personal data, including the need to register 
when necessary with the appropriate Data Protection Officer.
7. I understand that research records/data may be subject to inspection for audit purposes if required in future.
8. I understand that personal data about me as a researcher in this application will be held by the relevant RECs and 
their operational managers and that this will be managed according to the principles established in the Data 
Protection Act.
9. I understand that the information contained in this application, any supporting documentation and all 
correspondence with NHS Research Ethics Committees or their operational managers relating to the application:
-  Will be held by the main REC until at least 3 years after the end of the study.
-  May be disclosed to the operational managers or the appointing body for the REC in order to check  
that the application has been processed correctly or to investigate any complaint.
-  May be seen  by auditors appointed by the National Research Ethics Service to undertake 
accreditation of the REC.
-  Will be subject to the provisions of the Freedom of Information Acts and may be disclosed in 
response to requests made under the Acts except where statutory exemptions apply.
10. I understand that information relating to this research, including the contact details on this application, may be held 
on national research information system s, and that this will be managed according to the principles established in 
the Data Protection Act 1998.
11.1 understand that the lay summary of this study will be published on the website of the National Research Ethics 
Service (NRES) as it appears in this application. Publication will take place no earlier than 3 months after issue of 
the ethics committee's final opinion or the withdrawal of the application.
Optional -  please tick as appropriate:
□  I would be content for members of other RECs to have a ccess  to the information in the application in confidence for 
training purposes. All personal identifiers and references to sponsors, funders and research units would be removed.
Signature: .............................................
Print Name:
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Date: (dd/mm/yyyy)
Declaration by the sponsor's representative
if there is more than one sponsor, this declaration should be  signed on behalf of the co-sponsors by a representative of the 
sponsor nominated to take the lead for the REC application.
I confirm that:
1. This research proposal has been discussed with the Chief Investigator and agreement in principle to sponsor the 
research is in place.
2. An appropriate process of scientific critique has demonstrated that this research proposal is worthwhile and of high 
scientific quality.*
3. Any necessary indemnity or insurance arrangements, a s described in question A35, will be in place before this 
research starts.
4. Arrangements will be in place before the study starts for the research team to a cce ss  resources and support to 
deliver the research as proposed.
5. Arrangements to allocate responsibilities for the management, monitoring and reporting of the research will be in 
place before the research starts.
6. The duties of sponsors set out in the NHS Research Governance Framework for Health and Social Care will be 
undertaken in relation to this research.**
7 . 1 understand that the lay summary of this study will be published on the website of the National Research Ethics 
Service (NRES) as it appears in this application. Publication will take place no earlier than 3 months after issue of 
the ethics committee's final opinion or the withdrawal of the application.
* Not applicable to student research (except doctoral research).
** Not applicable to research outside the scope of the Research Governance Framework.
Signature: ..........................
Print Name:
Post:
Organisation:
Date: (dd/mm/yyyy)
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D oes this application relate to a research site for which the NHS (or HPSS in Northern Ireland) is responsible or to a 
non-NH S research site?
©  NHS site 
0  Non-NH S site
For HPSS sites in Northern Ireland, separate arrangements are in place for R&D applications. There is no need to 
complete questions marked "R&D only” on this form.
This question must be completed before proceeding. The filter will customise the form, disabling questions which are not 
relevant to this application.
In which country is the research site located?
0  England 
0  W ales 
0  Scotland 
O  Northern Ireland
The data in this box is populated from Part A:
Short title and version number:
A ssessing the effect of Exercise Therapy and IFT on OA Knee
Name of NHS Research Ethics Committee to which application for ethical review is being made:
Project reference number from above REC: 08/WMW02/76
Name of NHS care organisation to which application is being made for permission to 
conduct the research:
NHS organisation reference (for R&D office use only):
1. Title of the research (populated from A1)
Full title: A ssessing the effect of Exercise Therapy and Interferential Therapy on OA Knee: A feasability study.
Key words: Osteoarthritis
OA
Arthritis
Exercise
Exercise Therapy 
Rehabilitation 
Active Rehabilitation 
Physical Therapy 
Physiotherapy 
Physical Activity 
Electrotherapy 
Electrical Stimulation 
TENS
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IFT
US
Ultrasound 
PSWD 
Knee OA
2. Name of Chief Investigator (populated from A2)
Title: Forename/Initials: Surname: 
Mr Jonathan C Dyson
3. Name of organisation acting a s lead sponsor for the study (populated from A59) 
Sw ansea University
4. Research reference numbers if known (populated from A65) 
Applicant's/organisation's own reference number, e.g . R&D: 
Sponsor’s/protocol number:
Funder's reference number:
International Standard Randomized Controlled Trial Number (ISRCTN): 
ClinicalTrials.gov Identifier (NCT number):
Project website:
6. Give the name of the NHS site within or through which the research will take place under the responsibility of the 
PI or Local Collaborator. Please give the name only. Further details of locations should be given in question 8. The name of 
the site is normally the name of the relevant NHS organisation. Each NHS general or dental practice is a separate site unless 
a formal consortium/network is in place.
Abertawe Bro-Morgannwg University Health Trust 
Is this a primary care site?
Q V e s  © N o
If Yes, give the name of the primary care organisation responsible for the site below:
8. Specify all locations, departments, groups or units at which or through which research procedures will be 
conducted at this site and describe the activity that will take place.
List all locations/departments etc where research procedures will be conducted within the NHS organisation, describing the 
involvement in a few words. Where access to specific facilities will be required these should also be listed for each location.
Name the main location/department first. Include details of any centres at other NHS organisations where potential participants 
may be seen or referred for inclusion in the research at this site. Give details of any research procedures to be carried out off 
site, for example in participants' homes.
Location Activity/facilities
1 Physiotherapy 
Department, 
Singleton Hospital, 
Sketty Lane, 
Swansea,
SA28QA
Physiotherapy Department. All equipment needed for the study is available at the location. 
Data collection to take place at this site.
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2
12. Who is the Principal Investigator or Local Collaborator for this research at this site?
Post:
Qualifications: 
Organisation: 
Work Address:
Postcode:
E-mail:
Title: Forename/Initials: Surname: 
Mr P Dowdeswell
Physiotherapy Manager
Abertawe Bro-Morgannwg University Health Trust 
Physiotherapy Department, Singleton Hospital 
Sketty Lane 
Sw ansea  
SA2 8QA
Telephone: 01792 285383  
Fax:
Mobile:
R&D Only
a) Will this person interact with research participants, their organs, tissue or data in a 
way that has a direct bearing on the quality of care?
Q Y e s © N o
b) D oes this person hold a current substantive or honorary contract with the NHS 
organisation or accepted by the NHS organisation?
©  Yes © N o
Please provide a copy of the c.v. for the PI.
If an honorary contract is held, a copy of the contract should be submitted, unless previously provided to the R&D office.
14. Give details of all other members of the research team at this site, including academ ic supervisors and all people 
who will interact with research participants, their organs, tissu e or data in a way that has a direct bearing on the 
quality of care.
1. Research Member
Title: Forename/Initials: Surname:
Mr Ron Van
Heeswijk
Employing Abertawe Bro-Morgannwg University Health Trust
organisation:
Post: Physiotherapist
Qualifications:
Role in research researcher 
team:
R&D Only
a) Will this person interact with research participants, their organs, tissue or data in a 
way that has a direct bearing on the quality of care?
Q Y e s © N o
b) D oes this person hold a current substantive or honorary contract with the NHS 
organisation or accepted by the NHS organisation?
© Y e s Q N o
Please provide a copy of the c.v. for the research team member.
If an honorary contract is held, a copy of the contract should be submitted, unless previously provided to the R&D
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| office.
15. D oes the Principal Investigator or any other m em ber of the s ite  research team  have any direct personal 
involvem ent (e.g. financial, sh are-h o ld in g , personal relationship etc) in th e organisation  sp on sor in g  or funding the  
research that may g ive rise to  a p o ss ib le  conflict of interest?
Q  Yes 0  No
If Yes, give further details:
16. What is the proposed  local start and end date for the research  at th is s ite?
Start date: (dd/mm/yyyy)
Duration (Months):
End date: (dd/mm/yyyy)
17. Summary of the research (populated from A10-1 )
The purpose of the planned study is to s e e  whether the combination of exercise therapy and interferential therapy is 
more beneficial than either intervention alone when treating patient with osteo-arthritis of the knee.
It is planned to take thirty-six subjects, aged 4 5 -7 0  all suffering with Osteo-arthritis (OA) of the knee who will be 
recruited from specialist GP clinics and consultant clinics around Abertawe Bro-Morgannwg University NHS Trust. 
Subjects will have been referred into these clinics by their GP.
Inclusion Criteria are as follows:
1. Age 4 5 -70
2. Confirmed osteo-arthritis (OA) of the knee by way of radiological investigation (X-Ray).
3. Osteo-arthritis a s defined by (Altman 1986), i.e. the patient experiences pain and any five of the following:
1. Over 50 years of age,
2. Less than 30 minutes of morning stiffness,
3. Crepitus (noisy, grating sound) on active motion,
4. Bony tenderness,
5. Bony enlargement,
6. No palpable warmth of synovium,
7. Erythrocyte sedimentation rate (ESR) less than 40 mm/hr,
8. Rheumatoid factor less than 1 :40 titer (agglutination method),
9. Synovial fluid signs.
Patients will be excluded from the study if they:
1. Have had any other treatment in the previous six w eeks
2. Have any other medical condition which could explain their current complaints.
3. Have Kellgren Grade IV OA (large osteophytes (bony growths), marked joint sp ace  narrowing, severe sclerosis 
(hardening of the cartilage) and definite deformity of bone ends. This is applied when X -Ray show s a very high level 
of OA presence)(Kellgren 1957).
4. Are primarily suffering with patello-femoral joint OA (Osteo-arthritis of another joint)
5. Are contra-indicated for exercise treatment or Interferential Treatment (IFT). Contraindications for IFT are as 
follows: Patients w hose skin are easily damaged or bruised, patients who are on anti-coagulation therapy, patients 
with pacemakers, patients who have active malignancy. Contraindications to exercise therapy are as follows: Any 
uncontrolled cardiac conditions(aortic stenosis,cardiac enlargement,dysrhythmias,ventricular
aneurysm,cardiomyopathy .congestive heart failure) or uncontrolled metabolic disorders (Diabetes, thyrotoxicosis, 
myxedema.)
6. Are unable to read and understand English.
Procedure
Patients will be a ssessed  for their suitability for the study in the GP/consultant clinic. If suitable, subjects will be given 
an information sheet about the study s e e  attached). The information sheet will contain details of the investigation and
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state that they have the right to withdraw from the study at any time. The information sheet will also contain the 
contact details of the Chief Investigator. Subjects will be instructed to contact the Chief investigator if they wish to be
included in the study. On contact with the Chief Investigator, patient name and contact details will be taken, and th ese
details will be allocated to a number for randomisation. An appointment will be made to meet a physiotherapist who 
will act as the a ssessor  of patient outcome. The physiotherapist will be blinded to the patient treatment. Informed 
consent will be obtained via a consent form issued prior to the start of the data collection process by the blinded 
physiotherapist. The blinded physiotherapist will carry out the following outcome m easures during the initial 
assessm ent:
1. WOMAC Scale which consists of 24 questions, each corresponding to a visual analogue scale, designed to 
measure patients perceptions’ of pain, stiffness and dysfunction.
2. Numerical Rating Scale (NRS) pain score. This is a numerical rating scale between 0 -1 0 . The patient is asked to 
rate their current pain on a scale of 0 -1 0  with 0 meaning no pain and 10 meaning the worst pain imaginable.
3. Range of Movement. This will be a measurement of the patients knee flexion 
and extension by the blinded physiotherapist.
This collection of data should take 20 minutes.
Following collection of the data, patients will be given another appointment three w eeks following the initial 
assessm ent. This three week period will act a s the control period. After three w eeks, patients will again be a sse ssed  
by the sam e blinded physiotherapist using the sam e outcome measures, and will com m ence the treatment procedure 
that they will have been randomly allocated.
Patients will be randomly allocated into one of three groups:
1. Interferential Therapy only group
2. Exercise Therapy only Group
3. Combined therapy group
IFT Group
Patients in the IFT group will receive IFT twice a week, for three w eeks, i.e. six se ssio n s in total. Each session  will 
last for twenty-five minutes and IFT will be concentrated on the painful knee. Standardized IFT stimulation 
parameters for pain relief will be used: carrier frequency 3.85kHz; 8 0 -1 20Hz sw eep; pulse duration 1301/4S. Four 
electrodes will be placed around the knee joint so as to concentrate the effect of the IFT into the centre of the joint 
and will be attached via a velcro strap to ensure maximum skin contact.
IFT will be administered by the chief investigator.
Exercise Therapy Group
Patients in the exercise therapy group will also be treated twice a w eek for twenty minutes. The session  will be 
broken up into the following format:
1. Warm up using static exercise bike x 3min at slow pace.
2. 6 exercise stations. Patient to exercise at each station for 4 0sec  with 30 se c  for change of station. Patient to 
complete circuit 3 times.
3. Warm down using static bike x 3min at slow pace
For example, each patient will do a warm up followed by the following circuit three times. After doing the circuit three 
times the patient will do the warm down.
Participants will carryout the following commonly used exercises:
1. Inner Range Quads in long sitting (sitting with legs on plinth and contracting thigh muscle).
2. Single Leg Balance. (Balancing on one leg)
3. Straight Leg Raise (sitting with legs on plinth and, keeping the leg straight, lifting the leg 2 - 3 ” off the bed).
4. Step Up Exercise (stepping up onto a step)
5. Passive Knee Flexion (the participant pulls their knee into a bent position)
6. Hamstring Curl (the participant lies on their front and bends their knee against gravity).
Patients in the Exercise group will be supervised by the chief investigator. Patients will be encouraged to continue 
with the exercises at home.
Combined Group
Patients in the IFT and Exercise group will do the above exercise regime and then receive 25 minutes of IFT set at 
the above parameters.
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Control Group
Patients will act as their own control as they will be a sse ssed  following initial recruitment, wait three w eeks to simulate 
a control period, then be a sse ssed  again prior to starting the treatment. For any patients complaining of increased 
symptoms following an exercise period, their exercise protocol would be modified accordingly on the opinion of the 
supervising physiotherapist.
Following completion of the study, patients will be offered conventional physiotherapy.
The second set of outcome m easures will be recorded at least 48 hours after the last set of exercises to allow for any 
post-exercise stiffness.
Patients will be advised to continue using any medication prescribed prior to the start of the study, but will be 
excluded if any changes in analgesic medication occur during the study.
Patient name and contact details will be allocated to a reference number on allocation to the study. This data will be 
stored on password controlled university computers at Sw ansea University. This data will only be accessed  by the 
Chief investigator and the research team. All a ssessm ent data recorded during the study will be kept in a sealed  
container in a lockable cabinet in Singleton Hospital. This will be accessed  by the blinded physiotherapist carrying out 
the assessm ent, and the Chief investigator. Following completion of the study, all data will be stored at Sw ansea  
University for 10 years in compliance with the Data Protection Act 1998.
18. Details of clinical interventions (populated from A12  where enabled)
Additional
Intervention
A verage num ber per 
participant
A verage 
tim e taken
D etails of additional intervention or procedure, w ho will 
undertake it, and w hat training they have received.
Routine
Care
R esearch
Other 0 6 25mins Intervention is exercise therapy to be delivered over 6 stations, 
each lasting for 40seconds per station. Participants will 
exercise at each station 3 times per session  and do 2 session s  
per w eek over 3 weeks.Therefore the total treatment time will 
be 150mins.
Other 0 6 25mins Interferential Therapy (IFT) which will be delivered for 
25minutes, twice a w eek over three w eeks. Therefore total 
treatment time will be 150mins
19. Details of non-clin ica l interventions (populated fromA13 where enabled)
Additional Intervention A verage number 
per participant
A nticipated  
average tim e  
taken
Details of additional 
intervention or procedure, 
w ho will undertake it, and  
what training they have  
received .
20. Will any a sp e c ts  of the research  at th is s ite  be con d u cted  in a different w ay to  that d escrib ed  in Parts A and B or 
the study protocol?
0  Yes 0  No
If Yes, explain and give reasons.
NHS REC Application Form -  Version 5.6 31
Date: 21/08/2008 Reference: 08/WMW02/76 Online Form
21. How m any research participants/sam ples is  it exp ected  will be recruited/obtained from th is s ite?
22. Give d eta ils  of how potential participants will be identified locally and w ho will be m aking th e  first approach to  
them  to  take part in the study?
23. W ho will be respon sib le  for obtaining informed co n sen t at th is s ite?  What exp ertise  and training do  th e se  p erso n s  
have in obtaining co n sen t for research p u rp oses?
1 □ Mr P Dowdeswell
2 D Mr Ron Van Heeswijk
27. Is there a con tact point w here potential participants can se e k  independent ad v ice  about participating in the  
study?
_________________________________________ R&D Only
28. P lea se  provide a copy  on headed paper of th e  participant information sh e e t and c o n sen t form that will be u sed  
locally. This must be the same generic version submitted to/approved by the main REC for the study while including relevant 
local information about the site, investigator and contact points for participants (see guidance notes).
If you consider that changes should be made to the generic content of the information sheet to reflect site-specific issues in 
the conduct of the study (see 20), give details below. A substantial amendment may need to be discussed with the Chief 
Investigator and submitted to the main REC.
29. What arrangem ents have been  m ade for participants w ho might not adequately  understand verbal exp lanation s or 
written information given  in English, or w ho h ave sp ec ia l com m unication n e e d s?  (e.g. translation, use of interpreters 
etc.) (Populated from A29)
Patients who do not understand English will be excluded from the study.
What local arrangem ents have been  m ade to  m eet th e se  requirem ents (w here applicable)?
30. What arrangem ents will be m ade to  inform the GP or other health care p ro fessio n a ls  resp on sib le  for the care of 
the participants?
33. What arrangem ents (e.g. facilities, staffing, p sy ch o so c ia l support, em ergen cy  procedures) will be in p lace  at the  
site , w here appropriate, to m inim ise the risks to participants and staff and deal with th e  c o n se q u e n c e s  of any harm?
R&D Only
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35. What are the arrangements for the supervision of the conduct of the research at this site? Give name and contact 
details of any supervisor not already listed in the application.
___________________________________________________________________________________________________  R&D Only
37. Will any external funding be provided for the research at this site?
O  Yes 0  No
If Yes, indicate the source and details of the funding:
R&D Only
38. Which organisation will receive and manage this funding?
R&D Only
39. Authorisations required prior to R&D approval
This section deals with authorisations by managers within the NHS organisation. It should be signed in accordance with the 
guidance provided by the NHS organisation. This may include authorisation by line managers, service managers, support 
department managers, pharmacy, data protection officers or finance managers, depending on the nature of the research. 
Managers completing this section should confirm in the text what the authorisation means, in accordance with the guidance 
provided by the NHS organisation. This section may also be used by university employers or research staff to provide 
authorisation to NHS organisations, in accordance with guidance from the university.
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D eclaration by Principal Investigator or Local Collaborator
1. The information in this form is accurate to the best of my knowledge and I take full responsibility for it.
2 . 1 undertake to abide by the ethical principles underpinning the World Medical Association's Declaration of 
Helsinki and relevant good practice guidelines in the conduct of research.
3. If the research is approved by the main REC and NHS organisation, I undertake to adhere to the study protocol, 
the terms of the application of which the main REC has given a favourable opinion and the conditions requested  
by the NHS organisation, and to inform the NHS organisation within local timelines of any subsequent 
amendments to the protocol.
4. If the research is approved, I undertake to abide by the principles of the Research Governance Framework for 
Health and Social Care.
5 . 1 am aware of my responsibility to be up to date and comply with the requirements of the law and relevant 
guidelines relating to the conduct of research.
6. I undertake to disclose any conflicts of interest that may arise during the course of this research, and take 
responsibility for ensuring that all staff involved in the research are aware of their responsibilities to disclose  
conflicts of interest.
7 . 1 understand and agree that study files, documents, research records and data may be subject to inspection by 
the NHS organisation, the sponsor or an independent body for monitoring, audit and inspection purposes.
8. I take responsibility for ensuring that staff involved in the research at this site hold appropriate contracts for the 
duration of the research, are familiar with the Research Governance Framework, the NHS organisation's Data 
Protection Policy and ali other relevant policies and guidelines, and are appropriately trained and experienced.
9. I undertake to complete any interim and/or final reports a s requested by the NHS organisation and understand 
that continuation of permission to conduct research within the NHS organisation is dependent on satisfactory 
completion of such reports.
10. I undertake to maintain a project file for this research in accordance with the NHS organisation's policy.
11.1 take responsibility for ensuring that all serious adverse events are handled within the NHS organisation's policy 
for reporting and handling of adverse events.
12. I understand that information relating to this research, and about me as a researcher, will be held by the R&D 
office and may be held on national research information system s, and that this will be managed according to the 
principles established in the Data Protection Act 1998.
13. I understand that the information contained in this application, any supporting documentation and all 
correspondence with the R&D office and/or the REC system  relating to the application will be subject to the 
provisions of the Freedom of Information Acts and may be disclosed in response to requests made under the 
Acts except where statutory exemptions apply.
14. I understand that information relating to this research (including my contact details) may be publicly available 
through the National Research Register.
Signature of Principal Investigator 
or Local Collaborator:
Print Name:
Date:
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